 AGREEMENT AND PLAN OF
MERGER     

Exhibit 2 (A) 
 

  


  * * *

 

  


 

  

AGREEMENT AND PLAN OF MERGER

  

  

BY AND AMONG

  

  

U.S. RENAL CARE, INC.

  

  


 

  

  

URCHIN MERGER SUB, INC.

  

  


 

  

  

AND

  

  


 

  

  

DIALYSIS CORPORATION OF AMERICA

  

  


 

  

  

Dated as of April 13, 2010

   * * *

 

  

 

 

 

  

   

  

 

 

 

  

 


 

  

  


 

 

  

TABLE OF CONTENTS

  

  

Page

  

  

    

Article I

  |  

THE OFFER

   
---|--- 
 

  

  

    

  |  

Section 1.1

  |  

The Offer

  |  

2

   
---|---|---|--- 
 

  

    

  |  

Section 1.2

  |  

Company Actions

  |  

4

   
---|---|---|--- 
 

  

    

  |  

Section 1.3

  |  

Directors

  |  

5

   
---|---|---|--- 
 

  

    

  |  

Section 1.4

  |  

Top-Up Option

  |  

7

   
---|---|---|--- 
 

  

  

    

Article II

  |  

THE MERGER

   
---|--- 
 

  

  

    

  |  

Section 2.1

  |  

The Merger

  |  

7

   
---|---|---|--- 
 

  

    

  |  

Section 2.2

  |  

Effective Time

  |  

8

   
---|---|---|--- 
 

  

    

  |  

Section 2.3

  |  

Conversion or Cancellation of Company Common Stock

  |  

8

   
---|---|---|--- 
 

  

    

  |  

Section 2.4

  |  

Merger Sub Common Stock

  |  

9

   
---|---|---|--- 
 

  

    

  |  

Section 2.5

  |  

Dissenting Shares

  |  

9

   
---|---|---|--- 
 

  

    

  |  

Section 2.6

  |  

Company Options and Other Equity Interests.

  |  

9

   
---|---|---|--- 
 

  

    

  |  

Section 2.7

  |  

Articles of Incorporation; Bylaws

  |  

10

   
---|---|---|--- 
 

  

    

  |  

Section 2.8

  |  

Directors and Officers

  |  

10

   
---|---|---|--- 
 

  

    

  |  

Section 2.9

  |  

Exchange Fund

  |  

10

   
---|---|---|--- 
 

  

    

  |  

Section 2.10

  |  

Exchange of Shares

  |  

11

   
---|---|---|--- 
 

  

    

  |  

Section 2.11

  |  

Withholding

  |  

12

   
---|---|---|--- 
 

  

    

  |  

Section 2.12

  |  

Further Action

  |  

12

   
---|---|---|--- 
 

  

  

    

Article III

  |  

REPRESENTATIONS AND WARRANTIES OF THE COMPANY

   
---|--- 
 

  

  

    

  |  

Section 3.1

  |  

Corporate Organization and Qualification, Subsidiaries

  |  

12

   
---|---|---|--- 
 

  

    

  |  

Section 3.2

  |  

Articles of Incorporation and Bylaws; Minute Books

  |  

13

   
---|---|---|--- 
 

  

    

  |  

Section 3.3

  |  

Capitalization

  |  

13

   
---|---|---|--- 
 

  

    

  |  

Section 3.4

  |  

Authorization of Agreement; No Violation

  |  

15

   
---|---|---|--- 
 

  

    

  |  

Section 3.5

  |  

Consents and Approvals

  |  

16

   
---|---|---|--- 
 

  

    

  |  

Section 3.6

  |  

Regulatory Matters; Reports

  |  

16

   
---|---|---|--- 
 

  

    

  |  

Section 3.7

  |  

Financial Statements

  |  

18

   
---|---|---|--- 
 

  

    

  |  

Section 3.8

  |  

Undisclosed Liabilities

  |  

19

   
---|---|---|--- 
 

  

    

  |  

Section 3.9

  |  

Absence of Certain Changes or Events

  |  

19

   
---|---|---|--- 
 

  

    

  |  

Section 3.10

  |  

Property

  |  

22

   
---|---|---|--- 
 

  

    

  |  

Section 3.11

  |  

Contracts

  |  

23

   
---|---|---|--- 
 

  

    

  |  

Section 3.12

  |  

Compliance with Applicable Law; Permits

  |  

23

   
---|---|---|--- 
 

  

    

  |  

Section 3.13

  |  

Health Law Matters

  |  

24

   
---|---|---|--- 
 

  

    

  |  

Section 3.14

  |  

Legal Proceedings

  |  

27

   
---|---|---|--- 
 

  

    

  |  

Section 3.15

  |  

Employee Benefit Plans

  |  

27

   
---|---|---|--- 
 

  

    

  |  

Section 3.16

  |  

Taxes

  |  

29

   
---|---|---|--- 
 

  

    

  |  

Section 3.17

  |  

Intellectual Property

  |  

30

   
---|---|---|--- 
 

  

    

  |  

Section 3.18

  |  

Labor Matters

  |  

31

   
---|---|---|--- 
 

  

    

  |  

Section 3.19

  |  

Environmental Matters

  |  

31

   
---|---|---|--- 
 

  

    

  |  

Section 3.20

  |  

State Takeover Laws

  |  

32

   
---|---|---|--- 
 

  

    

  |  

Section 3.21

  |  

Insurance

  |  

33

   
---|---|---|--- 
 

  

    

  |  

Section 3.22

  |  

Interested Party Transactions

  |  

33

   
---|---|---|--- 
 

  

    

  |  

Section 3.23

  |  

Compliance with the U.S. Foreign Corrupt Practices Act and Other Applicable
Anti-Corruption Laws

  |  

33

   
---|---|---|--- 
 

  

    

  |  

Section 3.24

  |  

Opinion of Financial Advisor; Brokers

  |  

34

   
---|---|---|--- 
 

  

    

  |  

Section 3.25

  |  

No Discussions

  |  

34

   
---|---|---|--- 
 

  

    

  |  

Section 3.26

  |  

Vote Required

  |  

34

   
---|---|---|--- 
 

  

    

  |  

Section 3.27

  |  

Compensation Arrangements

  |  

34

   
---|---|---|--- 
 

  

    

  |  

Section 3.28

  |  

Company Information

  |  

35

   
---|---|---|--- 
 

  

    

  |  

Section 3.29

  |  

Full Disclosure

  |  

35

   
---|---|---|--- 
 

  

  

 

 

 

  

 

i  

  

 

 

 

  

  

    

Article IV

  |  

REPRESENTATIONS AND WARRANTIES OF PARENT AND MERGER SUB

   
---|--- 
 

  

  

    

  |  

Section 4.1

  |  

Organization and Qualification; Subsidiaries

  |  

35

   
---|---|---|--- 
 

  

    

  |  

Section 4.2

  |  

Authorization of Agreement; No Violation

  |  

35

   
---|---|---|--- 
 

  

    

  |  

Section 4.3

  |  

Consents and Approvals

  |  

36

   
---|---|---|--- 
 

  

    

  |  

Section 4.4

  |  

Parent Information

  |  

36

   
---|---|---|--- 
 

  

    

  |  

Section 4.5

  |  

Financing

  |  

37

   
---|---|---|--- 
 

  

  

    

Article V

  |  

CONDUCT PRIOR TO THE EFFECTIVE TIME

   
---|--- 
 

  

  

    

  |  

Section 5.1

  |  

Conduct of Business Prior to the Effective Time

  |  

37

   
---|---|---|--- 
 

  

    

  |  

Section 5.2

  |  

Company Forbearances

  |  

37

   
---|---|---|--- 
 

  

    

  |  

Section 5.3

  |  

Third Party Proposals

  |  

40

   
---|---|---|--- 
 

  

  

    

Article VI

  |  

ADDITIONAL AGREEMENTS

   
---|--- 
 

  

  

    

  |  

Section 6.1

  |  

Shareholders Meeting

  |  

44

   
---|---|---|--- 
 

  

    

  |  

Section 6.2

  |  

Proxy Statement

  |  

44

   
---|---|---|--- 
 

  

    

  |  

Section 6.3

  |  

Access to Information; Confidentiality

  |  

45

   
---|---|---|--- 
 

  

    

  |  

Section 6.4

  |  

Efforts; Regulatory Approvals

  |  

46

   
---|---|---|--- 
 

  

    

  |  

Section 6.5

  |  

Public Disclosure

  |  

48

   
---|---|---|--- 
 

  

    

  |  

Section 6.6

  |  

Cooperation

  |  

48

   
---|---|---|--- 
 

  

    

  |  

Section 6.7

  |  

Employee Matters

  |  

49

   
---|---|---|--- 
 

  

    

  |  

Section 6.8

  |  

Indemnification of Directors and Officers

  |  

50

   
---|---|---|--- 
 

  

    

  |  

Section 6.9

  |  

Section 16 Matters

  |  

51

   
---|---|---|--- 
 

  

    

  |  

Section 6.10

  |  

Shareholder Litigation

  |  

51

   
---|---|---|--- 
 

  

    

  |  

Section 6.11

  |  

State Takeover Laws

  |  

51

   
---|---|---|--- 
 

  

    

  |  

Section 6.12

  |  

Financing

  |  

52

   
---|---|---|--- 
 

  

    

  |  

Section 6.13

  |  

Notification

  |  

53

   
---|---|---|--- 
 

  

    

  |  

Section 6.14

  |  

Resignation of Directors and Officers

  |  

53

   
---|---|---|--- 
 

  

    

  |  

Section 6.15

  |  

NASDAQ Compliance; Delisting

  |  

53

   
---|---|---|--- 
 

  

    

  |  

Section 6.16

  |  

Payment of Company Expenses Upon Acceptance Time

  |  

53

   
---|---|---|--- 
 

  

  

    

Article VII

  |  

CONDITIONS PRECEDENT

   
---|--- 
 

  

  

    

  |  

Section 7.1

  |  

Conditions to Obligation of Each Party to Effect the Merger

  |  

54

   
---|---|---|--- 
 

  

  

    

Article VIII

  |  

TERMINATION

   
---|--- 
 

  

  

    

  |  

Section 8.1

  |  

Termination

  |  

54

   
---|---|---|--- 
 

  

    

  |  

Section 8.2

  |  

Effect of Termination

  |  

56

   
---|---|---|--- 
 

  

    

  |  

Section 8.3

  |  

Expenses and Termination Fees

  |  

57

   
---|---|---|--- 
 

  

  

 

 

 

  

 

ii  

  

 

 

 

  

  

    

Article IX

  |  

GENERAL PROVISIONS

   
---|--- 
 

  

  

    

  |  

Section 9.1

  |  

Certain Defined Terms

  |  

59

   
---|---|---|--- 
 

  

    

  |  

Section 9.2

  |  

No-Survival

  |  

71

   
---|---|---|--- 
 

  

    

  |  

Section 9.3

  |  

Specific Performance

  |  

71

   
---|---|---|--- 
 

  

    

  |  

Section 9.4

  |  

Notices

  |  

71

   
---|---|---|--- 
 

  

    

  |  

Section 9.5

  |  

Amendments and Waivers.

  |  

72

   
---|---|---|--- 
 

  

    

  |  

Section 9.6

  |  

Severability

  |  

73

   
---|---|---|--- 
 

  

    

  |  

Section 9.7

  |  

Entire Agreement

  |  

73

   
---|---|---|--- 
 

  

    

  |  

Section 9.8

  |  

Assignment

  |  

73

   
---|---|---|--- 
 

  

    

  |  

Section 9.9

  |  

No Third Party Beneficiaries

  |  

73

   
---|---|---|--- 
 

  

    

  |  

Section 9.10

  |  

Governing Law; Exclusive Jurisdiction

  |  

74

   
---|---|---|--- 
 

  

    

  |  

Section 9.11

  |  

Waiver of Jury Trial

  |  

74

   
---|---|---|--- 
 

  

    

  |  

Section 9.12

  |  

Disclosure Letters

  |  

75

   
---|---|---|--- 
 

  

    

  |  

Section 9.13

  |  

Interpretation; Rules of Construction

  |  

75

   
---|---|---|--- 
 

  

    

  |  

Section 9.14

  |  

Counterparts; Effectiveness

  |  

75

   
---|---|---|--- 
 

  

  

 

 

 

  

 

iii  

  

 

 

 

  

  

EXHIBITS

  

  

Annex I Conditions to the Offer

  

  

Annex II Persons Entering Into Employment Agreements

  

  

Exhibit "A" Articles of Incorporation of Surviving Corporation

  

  

Exhibit "B" Bylaws of Surviving Corporation

  

  


 

  

 

 

 

  

 

i  

  

 

 

 

  


 

  

AGREEMENT AND PLAN OF MERGER

  

  

THIS AGREEMENT AND PLAN OF MERGER, dated as of April 13, 2010 (this
"Agreement"), is by and among U.S. Renal Care, Inc., a Delaware corporation
("Parent"), Urchin Merger Sub, Inc., a Florida corporation and a wholly owned
subsidiary of Parent ("Merger Sub"), and Dialysis Corporation of America, a
Florida corporation (the "Company"). Unless the context clearly indicates
otherwise, capitalized terms used in this Agreement are defined in Section
9.1.

  

  

RECITALS:

  

  

WHEREAS, the board of directors of the Company (the "Company Board") has
determined that it is advisable and in the best interests of the Company and
its shareholders for Parent to acquire the Company upon the terms and subject
to the conditions set forth in this Agreement; and

  

  

WHEREAS, in furtherance of the acquisition of the Company by Parent, it is
proposed: (i) that Merger Sub make a cash tender offer to acquire all of the
issued and outstanding shares of Company Common Stock at a price of $11.25 per
share net to the seller in cash, without interest thereon and subject to any
required Tax withholding (such dollar amount, or any greater dollar amount per
share paid pursuant to such cash tender offer, subject to adjustment pursuant
to Section 1.1(e), the "Offer Price"), upon the terms and subject to the
conditions set forth in this Agreement (such cash tender offer, as it may be
amended from time to time in accordance with this Agreement, the "Offer"), and
(ii) that, after acquiring shares of Company Common Stock pursuant to the
Offer, Merger Sub merge with and into the Company, with the Company being the
surviving corporation, upon the terms and subject to the conditions set forth
in this Agreement; and

  

  

WHEREAS, the Company Board has unanimously (i) determined that this Agreement
and the transactions contemplated by this Agreement, including the Offer and
the Merger, are fair, advisable and in the best interests of the Company and
its shareholders, (ii) approved and adopted this Agreement and the
transactions contemplated by this Agreement, including the Offer and the
Merger, in accordance with the requirements of the Florida Business
Corporation Act (the "FBCA"), and (iii) resolved to recommend that the
shareholders of the Company accept the Offer, tender their shares of Company
Common Stock pursuant to the Offer and, if required by applicable Laws,
approve this Agreement and the Merger; and

  

  

WHEREAS, the board of directors of Parent has (i) determined that the Merger
is advisable and in the best interests of Parent and its stockholders, and
(ii) approved this Agreement and the transactions contemplated by this
Agreement, including the Offer and the Merger; and

  

  

WHEREAS, (i) the board of directors of Merger Sub has determined that the
Merger is advisable and in the best interests of Merger Sub and its sole
stockholder, and (ii) Parent, as sole stockholder of Merger Sub, has adopted
and approved this Agreement and the transactions contemplated by this
Agreement, including the Offer and the Merger; and

  

  

WHEREAS, immediately prior to the execution and delivery of this Agreement,
and as a condition and inducement to the willingness of Parent and Merger Sub
to enter into this Agreement and to consummate the transactions contemplated
hereby, (i) certain shareholders of the Company are executing and delivering
to Parent and Merger Sub tender and support agreements (the "Support
Agreements") and (ii) the individuals set forth on Annex II are executing and
delivering to Parent and Merger Sub amended and restated employment
agreements, effective upon the Closing, to, among other things, assist Parent
with transitional matters following the Closing (the "Employment Agreements").

  

  

 

 

 

  

 

1  

  

 

 

 

  

  

NOW, THEREFORE, in consideration of the foregoing and the mutual
representations, warranties, covenants and agreements herein contained, and
for other good and valuable consideration, the receipt and sufficiency of
which are hereby acknowledged, and intending to be legally bound hereby, the
parties hereto agree as follows:

  

  

ARTICLE I

  

  

THE OFFER

  

  

Section 1.1 The Offer.

  

  

(a) Subject to the provisions contained in the following sentence, Merger Sub
shall commence (within the meaning of Rule 14d-2 under the Exchange Act) the
Offer as promptly as reasonably practicable after the date of this Agreement.
If the Company: (i) shall have fully cooperated with Parent in connection with
the Offer and the preparation of the Offer Documents, including by promptly
providing to Parent any comments regarding the Offer Documents from the
Company and its advisors, and (ii) shall be prepared to file with the SEC, and
to disseminate to holders of Company Common Stock, the Schedule 14D-9 on the
date Parent files the Offer Documents with the SEC, then Parent shall cause
Merger Sub to, and Merger Sub shall, commence the Offer within seven (7)
Business Days after the date of this Agreement; provided, however, that Merger
Sub shall not be required to commence the Offer if (w) any of the conditions
set forth in clauses (a), (b), (c), (g), (h), (j), (k), (l) and (n) of Annex I
shall not be satisfied, or (x) the Company shall not be prepared to file
immediately with the SEC, and to disseminate to holders of shares of Company
Common Stock, the Schedule 14D-9 (the date on which Merger Sub commences the
Offer, within the meaning of Rule 14d-2 under the Exchange Act, is referred to
in this Agreement as the "Offer Commencement Date"). The obligation of Merger
Sub (and the obligation of Parent to cause Merger Sub) to accept for payment,
and pay for, any shares of Company Common Stock validly tendered pursuant to
the Offer shall be subject to the satisfaction of or (if permitted) waiver of
(y) the condition that there shall be validly tendered (not including any
shares of Company Common Stock validly tendered pursuant to procedures for
guaranteed delivery) and not withdrawn a number of shares of Company Common
Stock that, together with any shares of Company Common Stock owned by Parent
or Merger Sub immediately prior to the Acceptance Time, represents more than
50% of the Adjusted Outstanding Share Number (the "Minimum Condition"), and
(z) the other conditions set forth in Annex I hereto (the Minimum Condition
and the other conditions set forth in Annex I are referred to collectively as
the "Offer Conditions"). For purposes of this Agreement, the "Adjusted
Outstanding Share Number" shall be the sum of: (A) the aggregate number of
shares of Company Common Stock issued and outstanding immediately prior to the
Acceptance Time, plus (B) an additional number of shares up to (but not
exceeding) the aggregate number of shares of Company Common Stock issuable
upon the conversion, exchange or exercise, as applicable, of all options,
warrants and other rights to acquire, or securities convertible into or
exchangeable for, Company Common Stock that are outstanding immediately prior
to the Acceptance Time (other than potential (but not actual) dilution
attributable to the Top-Up Option). Subject to the Offer Conditions and the
terms and conditions of this Agreement, Parent shall cause Merger Sub to, and
Merger Sub shall, (1) accept for payment all shares of Company Common Stock
validly tendered (and not withdrawn) pursuant to the Offer as soon as
practicable after Merger Sub is permitted to do so under applicable Legal
Requirements, and (2) pay the Offer Price in exchange for each share of
Company Common Stock accepted for payment pursuant to the Offer.

  

  

 

 

 

  

 

2  

  

 

 

 

  

  

(b) Merger Sub expressly reserves the right, in its sole discretion, to (i)
increase the Offer Price, and (ii) waive any Offer Condition or make any other
changes to the terms and conditions of the Offer; provided, however, that
without the prior written consent of the Company, neither Parent nor Merger
Sub may (A) waive or amend the Minimum Condition, (B) change the form of
consideration to be paid to the holders of Company Common Stock pursuant to
the Offer, (C) decrease the Offer Price or the number of shares of Company
Common Stock sought to be purchased by Merger Sub in the Offer, (D) impose
conditions to the Offer in addition to the Offer Conditions, or (E) except as
provided in Section 1.1(c), extend the expiration date of the Offer.

  

  

(c) The Offer shall initially be scheduled to expire twenty (20) Business Days
following the Offer Commencement Date (determined pursuant to Rule 14d-1(g)(3)
and Rule 14e-1(a) under the Exchange Act) (the "Initial Expiration Date"; such
date or such subsequent date to which the expiration of the Offer is extended
in accordance with the terms of this Agreement, the "Expiration Date").
Notwithstanding anything to the contrary contained in this Agreement, but
subject to the parties' respective termination rights under Section 8.1: (i)
if, as of the scheduled Expiration Date, any Offer Condition is not satisfied
and has not been waived, Merger Sub may, in its sole discretion (and without
the consent of the Company or any other Person), extend the Offer on one or
more occasions, for an additional period of up to twenty (20) Business Days
per extension (but no later than the Outside Date), to permit such Offer
Condition to be satisfied, (ii) Merger Sub may, in its sole discretion (and
without the consent of the Company or any other Person), extend the Offer from
time to time for any period required by any Regulation of the SEC applicable
to the Offer, and (iii) Merger Sub may, in its sole discretion (and without
the consent of the Company or any other Person), elect to provide for a
"subsequent offering period" (and one or more extensions thereof) in
accordance with Rule 14d-11 under the Exchange Act (unless Parent has become
the owner, directly or indirectly, of 80% or more of the outstanding shares of
Company Common Stock). Subject to the parties' respective termination rights
under Section 8.1, (A) if: (1) each of the Offer Conditions set forth in
clauses (a), (b), (c), (e), (f), (g), (h), (i), (j), (k), (l), (m), and (n) of
Annex I is satisfied or has been waived as of the scheduled Expiration Date,
or Merger Sub reasonably determines that all of such Offer Conditions are
likely to be satisfied within fifteen (15) Business Days after such date, and
(2) any of the other Offer Conditions is not satisfied and has not been waived
on such date, then, to the extent requested in writing by the Company no less
than two (2) Business Days prior to such date, Merger Sub shall extend the
Offer beyond such date for an additional period of up to twenty (20) Business
Days, and (B) if each of the Offer Conditions set forth in Annex I is
satisfied or has been waived as of the scheduled Expiration Date, other than
the condition set forth in clause (m), then if such scheduled Expiration Date
is a date prior to the Designated Date, to the extent requested in writing by
the Company no less than two (2) Business Days prior to such scheduled
Expiration Date, Merger Sub shall extend the Offer to the Designated Date or
to such later date as may be required under applicable securities Laws (as
determined by Merger Sub in its reasonable discretion); provided that in the
case of either (A) or (B) in no event shall Merger Sub be required to extend
the Offer to a date later than the Outside Date.

  

  

 

 

 

  

 

3  

  

 

 

 

  

  

(d) On the Offer Commencement Date, Parent and Merger Sub shall (i) cause to
be filed with the SEC a Tender Offer Statement on Schedule TO (the "Schedule
TO") with respect to the Offer, which will contain or incorporate by reference
(A) Merger Sub's offer to purchase shares of Company Common Stock pursuant to
the Offer (the "Offer to Purchase") and (B) the forms of the related letter of
transmittal and summary advertisement (the Tender Offer Statement on Schedule
TO, the Offer to Purchase, and all exhibits, amendments and supplements
thereto, the "Offer Documents"), and (ii) cause the Offer to Purchase and
related documents to be disseminated to holders of shares of Company Common
Stock. Parent and Merger Sub shall use commercially reasonable efforts to
cause the Offer Documents to comply in all material respects with the
applicable requirements of the Exchange Act. The Company and its legal counsel
shall be given reasonable opportunity to review and comment on the Offer
Documents (including all amendments and supplements thereto) prior to filing
thereof with the SEC. Parent and Merger Sub shall promptly provide the Company
and its legal counsel with a copy of any written comments and a description of
any oral comments received by Parent, Merger Sub or their legal counsel from
the SEC or its staff with respect to the Offer Documents. Each of Parent,
Merger Sub and the Company: (1) shall use commercially reasonable efforts to
respond promptly to any comments of the SEC or its staff with respect to the
Offer Documents or the Offer and (2) to the extent required by the applicable
requirements of the Exchange Act, shall use commercially reasonable efforts to
correct promptly any information provided by it for use in the Offer Documents
if and to the extent that such information shall be or shall have become false
or misleading in any material respect, and Parent and Merger Sub shall take
all steps reasonably necessary to cause the Offer Documents, as supplemented
or amended to correct such information, to be filed with the SEC, to the
extent required by applicable Legal Requirements, and to be disseminated to
holders of shares of Company Common Stock. The Company shall promptly furnish
to Parent and Merger Sub all information concerning the Company and its
Subsidiaries and the Company's shareholders that may be required or reasonably
requested by Parent and Merger Sub in connection with any action contemplated
by this Section 1.1(d).

  

  

(e) If, between the date of this Agreement and the date on which any
particular share of Company Common Stock is accepted for payment pursuant to
the Offer, the outstanding shares of Company Common Stock are changed into a
different number or class of shares by reason of any stock split, division or
subdivision of shares, stock dividend, reverse stock split, consolidation of
shares, reclassification, recapitalization or other similar transaction, or if
a record date with respect to any such event shall occur during such period,
then the Offer Price shall be appropriately and proportionately adjusted.

  

  

Section 1.2 Company Actions.

  

  

(a) The Company hereby approves and consents to the Offer. The Company Board,
at a meeting duly called and held, has unanimously by a vote of all the
directors, (i) determined that this Agreement and the transactions
contemplated by this Agreement, including the Offer and the Merger, are fair,
advisable and in the best interests of the Company and its shareholders, (ii)
approved and adopted this Agreement and the transactions contemplated by this
Agreement, including the Offer and the Merger, in accordance with the
requirements of the FBCA, (iii) resolved to recommend that the shareholders of
the Company accept the Offer, tender their shares of Company Common Stock
pursuant to the Offer and, if required by applicable Laws, approve this
Agreement and the Merger (such unanimous recommendation, the "Company Board
Recommendation"), and (iv) taken all other actions necessary to exempt the
Offer, the Support Agreements and, to the extent required, this Agreement and
the transactions contemplated hereby, from any "fair price," "moratorium,"
"control share acquisition," "interested shareholder," "business combination,"
"affiliated transaction" or other similar Legal Requirement, including
Sections 607.0901 and 607.0902 of the FBCA. Subject to Section 5.3, the
Company consents to the inclusion of the Company Board Recommendation in the
Offer Documents.

  

  

 

 

 

  

 

4  

  

 

 

 

  

  

(b) Contemporaneously with the filing by Parent and Merger Sub of the Schedule
TO, the Company shall file with the SEC and (following or contemporaneously
with the dissemination of the Offer to Purchase and related documents)
disseminate to holders of shares of Company Common Stock a
Solicitation/Recommendation Statement on Schedule 14D-9 (together with any
amendments or supplements thereto, the "Schedule 14D-9") that shall reflect
the terms and conditions of this Agreement and the information required by
Section 1.3(c) and, subject only to Section 5.3, shall include the Company
Board Recommendation. Each of Parent and Merger Sub shall promptly furnish to
the Company all information concerning Parent and Merger Sub that may be
required or reasonably requested by the Company in connection with any action
contemplated by this Section 1.2(b). The Company shall cause the Schedule
14D-9 and the filings and dissemination thereof to comply in all material
respects with the Exchange Act and with all applicable Legal Requirements. To
the extent required by the applicable requirements of the Exchange Act or by
other Legal Requirements: (i) each of Parent, Merger Sub and the Company shall
use commercially reasonable efforts to promptly correct any information
provided by it or on its behalf for use in the Schedule 14D-9 if and to the
extent that such information shall be or shall have become false or misleading
in any material respect, and (ii) the Company shall take all steps reasonably
necessary to cause the Schedule 14D-9, as supplemented or amended to correct
such information, to be filed with the SEC and, to the extent required by
applicable Legal Requirements, to be disseminated to holders of shares of
Company Common Stock. Parent and its legal counsel shall be given a reasonable
opportunity to review and comment on the Schedule 14D-9 (including any
amendments or supplements thereto) prior to the filing thereof with the SEC.
The Company shall promptly provide Parent and its legal counsel with a copy of
any written comments and a description of any oral comments received by the
Company or its legal counsel from the SEC or its staff with respect to the
Schedule 14D-9, and the Company shall respond promptly to such comments.

  

  

(c) The Company shall promptly provide to Parent: (i) a list of the Company's
shareholders, non-objecting beneficial owners, mailing labels and any
available listing or computer file containing the names and addresses of all
record holders of shares of Company Common Stock and lists of securities
positions of shares of Company Common Stock held in stock depositories, in
each case accurate and complete as of the most recent practicable date, and
(ii) such additional information (including updated lists of shareholders,
non-objecting beneficial owners, mailing labels and lists of securities
positions) and such other assistance as Parent may reasonably request in
connection with the Offer or the Merger.

  

  

Section 1.3 Directors.

  

  

(a) Effective upon the Acceptance Time and from time to time thereafter,
Parent shall be entitled to designate, to serve on the Company Board, the
number of directors, rounded up to the next whole number, determined by
multiplying: (i) the total number of directors on the Company Board (giving
effect to any increase in the size of the Company Board pursuant to this
Section 1.3(a)), by (ii) a fraction having a numerator equal to the aggregate
number of shares of Company Common Stock then beneficially owned by Parent or
Merger Sub (including all shares of Company Common Stock accepted for payment
pursuant to the Offer), and having a denominator equal to the total number of
shares of Company Common Stock then issued and outstanding (provided that, in
no event shall Parent's director designees constitute less than a majority of
the entire Company Board). The Company shall take all action (including, to
the extent necessary, seeking and accepting the resignations of one or more
incumbent directors and increasing the size of the Company Board) necessary to
cause Parent's designees to be elected or appointed to the Company Board (the
date on which a majority of the Company's directors are designees of Parent
that have been effectively appointed to the Company Board in accordance
herewith, the "Board Appointment Date").

  

  

 

 

 

  

 

5  

  

 

 

 

  

  

(b) From and after the Acceptance Time, to the extent requested by Parent, the
Company shall also use its commercially reasonable efforts to: (i) obtain and
deliver to Parent the resignation of each individual who is an officer of the
Company or any of the Company Subsidiaries, and (ii) cause individuals
designated by Parent to constitute the number of members, rounded up to the
next whole number, on: (A) each committee of the Company Board, and (B) the
board of directors of each Company Subsidiary (and each committee thereof)
that represents at least the same percentage as individuals designated by
Parent represent on the Company Board. Notwithstanding the provisions of this
Section 1.3, the Company shall use commercially reasonable efforts, at all
times prior to the Effective Time, to cause at least two of the members of the
Company Board to be individuals who were directors of the Company on the date
of this Agreement ("Continuing Directors"); provided, however, that: (x) if at
any time prior to the Effective Time there shall be only one Continuing
Director serving as a director of the Company for any reason, then the Company
Board shall cause an individual selected by the remaining Continuing Director
to be appointed to serve on the Company Board (and such individual shall be
deemed to be a Continuing Director for all purposes under this Agreement), and
(y) if at any time prior to the Effective Time no Continuing Directors remain
on the Company Board, then the Company Board shall appoint two individuals who
are not officers, employees or Affiliates of the Company, Parent or Merger Sub
to serve on the Company Board (and such individuals shall be deemed to be
Continuing Directors for all purposes under this Agreement).

  

  

(c) In connection with the performance of its obligations to cause Parent's
designees to be elected or appointed to the Company Board, the Company shall
promptly take all actions, and shall include in the Schedule 14D-9 such
information with respect to the Company and its officers and directors, as
Section 14(f) of the Exchange Act and Rule 14f-1 thereunder require in order
to fulfill its obligations under this Section 1.3, subject to the Company's
receipt of the information with respect to Parent and its nominees, officers,
directors and Affiliates required by Section 14(f) of the Exchange Act and
Rule 14f-1 thereunder. The provisions of this Section 1.3 are in addition to,
and shall not limit, any right that Merger Sub, Parent or any Affiliate of
Merger Sub or Parent may have (with respect to the election of directors or
otherwise) under applicable Legal Requirements as a holder or beneficial owner
of shares of Company Common Stock.

  

  

(d) Following the election or appointment of Parent's designees to the Company
Board pursuant to Section 1.3(a) and until the Effective Time, the approval of
a majority of the Continuing Directors shall be required to authorize any of
the following actions of the Company (each, an "Adverse Action"), to the
extent the action in question could reasonably be expected to affect adversely
the holders of shares of Company Common Stock (other than Parent or Merger
Sub): (i) any action by the Company with respect to any amendment or waiver of
any term or condition of this Agreement, the Merger or the Company Articles or
Company Bylaws, (ii) any termination of this Agreement by the Company, or
(iii) any extension by the Company of the time for the performance of any of
the obligations or other acts of Parent or Merger Sub, or any waiver or
assertion of any of the Company's rights under this Agreement. The approval of
any Adverse Action by a majority of the Continuing Directors shall constitute
the valid authorization of the Company Board with respect to such Adverse
Action, and no other action on the part of the Company or by any other
director of the Company shall be required to authorize such Adverse Action.

  

  

 

 

 

  

 

6  

  

 

 

 

  

  

Section 1.4 Top-Up Option.

  

  

(a) The Company hereby grants to Parent and Merger Sub an assignable (provided
that any such assignment is in compliance with Section 9.8) and irrevocable
option (the "Top-Up Option") to purchase from the Company the number of newly-
issued, fully paid and nonassessable shares of Company Common Stock (the "Top-
Up Shares") equal to the lesser of: (i) the number of shares of Company Common
Stock that, when added to the number of shares of Company Common Stock owned
by Parent or Merger Sub at the time of exercise of the Top-Up Option,
constitutes 80% of the number of shares of Company Common Stock that would be
outstanding on a fully-diluted basis immediately after the issuance of all
shares of Company Common Stock subject to the Top-Up Option, or (ii) the
aggregate number of shares of Company Common Stock that the Company is
authorized to issue under the Company Articles but that are not issued and
outstanding (and are not subscribed for or otherwise committed to be issued or
reserved for issuance) at the time of exercise of the Top-Up Option.

  

  

(b) The Top-Up Option may be exercised by Parent or Merger Sub, in whole or in
part, at any time at or after the Acceptance Time. The aggregate purchase
price payable for the shares of Company Common Stock being purchased by Parent
or Merger Sub pursuant to the Top-Up Option shall be determined by multiplying
the number of such shares by the Offer Price. Such purchase price may be paid
by Parent or Merger Sub, at its election, either entirely in cash or by
executing and delivering to the Company a promissory note having a principal
amount equal to such purchase price, or by any combination of the foregoing.
Any such promissory note shall bear interest at the rate of 3% per annum,
shall mature on the first anniversary of the date of execution and delivery of
such promissory note and may be prepaid without premium or penalty.

  

  

(c) In the event Parent or Merger Sub wishes to exercise the Top-Up Option,
Parent or Merger Sub shall deliver to the Company a notice setting forth: (i)
the number of shares of Company Common Stock that Parent or Merger Sub intends
to purchase pursuant to the Top-Up Option, (ii) the manner in which the Parent
or Merger Sub intends to pay the applicable purchase price, and (iii) the
place and time at which the closing of the purchase of such shares of Company
Common Stock by Parent or Merger Sub is to take place. The Company shall, as
soon as practicable following receipt of such notice, notify Merger Sub of the
number of shares of Company Common Stock then outstanding, the number of
shares of Company Common Stock then outstanding on a fully-diluted basis and
the number of Top-Up Shares. At the closing of the purchase of such shares of
Company Common Stock, Parent or Merger Sub shall cause to be delivered to the
Company the consideration required to be delivered in exchange for such
shares, and the Company shall cause to be issued to Parent or Merger Sub (as
the case may be) a certificate representing such shares. The parties shall
cooperate to cause the issuance of the Top-Up Shares to be effected pursuant
to an exemption from registration under the Securities Act.

  

  

ARTICLE II

  

  

THE MERGER

  

  

Section 2.1 The Merger. At the Effective Time and subject to the terms and
conditions of this Agreement and the applicable provisions of the FBCA, Merger
Sub will merge with and into the Company and the separate corporate existence
of Merger Sub shall thereupon cease (the "Merger"). The Company shall be the
surviving corporation (sometimes hereinafter referred to as the "Surviving
Corporation") and shall continue to be governed by the Laws of the State of
Florida, and the separate corporate existence of the Company, with all its
rights, privileges, immunities, powers and franchises, shall continue
unaffected by the Merger, except as set forth in Section 2.7 and Section 2.8.
The effect of the Merger will be as provided in the applicable provisions of
the FBCA and the terms of this Agreement.

  

  

 

 

 

  

 

7  

  

 

 

 

  

  

Section 2.2 Effective Time.

  

  

(a) The closing of the Merger (the "Closing") shall take place at the offices
of Fulbright and Jaworski L.L.P., 2200 Ross Avenue, Suite 2800, Dallas, Texas,
75201 at 10:00 a.m. as soon as practicable, and in any event not later than
the second (2nd) Business Day following the date on which the conditions to
the Closing set forth in Article VII (excluding conditions that, by their
terms, cannot be satisfied until the Closing, but subject to the satisfaction
or waiver of such conditions at the Closing) have been satisfied or waived or
at such other place, time and date as the parties hereto may agree in writing
(the "Closing Date"). The acceptance of any shares of Company Common Stock by
Merger Sub, and the exchange of any related documentation and other
deliverables related thereto in accordance with the terms of this Agreement
and the Offer, shall take place at the offices of Fulbright and Jaworski L.L.P.,
2200 Ross Avenue, Suite 2800, Dallas, Texas, 75201 or at such other place as
the parties may agree in writing.

  

  

(b) At the Closing, the Company and Merger Sub shall cause articles of merger
(the "Articles of Merger") to be executed, acknowledged and filed with the
Secretary of State of the State of Florida in accordance with the relevant
provisions of the FBCA and other applicable Florida Law. The Merger will
become effective at such time as the Articles of Merger are duly filed with
the Secretary of State of the State of Florida on the Closing Date, or at such
subsequent date or time as the Company and Parent agree in writing and specify
in the Articles of Merger. The date and time the Merger becomes effective is
hereinafter referred to as the "Effective Time."

  

  

Section 2.3 Conversion or Cancellation of Company Common Stock.

  

  

(a) At the Effective Time, by virtue of the Merger and without any action on
the part of Parent, the Company or the holder of any of the following
securities:

  

  

(i) each share of the Company's $0.01 par value common stock (the "Company
Common Stock") issued and outstanding immediately prior to the Effective Time
(other than (A) shares of Company Common Stock held by Parent, Merger Sub or
any wholly owned Subsidiary of Parent or Merger Sub, (B) Dissenting Shares
held by Dissenting Shareholders and (C) shares of Company Common Stock held in
the Company's treasury or held by any wholly owned Subsidiary of the Company),
shall be converted into the right to receive an amount in cash per share equal
to the Offer Price, without interest (the "Merger Consideration");

  

  

(ii) each share of Company Common Stock issued and held in the Company's
treasury or held by any wholly owned Subsidiary of the Company shall (A) cease
to be outstanding, (B) be canceled and retired without payment of any
consideration therefor, and (C) cease to exist; and

  

  

(iii) each share of Company Common Stock held by Parent, Merger Sub or any
wholly owned Subsidiary of Parent or Merger Sub shall (A) cease to be
outstanding, (B) be canceled and retired without payment of any consideration
therefor, and (C) cease to exist.

  

  

(b) All shares of Company Common Stock converted into Merger Consideration
pursuant to this Section 2.3 (collectively, the "Shares"), shall no longer be
outstanding and shall automatically be cancelled and shall cease to exist as
of the Effective Time, and each certificate previously representing any such
Shares and non-certificated Shares represented by a book entry (the "Book
Entry Shares") shall thereafter represent the right to receive, with respect
to each underlying Share, the Merger Consideration.

  

  

 

 

 

  

 

8  

  

 

 

 

  

  

(c) If, prior to the Effective Time, the outstanding shares of Company Common
Stock are changed into a different number or class of shares by reason of any
stock split, division or subdivision of shares, stock dividend, reverse stock
split, consolidation of shares, recapitalization or other similar transaction,
or if a record date with respect to any such event shall occur during such
period, then an appropriate and proportionate adjustment shall be made to the
Merger Consideration.

  

  

Section 2.4 Merger Sub Common Stock. At the Effective Time, each share of
common stock, par value $0.01 per share, of Merger Sub issued and outstanding
immediately prior to the Effective Time shall, by virtue of the Merger and
without any action on the part of Parent or Merger Sub, be converted into one
validly issued, fully paid and nonassessable share of common stock, par value
$0.01 per share, of the Surviving Corporation (which shares shall not be
deemed to be shares of Company Common Stock outstanding immediately prior to
the Effective Time for purposes of this Agreement).

  

  

Section 2.5 Dissenting Shares. The provisions of this Section 2.5 shall not
apply unless the shareholders of the Company are determined to have the right
to dissent from the Merger, and receive the fair value of their shares of
Company Common Stock, pursuant to Sections 607.1301-607.1333 of the FBCA. In
such event, and notwithstanding anything in this Agreement to the contrary,
shares of Company Common Stock that are issued and outstanding immediately
prior to the Effective Time and which are held by a shareholder who did not
vote in favor of the Merger (or consent thereto in writing) and who is
entitled to demand and properly demands appraisal of such shares pursuant to,
and who complies in all respects with, the applicable provisions of the FBCA
(the "Dissenting Shareholders"), shall not be converted into or be
exchangeable for the right to receive the Merger Consideration (the
"Dissenting Shares"), but instead such holder shall be entitled to payment of
the appraised value of such shares in accordance with the applicable
provisions of the FBCA (and at the Effective Time, such Dissenting Shares
shall no longer be outstanding and shall automatically be cancelled and shall
cease to exist, and such holder shall cease to have any rights with respect
thereto, except the right to receive the appraised value of such Dissenting
Shares in accordance with the applicable provisions of the FBCA), unless and
until such holder shall have failed to perfect or shall have effectively
withdrawn or lost rights to appraisal under the FBCA. If any Dissenting
Shareholder shall have failed to perfect or shall have effectively withdrawn
or lost such right, such holder's shares shall thereupon become Shares and be
treated as if they had been converted into and become exchangeable for the
right to receive, as of the Effective Time, the Merger Consideration for each
such share of Company Common Stock in accordance with Section 2.3(a)(i),
without any interest thereon. The Company shall give Parent (a) prompt notice
of any written demands for appraisal of any shares of Company Common Stock,
attempted withdrawals of such demands and any other instruments served
pursuant to the FBCA and received by the Company relating to shareholders'
rights of appraisal, and (b) the opportunity to participate in negotiations
and Proceedings with respect to demands for appraisal under the FBCA. The
Company shall not, except with the prior written consent of Parent, make any
payment with respect to, or settle, or offer or agree to settle, any such
demand for payment.

  

  

Section 2.6 Company Options and Other Equity Interests.

  

  

(a) At the Effective Time, each option to purchase shares of Company Common
Stock issued pursuant to a Company Stock Plan that is outstanding immediately
prior to the Effective Time (each such option, a "Company Option") whether or
not then vested, shall be converted into the right to receive, at the
Effective Time, a cash payment from the Surviving Corporation equal to the
product of (i) the number of shares of Company Common Stock subject to such
Company Option, and (ii) the excess, if any, of (x) the Merger Consideration
over (y) the exercise price per share under such Company Option (such product,
the "Option Consideration").

  

  

 

 

 

  

 

9  

  

 

 

 

  

  

(b) Immediately prior to the Effective Time, each outstanding restricted stock
unit issued pursuant to a Company Stock Plan (a "Company Restricted Stock
Unit") that has not otherwise vested shall become fully vested and shall be
converted into the right to receive a cash payment from the Surviving
Corporation equal to the Merger Consideration, and each such Company
Restricted Stock Unit shall thereupon be cancelled.

  

  

(c) Immediately prior to the Effective Time, each outstanding restricted share
of Company Common Stock issued pursuant to a Company Stock Plan (each such
share, a "Company Restricted Share") that has not otherwise vested shall
become fully vested and shall be converted into the right to receive a cash
payment from the Surviving Corporation equal to the Merger Consideration, and
each such Company Restricted Stock Unit shall thereupon be cancelled.

  

  

(d) The Surviving Corporation shall pay the holders of Company Options, the
holders of Company Restricted Stock Units, and the holders of Company
Restricted Shares the cash payments described in this Section 2.6 on or as
soon as reasonably practicable after the Closing Date, but in any event within
ten (10) Business Days following the Closing Date.

  

  

(e) Prior to the Acceptance Time, the Compensation Committee of the Company
Board (the "Compensation Committee") or the Company Board, as applicable,
shall make such adjustments and amendments to or make such determinations with
respect to Company Options, Company Restricted Stock Units, and Company
Restricted Shares to implement the foregoing provisions of this Section 2.6.

  

  

Section 2.7 Articles of Incorporation; Bylaws.

  

  

(a) At the Effective Time, the Company Articles shall be amended so as to read
in their entirety as is set forth in Exhibit A annexed hereto, and, as so
amended, shall be the articles of incorporation of the Surviving Corporation
until thereafter amended in accordance with their terms and as provided by
Law.

  

  

(b) At the Effective Time, and without any further action on the part of the
Company and Merger Sub, the Company Bylaws shall be amended so as to read in
their entirety in the form as is set forth in Exhibit B annexed hereto, and,
as so amended, shall be the bylaws of the Surviving Corporation until
thereafter amended in accordance with their terms, the articles of
incorporation of the Surviving Corporation and as provided by Law.

  

  

Section 2.8 Directors and Officers. The directors and officers of Merger Sub
immediately prior to the Effective Time shall be the directors and officers of
the Surviving Corporation immediately following the Effective Time, each to
serve as a director or officer in accordance with the articles of
incorporation and bylaws of the Surviving Corporation.

  

  

Section 2.9 Exchange Fund. At or prior to the Effective Time, Parent shall
designate a bank or trust company (the "Paying Agent") to receive the
aggregate Merger Consideration that holders of Shares shall be entitled to
receive pursuant to Section 2.3(a)(i) (the "Exchange Fund"). The Exchange Fund
shall be invested by the Paying Agent as directed by Parent.

  

  

 

 

 

  

 

10  

  

 

 

 

  

  

Section 2.10 Exchange of Shares.

  

  

(a) As soon as practicable after the Effective Time, Parent will instruct the
Paying Agent to mail to the Persons who, immediately prior to the Effective
Time, were record holders of certificates representing shares of Company
Common Stock ("Certificates") whose Shares are being converted into the Merger
Consideration pursuant to Section 2.3: (i) a letter of transmittal (in
customary form and containing such provisions as Parent may reasonably
specify, including a provision confirming that delivery of Certificates shall
be effected, and risk of loss and title to Certificates shall pass, only upon
delivery of Certificates to the Paying Agent), and (ii) instructions for use
in effecting the surrender of the Certificates or Book Entry Shares in
exchange for the Merger Consideration. Upon proper surrender of a Certificate
or Book Entry Shares for exchange and cancellation to the Paying Agent,
together with a duly executed letter of transmittal and such other documents
as may reasonably be requested by the Paying Agent or Parent: (A) the holder
of such Certificate or Book Entry Shares shall be entitled to receive in
exchange therefor the amount of Merger Consideration provided in Section 2.3
in full satisfaction of all rights pertaining to the shares of Company Common
Stock formerly represented by such Certificate or Book Entry Shares, and (B)
the Certificate or Book Entry Shares so surrendered shall forthwith be
cancelled. No interest shall be paid or accrued on any cash or on any unpaid
dividends or distributions payable to holders of Certificates or Book Entry
Shares pursuant to the provisions of Article II.

  

  

(b) At the Effective Time, holders of Certificates and Book Entry Shares that
were outstanding immediately prior to the Effective Time shall cease to have
any rights as shareholders of the Company, other than with respect to
Dissenting Shares in accordance with Section 2.5, and the stock transfer books
of the Company shall be closed with respect to all shares of Company Common
Stock outstanding immediately prior to the Effective Time. After the Effective
Time, there shall be no transfers on the stock transfer books of the Company
of the shares of Company Common Stock which were issued and outstanding
immediately prior to the Effective Time. If, after the Effective Time, any
Certificates or Book Entry Shares representing such shares are presented for
transfer to the Paying Agent, each such share shall be cancelled and exchanged
for the Merger Consideration as provided in this Section 2.10. In the event of
a transfer of ownership of any shares of Company Common Stock which are not
registered in the transfer records of the Company, payment of the Merger
Consideration may be made to a Person other than the holder in whose name the
Certificate is so surrendered is registered, if any such Certificate shall be
properly endorsed or otherwise be in proper form for transfer, and such holder
shall pay any fiduciary or surety bonds or any transfer or other similar Taxes
required by reason of the payment of the Merger Consideration to a Person
other than such holder or establish to the reasonable satisfaction of Parent
that such Tax has been paid or is not applicable. Until surrendered as
contemplated by this Section 2.10, each Certificate and Book Entry Share shall
be deemed, from and after the Effective Time, to represent solely the right to
receive the Merger Consideration for each share of Company Common Stock
formerly evidenced by such Certificate or book entry. If any Certificate shall
have been lost, stolen or destroyed, Parent may, in its sole discretion and as
a condition to the payment of the Merger Consideration pursuant to Section
2.3(a)(i), require the owner of such lost, stolen or destroyed Certificate to
provide an appropriate affidavit and to deliver a bond (in customary form and
amount) as indemnity against any claim that may be made against the Paying
Agent, Parent or the Surviving Corporation with respect to such Certificate.

  

  

 

 

 

  

 

11  

  

 

 

 

  

  

(c) Any portion of the Exchange Fund that remains unclaimed by the Company's
shareholders as of the date 180 days after the Effective Time shall be paid to
Parent on demand, and any holders of Certificates or Book Entry Shares who
have not theretofore complied with this Article II shall thereafter look only
to Parent for payment of the Merger Consideration deliverable in respect of
each share of Company Common Stock formerly held by such shareholder as
determined pursuant to this Agreement without any interest thereon.
Notwithstanding the foregoing, none of the Company, Parent, the Paying Agent
or any other Person shall be liable to any former holder of shares of Company
Common Stock for any amount delivered in good faith to a public official
pursuant to applicable abandoned property, escheat or similar Laws.

  

  

Section 2.11 Withholding. Parent, the Surviving Corporation and the Paying
Agent shall be entitled to deduct and withhold from the Merger Consideration
deliverable under this Agreement, and from any other payments made pursuant to
this Agreement (including pursuant to Section 2.6) such amounts as Parent, the
Surviving Corporation and the Paying Agent are required to deduct and withhold
with respect to such delivery and payment under the Code or any provision of
applicable Tax Law. To the extent that amounts are so withheld, such withheld
amounts shall be treated for all purposes of this Agreement as having been
delivered and paid to the holder of shares of Company Common Stock and such
other Persons, as applicable, in respect of which such deduction and
withholding was made by Parent, the Surviving Corporation and the Paying
Agent.

  

  

Section 2.12 Further Action. If, at any time after the Effective Time, any
further action is determined by Parent to be necessary or desirable to carry
out the purposes of this Agreement or to vest the Surviving Corporation with
full right, title and possession of and to all rights and property of Merger
Sub and the Company, the officers and directors of the Surviving Corporation
and Parent shall be fully authorized (in the name of Merger Sub, in the name
of the Company and otherwise) to take such action.

  

  

ARTICLE III 
 

  

  

REPRESENTATIONS AND WARRANTIES OF THE COMPANY

  

  

Except as disclosed in the disclosure letter, dated as of the date of this
Agreement and delivered to Parent in connection with the execution and
delivery of this Agreement, which is arranged in numbered and lettered
sections corresponding to the numbered and lettered sections contained in this
Article III and Section 5.2 and, subject to Section 9.12 hereof, identifies
items of disclosure by reference to a particular section or subsection of this
Agreement (the "Company Disclosure Letter"), the Company represents and
warrants to Parent and Merger Sub as follows:

  

  

Section 3.1 Corporate Organization and Qualification, Subsidiaries.

  

  

(a) The Company is a corporation duly incorporated, validly existing and in
active status under the Laws of the State of Florida. The Company has the
requisite power and authority and possesses all material Permits, easements,
consents, waivers and Orders to own, lease or otherwise hold, use and operate
all of its properties, rights and assets and to carry on its business as it is
now being conducted. The Company is duly licensed and qualified to do business
and is in good standing in each jurisdiction in which the nature of the
business conducted by it or the character or location of the properties and
assets owned or leased by it makes such licensing or qualification necessary
or appropriate, except where the failure to be so duly licensed or qualified
to do business or in good standing would not, individually or in the
aggregate, reasonably be expected to have a Company Material Adverse Effect.

  

  

 

 

 

  

 

12  

  

 

 

 

  

  

(b) Section 3.1(b) of the Company Disclosure Letter sets forth a complete and
correct list of each Company Subsidiary with its place of organization. Each
Company Subsidiary (i) is duly incorporated or duly formed, as applicable to
each such Company Subsidiary, and validly existing and in good standing or
active status under the Laws of its jurisdiction of organization, (ii) has the
requisite power and authority and possesses all material Permits, easements,
consents, waivers and Orders to own, lease or otherwise hold, use and operate
all of its properties, rights and assets and to carry on its business as it is
now being conducted, and (iii) is duly licensed or qualified to do business
and is in good standing in each jurisdiction in which the nature of the
business conducted by it or the character or location of the properties and
assets owned or leased by it makes such licensing or qualification necessary
or appropriate except where the failure to be so duly licensed or qualified to
do business or in good standing would not (A) have a material effect with
respect to such Company Subsidiary or (B) individually or in the aggregate,
reasonably be expected to have a Company Material Adverse Effect.

  

  

Section 3.2 Articles of Incorporation and Bylaws; Minute Books.

  

  

(a) The Company has furnished to Parent, prior to the date of this Agreement,
complete and correct copies of the Company Articles and Company Bylaws, and
the articles of incorporation and the bylaws (or the equivalent organizational
documents), in each case as amended or restated to the date hereof, of each
Company Subsidiary. The Company Articles and Company Bylaws and the
organizational documents of each Company Subsidiary are in full force and
effect and no other organizational documents are applicable to or binding upon
the Company or any Company Subsidiary. The Company is not in violation of any
of the provisions of the Company Articles or the Company Bylaws. No Company
Subsidiary is in violation of its articles of incorporation or bylaws (or
equivalent organizational documents).

  

  

(b) The minute books of the Company and each Company Subsidiary contain true,
complete and correct records of all meetings and other corporate actions held
or taken since December 31, 2006 of their respective shareholders, the board
of directors and each committee of the board of directors.

  

  

Section 3.3 Capitalization.

  

  

(a) The authorized capital stock of the Company consists of 20,000,000 shares
of Company Common Stock. As of April 13, 2010, (the "Company Capitalization
Date") (i) 9,610,373 shares of Company Common Stock are issued and
outstanding, all of which are duly authorized, validly issued, fully paid and
nonassessable and free from preemptive rights, whether statutory, contractual
or otherwise, with no personal liability attaching to the ownership thereof,
(ii) no shares of Company Common Stock are held in the treasury of the
Company, (iii)(A) 100,000 shares of Company Common Stock were reserved and
available for issuance pursuant to outstanding Company Options, with the grant
date, vesting terms and exercise price per share of Company Common Stock for
each Company Option set forth on Section 3.3(a) of the Company Disclosure
Letter, and (B) 16,250 shares of Company Common Stock were reserved and
available for issuance pursuant to outstanding awards of Company Restricted
Shares and Company Restricted Stock Units, in each case with respect to
clauses (A) and (B) issued pursuant to Company Stock Plans, (iv) 173,700
shares of Company Common Stock were granted in the form of Company Restricted
Shares under the Company Stock Plans, and (v) no other shares of Company
Common Stock are reserved for issuance other than as provided in clauses (iii)
and (iv). No bonds, debentures, notes or other indebtedness or securities of
the Company that have the right to vote (or that are convertible into, or
exchangeable for, securities having the right to vote) on any matters on which
shareholders of the Company may vote ("Voting Debt") are outstanding. Except
as set forth above, no shares of capital stock or other voting securities

  

  

 

 

 

  

 

13  

  

 

 

 

  

  

of the Company are issued or outstanding. Section 3.3(a) of the Company
Disclosure Letter sets forth a true, complete and correct list of (x) the
aggregate number of shares of Company Common Stock issuable upon the exercise
of each Company Option and settlement of each Company Restricted Stock Unit
granted under the Company Stock Plans and the weighted average exercise price
for the Company Options, and (y) all other rights to purchase any Voting Debt,
issued or unissued capital stock of the Company and the Company Subsidiaries,
or obligating the Company or any of the Company Subsidiaries to issue, grant
or sell any Voting Debt, shares of capital stock of, or other equity interests
in, or securities convertible into equity interests in, the Company or any of
the Company Subsidiaries. Other than the Company Options, the Company
Restricted Stock Units and the Top-Up Option, no other options to purchase
Company Common Stock or equity-based awards of the Company or any Company
Subsidiary are outstanding. Since the Company Capitalization Date, the Company
has not (A) issued or repurchased any shares of Company Common Stock, Voting
Debt or other equity securities of the Company, other than the issuance of
shares of Company Common Stock in connection with the exercise of Company
Options or settlement of the Company Restricted Stock Units, in each case,
granted under the Company Stock Plans, or (B) other than the Top-Up Option,
issued or awarded any options, stock appreciation rights, restricted shares,
restricted stock units, deferred equity units, awards based on the value of
Company capital stock or any other equity-based awards under any of the
Company Stock Plans or otherwise. All shares of Company Common Stock subject
to issuance as described above shall, upon issuance on the terms and
conditions specified in the instruments pursuant to which they are issuable,
be duly authorized, validly issued, fully paid and nonassessable and free from
preemptive rights, whether statutory, contractual or otherwise, with no
personal liability attaching to the ownership thereof. Except as set forth on
Section 3.3(a) of the Company Disclosure Letter, there are no obligations of
the Company or any of the Company Subsidiaries to repurchase, redeem or
otherwise acquire any Voting Debt, shares of Company Common Stock or any
capital stock of any of the Company Subsidiaries or any securities
representing the right to purchase or otherwise receive any Voting Debt,
shares of Company Common Stock or any capital stock of any of the Company
Subsidiaries, or make any investment (in the form of a loan, capital
contribution or otherwise) in any of the Company Subsidiaries or any other
Person, or pursuant to which the Company or any of the Company Subsidiaries is
or could be required to register shares of Company Common Stock, Voting Debt
or other securities under the Securities Act. There are no voting trusts,
proxies or other agreements, commitments or understandings of any character to
which the Company or any Company Subsidiary is a party or by which any of them
is bound with respect to the holding, voting or disposition of any shares of
capital stock of the Company or any of its Subsidiaries.

  

  

(b) Except as set forth in Section 3.3(b) of the Company Disclosure Letter,
all of the outstanding shares of capital stock and voting securities of each
Company Subsidiary are owned, directly or indirectly, by the Company and are
duly authorized, validly issued, fully paid and nonassessable and free from
preemptive rights, whether statutory, contractual or otherwise, with no
personal liability attaching thereto, and those shares of capital stock and
voting securities of each of the Company Subsidiaries owned by the Company,
directly or indirectly, are free and clear of all Liens and all other
limitations or restrictions (including any restriction on the right to vote,
sell or otherwise dispose of such capital stock or other voting securities or
ownership interests). Except as otherwise set forth in this Section 3.3 or in
Section 3.3(a) of the Company Disclosure Letter, there are no outstanding
subscriptions, options, warrants, puts, calls, rights, exchangeable or
convertible securities or other commitments or agreements of any character
relating to the issued or unissued capital stock or other securities of any
Company Subsidiary, or otherwise obligating the Company or any Company
Subsidiary to issue, transfer, sell, purchase, redeem or otherwise acquire any
such securities.

  

  

 

 

 

  

 

14  

  

 

 

 

  

  

(c) Neither the Company nor any of the Company Subsidiaries owns, or has any
contractual or other obligation to acquire, any equity securities or other
securities of any Person (other than Company Subsidiaries) or any direct or
indirect equity or ownership interest in any other business.

  

  

Section 3.4 Authorization of Agreement; No Violation.

  

  

(a) The Company has full corporate power and authority to execute and deliver
this Agreement and to consummate the transactions contemplated by this
Agreement. The execution and delivery by the Company of this Agreement and the
consummation of the transactions contemplated by this Agreement have been
duly, validly and unanimously approved by the Company Board. The Company Board
(at a meeting duly called and held) has, by the unanimous vote of all
directors of the Company, made the Company Board Recommendation and taken the
other actions described in Section 1.2(a) and such board resolutions have not
been amended, withdrawn or rescinded in any way. The Company Board has taken
all actions necessary so that the provisions of Section 607.0901 of the FBCA
and the voting restrictions contained in Section 607.0902 of the FBCA will not
apply with respect to or as a result of the Offer, the Merger, this Agreement,
the Support Agreements and the transactions contemplated hereby and thereby.
This Agreement has been duly and validly executed and delivered by the Company
and, assuming due authorization, execution and delivery hereof by Parent and
Merger Sub, constitutes the valid and binding obligation of the Company,
enforceable against the Company in accordance with its terms, except as such
enforcement may be limited by (i) the effect of bankruptcy, insolvency,
reorganization, receivership, conservatorship, arrangement, moratorium or
other Laws affecting or relating to creditors' rights generally or (ii) the
rules governing the availability of specific performance, injunctive relief or
other equitable remedies and general principles of equity, regardless of
whether considered in a Proceeding in equity or at law.

  

  

(b) None of (i) the execution, delivery or performance of this Agreement or
the Support Agreements, (ii) the purchase of the shares of Company Common
Stock tendered pursuant to the Offer, (iii) the compliance by the Company with
the provisions of this Agreement or (iv) the consummation of the Merger and
the other transactions contemplated by this Agreement, will, directly or
indirectly, (with or without notice or lapse of time, or both) (A) contravene,
conflict with, or result in any violation or breach of (1) any provision of
the Company Articles or Company Bylaws or comparable governing documents of
the Company Subsidiaries, or (2) any resolution adopted by the Company's
shareholders, the Company Board, or any committee of the Company Board, (B)
assuming that the Company Consents are duly obtained, (1) violate any Law or
Order applicable to the Company or any of the Company Subsidiaries or any of
their respective properties or assets, or (2) violate, conflict with, result
in a breach of any provision of or the loss of any benefit under, constitute a
default (or an event which, with notice or lapse of time, or both, would
constitute a default) under, result in the modification, cancellation,
acceleration or termination of or a right of modification, cancellation,
acceleration or termination under, accelerate the performance required by, or
result in the creation of any Lien upon any of the respective properties,
rights or assets of the Company or the Company Subsidiaries under, any of the
terms, conditions or provisions of any Contract to which the Company or any of
the Company Subsidiaries is a party, or by which any of them or any of their
respective properties, rights or assets is bound, except, with respect solely
to clause (B)(2), for such Contracts, properties, rights or assets that would
not be material to the Company or any Company Subsidiary.

  

  

 

 

 

  

 

15  

  

 

 

 

  

  

Section 3.5 Consents and Approvals.

  

  

(a) Except for (i) any notices or filings required by the Hart-Scott-Rodino
Antitrust Improvements Act of 1976, as amended (the "HSR Act"), (ii) the
filing with the SEC of (A) the Schedule 14D-9, and (B) such other reports or
filings under the Exchange Act or the Securities Act as may be required in
connection with this Agreement and the transactions contemplated by this
Agreement, (iii) the filing of the Articles of Merger with the Secretary of
State of the State of Florida pursuant to the FBCA, (iv) such filings as may
be required under the Regulations of NASDAQ, and (v) the consents, notices and
approvals set forth in Section 3.5 of the Company Disclosure Letter (the
consents and approvals referred to in clauses (i) through (v), the "Company
Consents"), no consents or approvals of or filings or registrations with any
Governmental Entity or any Third Party are necessary in connection with the
execution and delivery by the Company of this Agreement, the purchase of the
shares of Company Common Stock pursuant to the Offer, or the consummation by
the Company of the Merger and the other transactions contemplated by this
Agreement.

  

  

(b) The Company has delivered to Parent a true and correct copy of the
executed consent of KeyBank National Association under the Company Credit
Agreement to the Offer, the Merger and the other transactions contemplated
hereby, which consent has not been withdrawn, revoked, waived, amended,
modified or supplemented in any respect.

  

  

Section 3.6 Regulatory Matters; Reports.

  

  

(a) The Company and the Company Subsidiaries have each timely filed all
reports, schedules, forms, registrations, statements and certifications,
together with any amendments required or requested to be made with respect
thereto, that they were required to file since December 31, 2006 with (i) the
SEC, (ii) NASDAQ, and (iii) each other applicable Governmental Entity, and all
other reports and statements required to be filed by them since December 31,
2006, and have paid all fees and assessments due and payable in connection
therewith. Since December 31, 2006, no Governmental Entity has resolved any
Proceeding into the business, disclosures or operations of the Company or any
of the Company Subsidiaries. Except with respect to routine regulatory
investigations in the ordinary course of business consistent with past
practice, none of which have raised or revealed any issue or matter that would
be material to the Company or any of the Company Subsidiaries, (A) there is no
unresolved or threatened in writing criticism, comment, exception or stop
order by any Governmental Entity with respect to any report or statement
relating to any examinations or inspections of the Company or any of the
Company Subsidiaries and (B) no Governmental Entity has initiated since
December 31, 2006 or has pending any Proceeding with respect to the business,
disclosures or operations of the Company or any of the Company Subsidiaries.
Since December 31, 2006, there have been no civil investigative demands or
other formal or informal inquiries by, or disagreements or disputes with, any
Governmental Entity with respect to the business, operations, policies or
procedures of the Company or any of the Company Subsidiaries.

  

  

(b) The Company and the Company Subsidiaries are and have at all times been in
material compliance with all filing requirements with respect to the Centers'
Medicare cost reports or state Medicaid reports. Such reports do not claim,
and neither the Company nor any of the Company Subsidiaries have received,
payment or reimbursement in excess of the amount provided or allowed by
applicable Law or any applicable agreement, except where excess reimbursement
was noted on the report. There are no facts or circumstances which may
reasonably be expected to give rise to any material disallowance under any
Center Medicare cost report or similar state report. There are no currently
pending or, to the Company's Knowledge, threatened audits or compliance
reviews of any Company, Company Subsidiary or Center cost or other report with
Medicare or any state Medicaid agency. To the Knowledge of the Company, since
December 31, 2006, neither the Company nor any Company Subsidiary has received
any notice (whether oral or in writing) that any Governmental Entity,
including any Medicare administrative contractor or state Medicaid or Medicare
review board has conducted any audit or compliance review of any Company or
Company Subsidiary cost or other report.

  

  

 

 

 

  

 

16  

  

 

 

 

  

  

(c) Neither the Company nor any of the Company Subsidiaries is subject to any
cease-and-desist or other Order or Proceeding issued by, or is a party to any
written agreement, consent agreement or memorandum of understanding with, or
is a party to any commitment letter or similar undertaking to, or is subject
to any directive by, or has been ordered to pay any civil money penalty or
other material amount by, or has adopted any policies, procedures or board
resolutions at the request of, any Governmental Entity that currently
restricts or affects in any material respect the conduct of its business (or
that, upon consummation of the Offer and the Merger, would restrict in any
material respect the conduct of the business of Parent or any of its
Subsidiaries), or that in any material manner relates to its ability to pay
dividends, its credit, risk management or compliance policies, its internal
controls, its management or its business, other than those of general
application that apply to similarly situated companies or their Subsidiaries
(each item in this sentence, a "Company Regulatory Agreement"), nor has the
Company or any of the Company Subsidiaries been advised in writing since
December 31, 2006 by any Governmental Entity that it is considering issuing,
initiating, ordering, or requesting any such Company Regulatory Agreement.

  

  

(d) The Company has timely filed or otherwise furnished (as applicable) all
registration statements, prospectuses, schedules, proxy statements, forms,
documents and reports (including exhibits, other information incorporated
therein, and any amendments thereto) with the SEC required to be filed by the
Company under the Securities Act or the Exchange Act, as the case may be, from
(and including) December 31, 2006 (such documents, together with any other
documents filed or furnished by the Company to the SEC, including exhibits and
other information incorporated therein as they may have been supplemented,
modified or amended since the time of filing, collectively, the "Company SEC
Documents"), true correct and complete copies of which have been provided to
Parent or are available in full (without redaction and including the full text
of any document filed subject to a request for confidential treatment) on the
SEC's website through the Electronic Data Gathering, Analysis and Retrieval
System two (2) Business Days prior to the date of this Agreement. No such
Company SEC Document, at the time filed or furnished (and in the case of
registration statements and proxy statements, on the dates of effectiveness
and the dates of relevant meetings, respectively) contained any untrue
statement of a material fact or omitted to state a material fact required to
be stated therein or necessary in order to make the statements made therein,
in light of the circumstances under which they were made, not misleading,
except that information as of a later date (but before the date of this
Agreement) shall be deemed to modify information as of an earlier date. As of
their respective dates, all Company SEC Documents complied as to form in all
material respects with the Regulations of the SEC with respect thereto. No
executive officer of the Company has failed in any respect to make the
certifications required of him or her under Section 302 or 906 of SOX and, at
the time of filing or submission of each such certification, such
certification was true and accurate and complied with SOX.

  

  

(e) The Company has made available to Parent copies of all comment letters
received by the Company from the SEC since December 31, 2006 relating to the
Company SEC Documents, together with all written responses of the Company
thereto. There are no outstanding or unresolved comments in any such comment
letters received by the Company from the SEC. To the Knowledge of the Company,
none of the Company SEC Documents is the subject of any ongoing review by the
SEC.

  

  

 

 

 

  

 

17  

  

 

 

 

  

  

Section 3.7 Financial Statements.

  

  

(a) Each of the financial statements of the Company and the Company
Subsidiaries included (or incorporated by reference) in the Company SEC
Documents (including the related notes, where applicable) (i) have been
prepared from, and are in accordance with, the books and records of the
Company and the Company Subsidiaries, (ii) fairly present in all material
respects the consolidated results of operations, cash flows, changes in
shareholders' equity and consolidated financial position of the Company and
the Company Subsidiaries for the respective fiscal periods or as of the
respective dates therein set forth (subject in the case of unaudited
statements to the absence of footnotes to the extent permitted by Regulation
S-X that would not differ materially from the footnotes to the financial
statements included in audited financial statements and recurring year-end
audit adjustments normal in nature and amount, the effect of which is not,
individually or in the aggregate, material), (iii) complied as to form, as of
their respective dates of filing with the SEC, in all material respects with
applicable accounting requirements and with the published Regulations of the
SEC with respect thereto, and (iv) have been prepared in accordance with GAAP
consistently applied during the periods involved, except, in each case, as
indicated in such statements or in the notes thereto. The books and records of
the Company and the Company Subsidiaries have been, and are being, maintained
in all material respects in accordance with GAAP and any other applicable
legal and accounting requirements. MSPC Certified Public Accountants and
Advisors, P.C. has not resigned or been dismissed as independent public
accountants of the Company as a result of or in connection with any
disagreements with the Company on a matter of accounting principles or
practices, financial statement disclosure or auditing scope or procedure.

  

  

(b) The records, systems, controls, data and information of the Company and
the Company Subsidiaries are recorded, stored, maintained and operated under
means (including any electronic, mechanical or photographic process, whether
computerized or not) that are under the exclusive ownership and direct control
of the Company or the Company Subsidiaries or accountants (including all means
of access thereto and therefrom). The Company (x) has implemented and
maintains disclosure controls and procedures (as defined in Rule 13a-15(e) of
the Exchange Act) to ensure that material information relating to the Company,
including the Company Subsidiaries, is made known to the chief executive
officer and the chief financial officer of the Company by others within those
entities, and (y) has disclosed, based on its most recent evaluation prior to
the date hereof, to the Company's outside auditors and the audit committee of
the Company Board (i) any significant deficiencies and material weaknesses in
the design or operation of internal controls over financial reporting (as
defined in Rule 13a-15(f) of the Exchange Act) which are reasonably likely to
adversely affect the Company's ability to record, process, summarize and
report financial information and (ii) any fraud, whether or not material, that
involves management or other employees who have a significant role in the
Company's internal controls over financial reporting. These disclosures were
made in writing by management to the Company's auditors and audit committee, a
copy of which has previously been made available to Parent. There is no reason
to believe that the Company's outside auditors, chief executive officer and
chief financial officer will not be able to give the certifications and
attestations required pursuant to the Regulations adopted pursuant to Section
404 of SOX, without qualification, when next due.

  

  

 

 

 

  

 

18  

  

 

 

 

  

  

(c) Since December 31, 2006, neither the principal executive officer nor the
principal financial officer of the Company has become aware of any fact,
circumstance or change that is reasonably likely to result in a "significant
deficiency" or a "material weakness" in the Company's internal controls over
financial reporting.

  

  

(d) The audit committee of the Company Board includes an Audit Committee
Financial Expert, as defined by Item 407(d)(5)(ii) of Regulation S-K.

  

  

(e) The Company has adopted a code of ethics, as defined by Item 406(b) of
Regulation S-K, for senior financial officers, applicable to its principal
financial officer, comptroller or principal accounting officer, or persons
performing similar functions. The Company has promptly disclosed any change in
or waiver of the Company's code of ethics with respect to any such persons, as
required by Section 406(b) of SOX. To the Knowledge of the Company, there have
been no violations of provisions of the Company's code of ethics by any such
persons since December 31, 2006.

  

  

(f) Since December 31, 2006, (i) neither the Company nor any of the Company
Subsidiaries nor, to the Knowledge of the Company, any director, officer,
Employee, auditor, accountant or representative of the Company or any of the
Company Subsidiaries has received or otherwise had or obtained knowledge of
any material complaint, allegation, assertion or claim, whether written or
oral, regarding the accounting or auditing practices, procedures,
methodologies or methods of the Company or any of the Company Subsidiaries or
their respective internal accounting controls, including any material
complaint, allegation, assertion or claim that the Company or any of the
Company Subsidiaries has engaged in questionable accounting or auditing
practices, and (ii) no attorney representing the Company or any of the Company
Subsidiaries, whether or not employed by the Company or any of the Company
Subsidiaries, has reported evidence of a material violation of securities
Laws, breach of fiduciary duty or similar violation by the Company or any of
its officers, directors, employees or agents to the Company Board or any
committee thereof or to any director or officer the Company.

  

  

Section 3.8 Undisclosed Liabilities. Neither the Company nor any of the
Company Subsidiaries has any liability or obligation of any nature whatsoever
(whether absolute, accrued, contingent, determined, determinable or otherwise
and whether due or to become due), except for (a) those liabilities that are
reflected or reserved against on the consolidated balance sheet of the Company
included in its Annual Report on Form 10-K for the fiscal year ended December
31, 2009 (the "Company Balance Sheet Date") (including any notes thereto) and
(b) liabilities incurred in the ordinary course of business consistent with
past practice since the Company Balance Sheet Date. Neither the Company nor
any of the Company Subsidiaries is a party to, or has any commitment to become
a party to, any off-balance sheet partnership, joint venture, or any similar
Contract or arrangement (including any Contract or arrangement relating to any
transaction or relationship between or among the Company and any of the
Company Subsidiaries, on the one hand, and any unconsolidated Affiliate,
including any structured finance, special purpose or limited purpose entity or
Person, on the other hand, or any "off-balance sheet arrangement" (as defined
in Item 303(a) of Regulation S-K)).

  

  

Section 3.9 Absence of Certain Changes or Events. From the Company Balance
Sheet Date to the date of this Agreement, each of the Company and the Company
Subsidiaries has conducted its respective business in the ordinary course, and
during such period, there has not occurred:

  

  

(a) a Company Material Adverse Effect;

  

  

 

 

 

  

 

19  

  

 

 

 

  

  

(b) any action or event of the type described in Section 5.2;

  

  

(c) any material loss, damage or destruction to, or any material interruption
in the use of, any of the assets of any of the Company or the Company
Subsidiaries (whether or not covered by insurance);

  

  

(d) (i) any declaration, accrual, set aside or payment of any dividend or any
other distribution in respect of any shares of capital stock of the Company or
the Company Subsidiaries, or (ii) any repurchase, redemption or other
acquisition by the Company or the Company Subsidiaries of any shares of
capital stock or other securities;

  

  

(e) any sale, issuance or grant, or authorization of the issuance of, (i) any
capital stock or other security of the Company or the Company Subsidiaries
(except for Company Common Stock issued upon the valid exercise of outstanding
Company Options or settlement of Company Restricted Stock Units), (ii) any
option, warrant or right to acquire any capital stock or any other security of
the Company or the Company Subsidiaries (except for Company Options and
Company Restricted Stock Units set forth in Section 3.3(a)), or (iii) any
instrument convertible into or exchangeable for any capital stock or other
security of the Company or the Company Subsidiaries;

  

  

(f) any amendment or waiver of any of the rights of the Company or the Company
Subsidiaries under, or acceleration of vesting under, (i) any provision of any
of the Company Benefit Plans, or (ii) any provision of any Contract evidencing
any outstanding Company Option, Company Restricted Stock Unit, or Company
Restricted Share granted under the Company Stock Plans;

  

  

(g) (i) any amendment to the Company Articles or the Company Bylaws, or any
organizational document of any Company Subsidiary, or (ii) any merger,
consolidation, share exchange, business combination, recapitalization,
reclassification of shares, stock split, reverse stock split or similar
transaction involving the Company or any Company Subsidiary;

  

  

(h) [reserved]

  

  

(i) any creation of any Subsidiary of the Company or any Company Subsidiary or
acquisition by the Company or any Company Subsidiary of any equity interest or
other interest in any other Person;

  

  

(j) any capital expenditure by the Company or any Company Subsidiary which,
when aggregated with all other capital expenditures made on behalf of the
Company and the Company Subsidiaries since the date of the Company Balance
Sheet, exceeds $30,000 individually or $400,000 in the aggregate;

  

  

(k) any action by the Company or any Company Subsidiary to (i) enter into or
suffer any of the assets owned or used by it to become bound by any Material
Contract, or (ii) amend or terminate, or waive any right or remedy under, any
Material Contract;

  

  

(l) any (i) acquisition, lease or license by the Company or any Company
Subsidiary of any material right or other material asset from any other
Person, (ii) sale or other disposal or lease or license by the Company or any
Company Subsidiary of any material right or other material asset to any other
Person, or (iii) waiver or relinquishment by the Company or any Company
Subsidiary of any right, except for rights or other assets acquired, leased,
licensed or disposed of in the ordinary course of business and consistent with
past practices;

  

  

 

 

 

  

 

20  

  

 

 

 

  

  

(m) any write-off as uncollectible, or establishment of any extraordinary
reserve with respect to, any account receivable or other indebtedness of the
Company or any Company Subsidiary that exceeds $25,000 individually or
$100,000 in the aggregate;

  

  

(n) any pledge of any assets of or sufferance of any of the assets of the
Company or any Company Subsidiary to become subject to any Lien, except for
pledges of immaterial assets made in the ordinary course of business and
consistent with past practices;

  

  

(o) any (i) loan by the Company or any Company Subsidiary to any Person (other
than any wholly owned Company Subsidiary other than any such Company
Subsidiary listed in Section 3.9(o) of the Company Disclosure Letter), or (ii)
incurrence or guarantee by the Company or any Company Subsidiary of any
indebtedness for borrowed money;

  

  

(p) any (i) adoption, establishment, entry into or amendment by the Company or
any Company Subsidiary of any Company Benefit Plan, or (ii) payment of any
bonus or any profit sharing or similar payment to, or material increase in the
amount of the wages, salary, commissions, fringe benefits or other
compensation or remuneration payable to, any of the directors, officers or
Employees of the Company or the Company Subsidiaries;

  

  

(q) any change of the methods of accounting or accounting practices of the
Company or any Company Subsidiary in any material respect;

  

  

(r) any material Tax election by the Company or any Company Subsidiary;

  

  

(s) any notice of audit or recoupment of amounts previously reimbursed by any
Governmental Entity or Third Party payor, in an amount in excess of $100,000;

  

  

(t) any adjustment in excess of $200,000 to balances reflected in the
Company's consolidated financial statements that do not pertain to the period
covered by such consolidated financial statements;

  

  

(u) any amendment to any Third Party payor Contract that would result in a
change in an amount to be received by the Company or the Company Subsidiaries
in excess of $200,000, individually or in the aggregate, in any twelve-month
period;

  

  

(v) any commencement or settlement of any Proceeding by the Company or any
Company Subsidiary; or

  

  

(w) any agreement or commitment to take any of the actions referred to in
clauses (b) through (v) above.

  

  

 

 

 

  

 

21  

  

 

 

 

  

  

Section 3.10 Property.

  

  

(a) Section 3.10(a) of the Company Disclosure Letter identifies all real
property and interests in real property owned in fee by the Company or the
Company Subsidiaries. The Company or one of its Subsidiaries, as applicable,
has good, valid and marketable title to the Owned Real Property, free and
clear of any Lien, other than Permitted Encumbrances. There are no outstanding
options or rights of first refusal to purchase the Owned Real Property, or any
portion of the Owned Real Property or interest therein. The major structural
elements of the improvements comprising each parcel of Owned Real Property,
including mechanical, electrical, heating, ventilation, air conditioning or
plumbing systems, elevators or parking elements, are in sufficiently good
condition in all material respects to allow the business of the Company and
its Subsidiaries to be operated in the ordinary course of business consistent
with past practice.

  

  

(b) Section 3.10(b) of the Company Disclosure Letter sets forth, as of the
date hereof, a true, correct and complete list of the Company's real property
which is leased, subleased or licensed to the Company or the Company
Subsidiaries (the "Leased Real Property" and together with the Owned Real
Property, the "Real Property"). The lease, sublease or license for each such
Leased Real Property (each a "Lease") is valid, legally binding, enforceable
and in full force and effect in all material respects with respect to the
applicable Company or Company Subsidiary and, to the Company's Knowledge, the
applicable counterparty thereto. Neither the Company nor any Company
Subsidiary is in breach of or default under, in any material respects, the
terms of any Lease (or has taken or failed to take any action which with
notice or lapse of time, or both, would constitute a default thereunder).
Prior to the date hereof, the Company has provided or made available to Parent
true and complete copies of each Lease as in effect on the date of this
Agreement.

  

  

(c) To the Knowledge of the Company, the Real Property is in material
compliance with all applicable zoning Laws and building codes, and the
buildings and improvements located on the Real Property are in good operating
condition and in a state of good working order, in all material respects.
There are no pending or, to the Knowledge of the Company, threatened
Proceedings with respect to or otherwise affecting the Real Property. The
Company and the Company Subsidiaries are in compliance in all material
respects with all applicable health and safety related Legal Requirements for
the Real Property, including those under the Americans with Disabilities Act
of 1990 and the Occupational Health and Safety Act of 1970. The Company or the
Company Subsidiaries, individually or together, own, lease or have the right
to use all of their properties and assets reflected in the Company Balance
Sheet or otherwise used by them in connection with the conduct of their
businesses, other than any properties or assets that have been sold or
otherwise disposed of since the Company Balance Sheet Date in the ordinary
course of business consistent with past practice (all such properties and
assets, excluding the Owned Real Property, the Leased Real Property, and the
Company IP (which is solely covered by the representation included in Section
3.17), are referred to as "Assets"). Each of the Company and the Company
Subsidiaries has good title to, or in the case of leased or subleased Assets,
valid and subsisting leasehold interests in, all of the Assets free and clear
of Liens of any nature whatsoever, other than Permitted Encumbrances.

  

  

 

 

 

  

 

22  

  

 

 

 

  

  

Section 3.11 Contracts.

  

  

(a) Except as disclosed in Section 3.11(a) of the Company Disclosure Letter,
neither the Company nor any of the Company Subsidiaries is a party to, bound
by or subject to any Contract (whether written or oral) (i) that is a
"material contract" (within the meaning of Item 601(b)(10) of the SEC's
Regulation S-K) to be performed after the date of this Agreement, (ii) that
contains a non-compete or non-solicit requirement or other provision that
restricts in any material respect the conduct of, or the manner of conducting,
any line of business by the Company or any of the Company Subsidiaries
(including any geographic limitations), or upon consummation of the Offer or
the Merger could restrict in any material respect the ability of Parent, the
Surviving Corporation or any of their respective Subsidiaries to engage in any
line of business (including any geographic limitations), (iii) that obligates
the Company or any of the Company Subsidiaries to conduct business on an
exclusive or preferential basis with any Third Party or containing "most
favored nation" rights or upon consummation of the Offer or the Merger will
obligate Parent, the Surviving Corporation or any of their respective
Subsidiaries to conduct business with any Third Party on an exclusive or
preferential basis or pursuant to "most favored nation" rights, (iv) with or
to a labor union or guild (including any collective bargaining agreement), (v)
that creates a partnership, joint venture, strategic alliance or similar
arrangement with respect to any business of the Company, including all
operating agreements for all Joint Venture Subsidiaries, (vi) that is an
indenture, credit agreement, loan agreement, security agreement, guarantee,
note, mortgage or other Contract providing for or guaranteeing indebtedness in
excess of $50,000, (vii) that, individually or together with related
Contracts, provides for the acquisition, disposition, license, use,
distribution or outsourcing, after the date of this Agreement, of assets,
services, rights or properties with a value or requiring annual fees in excess
of $75,000, (viii) that involves aggregate payments by or to the Company or
any of its Subsidiaries in excess of $75,000 in any twelve month period or
more than $100,000 through the remaining term of the Contract, except for any
Contract that may be cancelled without penalty by the Company or any of its
Subsidiaries upon notice of 60 days or less, (ix) that includes an
indemnification obligation of the Company or any of its Subsidiaries with a
maximum potential liability in excess of $50,000, (x) that is a Lease, (xi)
concerning Intellectual Property (other than generally commercially available,
non-custom, off-the-shelf software licenses having a retail acquisition price
of less than $2,000), (xii) with a physician or other Third Party who is in a
position to make or influence referrals to or otherwise generate business for
the Company or any Company Subsidiary, including the Physician Contracts,
(xiii) that is a medical directorship service agreement or any similar
agreement, (xiv) that is a Third Party payor Contract, or (xv) the loss of
which would reasonably be expected to have a Company Material Adverse Effect.
Each Contract of the type described in this Section 3.11(a) is referred to
herein as a "Material Contract." True and complete copies of all Material
Contracts in effect on the date hereof have been made available to Parent on
or prior to the date hereof.

  

  

(b) (i) Each Material Contract is valid and binding on the Company or the
applicable Company Subsidiary, enforceable against it in accordance with its
terms and is in full force and effect, (ii) the Company and each of the
Company Subsidiaries and, to the Knowledge of the Company, each other party
thereto has duly performed all obligations required to be performed by it
under each Material Contract, and (iii) no event or condition exists that
constitutes or, after notice or lapse of time or both, will constitute, a
breach, violation or default on the part of the Company or any of the Company
Subsidiaries or, to the Knowledge of the Company, any other party thereto,
under any such Material Contract. There are no disputes pending or to the
Knowledge of the Company, threatened with respect to any Material Contract.

  

  

Section 3.12 Compliance with Applicable Law; Permits.

  

  

(a) The Company and the Company Subsidiaries have complied in all material
respects with all applicable Laws, and are not in default or violation of, and
have not received any notices of violation with respect to, any Laws in
connection with the conduct of their respective businesses or the ownership or
operation of their respective businesses, assets and properties.

  

  

(b) The Company and the Company Subsidiaries have obtained and hold all
Permits that are necessary to own, lease or otherwise hold, use and operate
their properties, rights and other assets and are necessary for the lawful
conduct of their respective businesses, including all Permits to operate end-
stage renal disease facilities or dialysis facilities, under and pursuant to
each, and have complied in all material respects with, and are not in default
or in violation in any material respect of, any Laws or legal requirements
applicable to the Company or any of the Company Subsidiaries. Such Permits are
in full force and effect and there are no Proceedings pending or, to the
Knowledge of the Company, threatened that seek the revocation, cancellation,
suspension or adverse modification thereof. The consummation of the Offer or
the Merger, in and of itself, would not cause any revocation, modification or
cancellation of any such Permit.

  

  

 

 

 

  

 

23  

  

 

 

 

  

  

(c) The Company has been and is in compliance with the applicable listing and
corporate governance rules and regulations of NASDAQ.

  

  

Section 3.13 Health Law Matters. Without limiting the scope or application of
representations or warranties of general application set forth elsewhere in
this Article III:

  

  

(a) Each of the Centers operated by the Company or a Company Subsidiary is
certified under the conditions of coverage and participation of the federal
Medicare program as a Medicare provider, specifically an end-stage renal
disease facility and each Center is certified or otherwise qualified as a
state Medicaid provider in the applicable State of operation. The Company has
provided copies of all surveys, reports or deficiency notices concerning the
Centers by the Medicare program, any state survey agency, and the applicable
state Medicaid programs for the five (5) year period prior to the date hereof.
The Medicare certification and applicable Medicaid certifications of each of
the Centers is in full force and effect, and each applicable Company
Subsidiary is under no suspension or plan of correction. To the Knowledge of
the Company, no violation of the Medicare conditions of coverage or Medicaid
certification conditions or qualifications exists and no event or
circumstances exists that with the giving of notice or passage of time, or
both, would constitute a violation. Neither CMS nor any state agency has
conducted or has given the Company or any Company Subsidiary any notice that
it intends to conduct any audit or other review of the Company's or any
Company Subsidiaries' participation in any governmental healthcare program,
including the Medicare and Medicaid programs, and, to the Knowledge of the
Company, no such audit or review would result in any material liability by the
Company or any Company Subsidiary for any repayment, reimbursement, penalty or
interest with respect to payments received by the Company or any Company
Subsidiary thereunder or the suspension or exclusion of the Company or a
Company Subsidiary from participation in the applicable governmental health
program. There is not pending or threatened any Proceeding under a program by
a Governmental Entity involving the Company, a Company Subsidiary or any
Center. To the Knowledge of the Company, each Center medical director is
qualified in accordance with the Medicare conditions of coverage and
applicable Law to serve as the medical director of such Center. Except as set
forth in Section 3.13(a) of the Company Disclosure Letter, there are no
certificate of need requirements in the states in which the Company and each
Company Subsidiary operates or has operated since December 31, 2006.

  

  

(b) Section 3.13(b) of the Company Disclosure Letter contains a complete list
of all Company Subsidiaries owned in part (directly or indirectly) by
physicians, Immediate Family Members of physicians or other Persons who are in
a position to make or influence referrals to or otherwise generate business
for the Company or any Company Subsidiary, the names of each physician or
other such owner and the percentage interest of each owner of the Company
Subsidiary ("Joint Venture Subsidiaries"). The terms upon which physicians,
Immediate Family Members of physicians and other Third Party investors in a
position to make or influence referrals to or otherwise generate business for
the applicable Company Subsidiary were offered investment interests in the
Joint Ventures Subsidiaries were no different than the terms offered to Third
Party investors not in a position to make referrals and were not related to
the previous or expected volume or value of referrals, items or services
furnished or the amount of business otherwise generated by the physician,
Immediate Family Member or Third Party investors to the applicable Company
Subsidiary. There is no requirement that physician owners or non-owners
attending patients of a Joint Venture Subsidiary make referrals to, furnish
items or services to, or otherwise generate business for the Joint Venture
Subsidiary in order to remain an owner of or to be eligible to provide
services at the Joint Venture Subsidiary. All Joint Venture Subsidiary
distributions or payments to owners are directly proportional to the owner's
capital investment in the Joint Venture Subsidiary. Except as set forth in
Section 3.13(b) of the Company Disclosure Letter, neither the Company nor any
Company Subsidiary has loaned funds to, or guaranteed a loan for, any Third
Party investor for use by such Third Party investor in investing in a Joint
Venture Subsidiary.

  

  

 

 

 

  

 

24  

  

 

 

 

  

  

(c) Section 3.13(c) of the Company Disclosure Letter contains a complete list
of all agreements between the Company or any Company Subsidiary, on one hand,
and any physician or Immediate Family Member of a physician on the other hand,
including all medical director agreements, equipment or space leases and
sublease agreements ("Physician Contracts"). True and complete copies of all
Physician Contracts in effect on the date hereof have been made available to
Parent on or prior to the date hereof. Except as set forth in Section 3.13(c)
of the Company Disclosure Letter, each Physician Contract is in full force and
effect, is on commercially reasonable terms, is in writing and is signed by
the parties thereto with an initial term of at least one year. The
compensation or rental charge of each Physician Contract was negotiated at
arms' length, is consistent with fair market value and was not determined in a
manner that takes into account the volume or value of any referrals or
business otherwise generated between the parties or using a percentage-based
or per unit of service compensation formula. Except as set forth in Section
3.13(c) of the Company Disclosure Letter, each Physician Contract involving
the lease of equipment or space is for the full time use of the equipment or
space by the lessee. No Physician Contract for the lease of space or equipment
exceeds that which is reasonably necessary for the legitimate business
purposes of the lease or rental.

  

  

(d) Each Company Subsidiary is in compliance with the anti-kickback provisions
of the federal Social Security Act, 42 U.S.C. Sections 1320a-7a and 7b (in all
material respects), and the federal anti-physician self referral Law commonly
known as the "Stark" law (42 U.S.C. Section 1395nn) (the "Stark Law"), and
equivalent state Laws, as those Laws relate to the ownership interests in the
Company and in Company Subsidiaries and any financial relationships or
compensation arrangements that the Company or any Company Subsidiary may have
with any partners, owners or Affiliates of the Company or any Company
Subsidiary or with any health care facility or physician, including any
medical director. Neither the Company nor any Company Subsidiary furnishes any
items or services considered "designated health services" under the Stark Law
or any item or service (including outpatient prescription drugs) not excluded
from Stark Law restrictions under applicable Regulations.

  

  

(e) The Company's and each of the Company Subsidiaries' billing practices are
in compliance in all material respects with all Laws and, where applicable, in
compliance with all contracts with insurance companies, health maintenance
organizations and other managed care and third-party payors. Neither the
Company nor any Company Subsidiary, and, to the Knowledge of the Company, none
of the predecessors of the Company or any Company Subsidiaries, in respect of
any dialysis or other business to which the Company or any Company Subsidiary
succeeded, and, to the Knowledge of the Company, no Person providing
professional, billing, management or marketing services to or on behalf of the
Company or any Company Subsidiary, has engaged in any activities that are
prohibited under 42 U.S.C. Section 1320a-7b, 42 U.S.C. Section 1320a-7, 42
U.S.C. Section 1395nn or 31 U.S.C. Section 3729-3733, inclusive of the federal
False Claims Act (or any other federal or state statute related to false or
fraudulent claims) or the Regulations promulgated under such statutes
including the following: (i) making or causing to be made a false statement or
representation of a fact in any application for any benefit or payment from
any federal or state health care program, including Medicare and Medicaid,
(ii) making or causing to be made any false statement or representation of a
fact for use in determining rights to any benefit or payment from any federal
or state health care program, including Medicare and Medicaid, (iii) failing
to disclose knowledge by a claimant of the occurrence of any event affecting
the initial or continued right to any benefit or payment on its own behalf or
on behalf of another, and (iv) soliciting, offering, paying or receiving any
remuneration (including any kickback, bribe or rebate), directly or
indirectly, overtly or covertly, in cash or in kind or offering to pay or
receive such remuneration (A) in return for referring an individual to a
Person for the furnishing or arranging for the furnishing of any item or
service for which payment may be made in whole or in part by any federal or
state health care program, including Medicare and Medicaid, or (B) in return
for purchasing, leasing or ordering or arranging for or recommending
purchasing, leasing, or ordering any good, facility, service or item for which
payment may be made in whole or in part by any federal or state health care
program, including Medicare and Medicaid.

  

  

 

 

 

  

 

25  

  

 

 

 

  

  

(f) (i) None of the Company, any Company Subsidiary or, to the Knowledge of
the Company, any of their respective predecessors in respect of any dialysis
or other business to which any of the Company and the Company Subsidiaries
have succeeded, has engaged in activities that are prohibited under the
applicable administrative simplification provisions of the Health Insurance
Portability and Accountability Act of 1996, including the criminal provisions
thereunder related to federal health care offenses, or any Regulations
promulgated thereunder (collectively, "HIPAA"), and (ii) the Company and the
Company Subsidiaries have complied in all material respects with HIPAA,
including applicable HIPAA administrative simplification provisions and the
standards and regulations regarding privacy, security and transaction and code
set standards, as well as applicable state Laws and Regulations respecting
privacy and data security. Except as set forth in Section 3.13(f) of the
Company Disclosure Letter, there are no current and since December 31, 2006
there have not been, any breaches of HIPAA, or the Regulations promulgated
thereunder, including any breach of the privacy standards or an unauthorized
disclosure of protected health information, and no notifications or reports
have been issued by or required to be filed by the Company or any Company
Subsidiary to patients of the Centers or with any Governmental Entity with
respect to a breach of HIPAA or applicable state Laws and Regulations
respecting privacy and security.

  

  

(g) The Company currently maintains in respect of the operations of the
Company and each Company Subsidiary a compliance program designed to promote
compliance with applicable Laws and ethical standards (including those Laws
described in Section 3.13(d) and (e) hereof and Laws requiring written
identity theft prevention programs (e.g., the FTC "Red Flag" rules)), to
improve the quality and performance of operations, and to detect, prevent, and
address violations of legal or ethical standards applicable to the operations
of its business (the "Compliance Program"). To the Company's Knowledge, the
Compliance Program incorporates any applicable guideline issued by the U.S.
Department of Health and Human Services and other federal and state agencies.
The Company has conducted its operations in accordance with all material
requirements of its Compliance Program. The Company has not received any
notice that (i) any Person providing services under the Contracts, including
the Physician Contracts, or (ii) any employee or contractor, in either case of
clause (i) or (ii), has been charged with, or has been convicted of, a
criminal offense related to the Medicare, Medicaid or TRICARE programs, or the
provision of health care items or services but has not yet been excluded,
debarred or otherwise declared ineligible to participate in such programs or
is proposed for exclusion therefrom. The Company is not in the process of
preparing and has not previously submitted or filed any voluntary disclosure
report to any Governmental Entity, including with the U.S. Department of
Health and Human Service's Office of Inspector General pursuant to its
provider self-disclosure protocol.

  

  

(h) Prior to the date hereof, the Company has delivered to Parent true,
correct and complete copies of Compliance Certificates executed by the persons
set forth in Section 3.13(h)(ii) of the Company Disclosure Letter.

  

  

 

 

 

  

 

26  

  

 

 

 

  

  

Section 3.14 Legal Proceedings. Except as disclosed in Section 3.14 of the
Company Disclosure Letter, neither the Company nor any of the Company
Subsidiaries is a party to, and there are no pending or, to the Knowledge of
the Company, threatened, Proceedings of any nature against the Company or any
of the Company Subsidiaries or to which any of their assets are subject. There
is no Order or settlement agreement imposed upon the Company, any of the
Company Subsidiaries or the assets of the Company or any of the Company
Subsidiaries (or that, upon consummation of the Offer or the Merger, would
apply to Parent or any of its Subsidiaries).

  

  

Section 3.15 Employee Benefit Plans.

  

  

(a) Section 3.15(a)(i) of the Company Disclosure Letter lists all Company
Benefit Plans. With respect to each Company Benefit Plan, the Company has made
available to Parent true, correct and complete copies of (where applicable)
(i) any and all plan documents (including trust agreements), summary plan
descriptions, summaries of material modifications, amendments and resolutions
related to such Company Benefit Plan, (ii) the three most recent audited
financial statements and actuarial valuation reports, if any, (iii) the three
most recent IRS Form 5500 Annual Reports, if any, (iv) the most recent IRS
determination letters or opinion letters, if any, and all material
communications to or from the IRS or any other Governmental Entity, and (vi)
any and all insurance Contracts and other Contracts related to such Company
Benefit Plan. Except as set forth in Section 3.15(a)(ii) of the Company
Disclosure Letter, there are no restrictions on the ability of the Company or
Parent or Merger Sub to amend or terminate any Company Benefit Plan.

  

  

(b) There has been no non-exempt "prohibited transaction" (as such term is
defined in Section 406 of ERISA and Section 4975 of the Code) with respect to
any Company Benefit Plan.

  

  

(c) Each Company Benefit Plan has been maintained and administered in
compliance with its terms and the provisions of applicable Laws. All equity
compensation awards issued by the Company have been made, accounted for,
reported and disclosed in accordance with applicable Law, accounting rules and
stock exchange requirements. Each Company Benefit Plan that is intended to be
qualified under Section 401(a) of the Code is so qualified.

  

  

(d) No Company Benefit Plan is an "employee benefit pension plan" (within the
meaning of Section 3(2) of ERISA) subject to Title IV of ERISA, and neither
the Company nor any of its ERISA Affiliates has ever incurred any liability
under Title IV of ERISA, and no condition exists that presents a material risk
to the Company or any of its ERISA Affiliates of incurring any liability under
such Title. No Company Benefit Plan is subject to Sections 302, 303, 304, or
305 of ERISA or Sections 412, 430, 431 or 432 of the Code. None of the Company
or any of its ERISA Affiliates has incurred any liability under such Sections,
and no condition exists that presents a material risk to the Company or any of
its ERISA Affiliates of incurring a liability under such Sections. No Company
Benefit Plan is a "multiemployer plan" (within the meaning of Section
4001(a)(3) of ERISA) or a "multiple employer welfare arrangement" (within the
meaning of Section 3(40) of ERISA), and none of the Company or any of its
ERISA Affiliates has ever contributed to or had an obligation to contribute,
or incurred any liability in respect of a contribution, to any multiemployer
plan or multiple employer welfare arrangement.

  

  

 

 

 

  

 

27  

  

 

 

 

  

  

(e) There are no pending or, to the Knowledge of the Company, threatened
claims (other than routine claims for benefits), and no pending or, to the
Knowledge of the Company, threatened Proceedings against any Company Benefit
Plan, or against the assets of any Company Benefit Plan, and, to the Knowledge
of the Company, no facts or circumstances exist that could reasonably be
expected to give rise to any such claims or Proceedings.

  

  

(f) No Company Benefit Plan subject to Title I or ERISA holds any "employer
security" or "employer real property" (each as defined in Section 407(d) of
ERISA).

  

  

(g) Each compensation arrangement between the Company and a service provider
and each Company Benefit Plan that is subject to Section 409A of the Code
complies with Section 409A of the Code (and has so complied for the entire
period during which Section 409A of the Code has applied to such arrangement
or Company Benefit Plan). None of the transactions contemplated by this
Agreement will constitute or result in a deferral of compensation subject to
Section 409A of the Code.

  

  

(h) Except as set forth on Section 3.15(h) of the Company Disclosure Letter,
neither the execution of this Agreement or the consummation of the
transactions contemplated by this Agreement (either alone or in combination
with any other event) will (i) entitle any Employee or former Employee,
director or officer of the Company or any of the Company Subsidiaries to
severance pay, unemployment compensation or any other payment or benefit, (ii)
accelerate the time of payment or vesting, or increase the amount of any
compensation due to, any Employee or former Employee, director or officer of
the Company or any of the Company Subsidiaries, or (iii) require the Company
to place in trust or otherwise set aside any amounts in respect of severance
pay or any other payment or benefit.

  

  

(i) Except as set forth in Section 3.15(i) of the Company Disclosure Letter,
since December 31, 2004, all payments, awards, grants or bonuses made or other
property provided pursuant to any Company Benefit Plan, Contract or
arrangement (written or otherwise) have been, or will be, fully deductible
notwithstanding Sections 162(m) and 280G of the Code.

  

  

(j) Each Company Benefit Plan that is a "group health plan" (within the
meaning of Section 5000(b)(1) of the Code) has been operated in compliance in
all material respects with the group health plan continuation coverage
requirements of Section 4980B of the Code and Sections 601 through 608 of
ERISA ("COBRA Coverage") or similar state Law, Section 4980D of the Code and
Sections 701 through 707 of ERISA, Title XXII of the U.S. Public Health
Service Act and the provisions of the U.S. Social Security Act, to the extent
such requirements are applicable. No Company Benefit Plan obligates the
Company to provide benefits (whether or not insured) to any Employee or former
Employee, consultant or other service provider of or to the Company following
such individual's termination of employment or consultancy, other than COBRA
Coverage or coverage mandated by state Law. No Company Benefit Plan is funded
through a "welfare benefit fund" as defined in Section 419 of the Code.

  

  

 

 

 

  

 

28  

  

 

 

 

  

  

Section 3.16 Taxes. Except as described in Section 3.16 of the Company
Disclosure Letter:

  

  

(a) The Company and each Company Subsidiary has duly and timely filed or
caused to be duly and timely filed all material Tax Returns required to be
filed by or with respect to them (all such Tax Returns being accurate, correct
and complete in all material respects) and has paid all Taxes shown on any
such Tax Returns;

  

  

(b) The Company and each Company Subsidiary has duly paid all material Taxes
that have been incurred or are due or claimed to be due from any of them,
other than Taxes that (i) are not yet delinquent and have been fully and
adequately reserved against under GAAP, or (ii) are being contested in good
faith, have not been finally determined and have been fully and adequately
reserved against under GAAP;

  

  

(c) There are no material foreign, federal, state or local Tax audits or
administrative or judicial Tax proceedings or disputes pending or being
conducted, or written claims asserted, for Taxes or assessments upon the
Company or any Company Subsidiary for which the Company has not fully and
adequately reserved against under GAAP;

  

  

(d) Except for statutory Liens for Taxes not yet delinquent, (i) there are no
Liens for unpaid Taxes upon any of the assets of the Company or any Company
Subsidiary, and (ii) no claim for unpaid Taxes has been made by any taxing
authority that could give rise to any such Lien;

  

  

(e) Neither the Company nor any Company Subsidiary has agreed to or granted
any extension or waiver of the statute of limitations period applicable to any
Tax, or agreed to any extension of time with respect to a Tax assessment or
deficiency, which (after giving effect to such extension or waiver) has not
yet expired;

  

  

(f) No power of attorney granted by the Company or any Company Subsidiary with
respect to any Tax is currently in force;

  

  

(g) Neither the Company nor any Company Subsidiary is a party to or is bound
by any Tax sharing, Tax allocation or other agreement, Tax indemnification
agreement or arrangement or similar written or oral agreement, arrangement,
understanding or practice with respect to Taxes (other than such an agreement
or arrangement exclusively between or among the Company and the Company
Subsidiaries);

  

  

(h) The Company and each Company Subsidiary has complied in all material
respects with all applicable Laws relating to the payment or withholding of
Taxes and has, within the time and in the manner prescribed by applicable Law,
withheld and paid over to the relevant Tax authority all Taxes required by
applicable Law to have been withheld and paid;

  

  

(i) The Company has never been a United States real property holding
corporation within the meaning of Section 897(c)(2) of the Code;

  

  

 

 

 

  

 

29  

  

 

 

 

  

  

(j) Neither the Company nor any Company Subsidiary has distributed the stock
of another Person, or had its stock distributed by another Person, in a
transaction that was purported or intended to be governed by Sections 355 or
361 of the Code;

  

  

(k) The Company and each Company Subsidiary has disclosed on its Tax Returns
all positions taken therein that could give rise to a substantial
understatement of federal income tax within the meaning of Sections 6662 or
6662A of the Code. The Company has not engaged in, nor has any liability for
the payment of any Tax resulting from another Person's engagement in, any
transactions described as a "reportable transaction" in Treasury Regulations
Section 1.6011-4(b), including any transaction that is the same or
substantially similar to a transaction which the IRS has determined to be a
tax avoidance transaction or which the IRS has identified through a notice,
Treasury Regulation or other form of published guidance as a "listed
transaction," as such term is defined in Treasury Regulations Section
1.6011-4(b)(2);

  

  

(l) Neither the Company nor any Company Subsidiary is a party to any
agreement, contract, arrangement or plan that has resulted, or could result,
individually or in the aggregate, upon the consummation of the transactions
contemplated by this Agreement (i) in the payment of "excess parachute
payments" within the meaning of Section 280G of the Code, or (ii) in an
obligation to indemnify, gross-up or otherwise compensate any Person, in whole
or in part, for any excise tax under Section 4999 of the Code that is imposed
on such Person or any other Person; and

  

  

(m) Neither the Company nor any Company Subsidiary (i) is or has been a member
of an affiliated group of corporations within the meaning of Section 1504 of
the Code or any group that has filed an affiliated, combined, consolidated or
unitary Tax Return (other than the group of which the Company was the common
parent), or (ii) has any liability for the Taxes of any Person (other than the
Company or any Company Subsidiary) under Treasury Regulations Section 1.1502-6
(or any similar provision of state, local or foreign Law), as a transferee or
successor, by contract or otherwise.

  

  

Section 3.17 Intellectual Property.

  

  

(a) The Company and the Company Subsidiaries collectively own all right, title
and interest in, or have the valid right to use, all of the Company IP, free
and clear of any Liens, and there are no obligations to, covenants to or
restrictions from Third Parties affecting the Company's or any Company
Subsidiary's use, enforcement, transfer or licensing of the Owned Company IP.

  

  

(b) The Owned Company IP and Licensed Company IP constitute all the
Intellectual Property necessary and sufficient to conduct the businesses of
the Company and the Company Subsidiaries as they are currently conducted, and
as they have been conducted since December 31, 2008.

  

  

(c) The Owned Company IP and, to the Knowledge of the Company, Licensed
Company IP, are valid and enforceable.

  

  

(d) Neither the Company nor any of the Company Subsidiaries has infringed,
misappropriated or otherwise violated any Intellectual Property of any Third
Party.

  

  

 

 

 

  

 

30  

  

 

 

 

  

  

(e) No Owned Company IP or Licensed Company IP is being used or enforced in a
manner that would result in the abandonment, cancellation or unenforceability
of such Intellectual Property. To the Knowledge of the Company, no Third Party
has infringed, misappropriated or otherwise violated any Owned Company IP.

  

  

Section 3.18 Labor Matters.

  

  

(a) Neither the Company nor any of the Company Subsidiaries is a party to, or
bound by, any collective bargaining agreement or other Contract or
understanding with a labor union or labor organization. No labor organization
or group of Employees of the Company or of any of the Company Subsidiaries has
made a demand for recognition or certification, and there are no
representation or certification Proceedings or petitions seeking a
representation proceeding currently pending or, to the Knowledge of the
Company, threatened to be brought or filed with the National Labor Relations
Board or any other labor relations tribunal or authority. There are no
organizing activities, strikes, work stoppages, slowdowns, lockouts, material
arbitrations or material grievances or other material labor disputes pending
or, to the Knowledge of the Company, threatened against or involving the
Company or any of the Company Subsidiaries.

  

  

(b) Each of the Company and the Company Subsidiaries is in compliance in all
respects with all applicable Laws and collective bargaining agreements
respecting employment and employment practices, terms and conditions of
employment, worker classification (including the proper classification of
workers as independent contractors and consultants), wages and hours and
occupational safety and health, including the Immigration Reform and Control
Act, and is not engaged in any unfair labor practice.

  

  

(c) Since December 31, 2006, (i) there has been no "mass layoff" or "plant
closing" as defined by the Worker Adjustment and Retraining Notification Act
of 1998 (the "WARN Act") in respect of the Company or any of the Company
Subsidiaries, and (ii) neither the Company nor any of the Company Subsidiaries
has been affected by any transactions or engaged in layoffs or employment
terminations sufficient in number to trigger application of any state, local,
or foreign Law or regulation which is similar to the WARN Act.

  

  

Section 3.19 Environmental Matters.

  

  

(a) To the Knowledge of the Company, the Company and the Company Subsidiaries
are and have been in compliance with all Environmental Laws, and are not in
default or violation of, and have not received any notices of violation with
respect to, any Environmental Laws in connection with the conduct of their
respective businesses or the ownership or operation of their respective
businesses, assets and Real Property.

  

  

(b) The Company and the Company Subsidiaries have obtained and hold all
Environmental Permits that are necessary to own, lease or operate their
properties, rights and other assets and are necessary for the lawful conduct
of their respective businesses under and pursuant to each, and the Company and
the Company Subsidiaries are and have been in compliance with all such
Environmental Permits. Such Environmental Permits are in full force and
effect, and there are no Proceedings pending or, to the Knowledge of the
Company, threatened that seek the revocation, cancellation, suspension or
adverse modification thereof. The consummation of the Merger, in and of
itself, would not cause any revocation, modification or cancellation of any
such Environmental Permit.

  

  

 

 

 

  

 

31  

  

 

 

 

  

  

(c) Neither the Company nor any of the Company Subsidiaries has received any
notice, demand, request for information, citation, summons or order, and there
are no Proceedings pending or, to the Knowledge of the Company, threatened
against the Company or any of the Company Subsidiaries or to which any of
their assets are subject, arising out of or relating to (i) any remedial
obligations under any applicable Environmental Law, (ii) violations by the
Company or any of the Company Subsidiaries of any Environmental Law, (iii)
personal injury or property damage claims relating to a Release of Hazardous
Materials, or (iv) response, removal, or remedial costs under the
Comprehensive Environmental Response, Compensation, and Liability Act
("CERCLA") or any similar state Law.

  

  

(d) To the Knowledge of the Company, no portion of the Real Property or any
other property formerly owned, leased or operated by the Company or any of the
Company Subsidiaries is part of a site listed on the National Priorities List
under CERCLA or any similar ranking or listing under any state Law.

  

  

(e) To the Knowledge of the Company, all Hazardous Materials generated by the
Company and any of the Company Subsidiaries have been transported, stored,
treated and disposed of by carriers or treatment, storage and disposal
facilities authorized or maintaining valid permits under all applicable
Environmental Laws.

  

  

(f) To the Knowledge of the Company, no Person has Released any Hazardous
Materials on, at, or under the Real Property or any other property formerly
owned, leased or operated by the Company or any of the Company Subsidiaries.

  

  

(g) The Company and the Company Subsidiaries have not generated, manufactured,
stored, transported, treated, recycled, disposed of, Released or otherwise
handled in any way any Hazardous Materials on, at, under, or about the Real
Property or any other property formerly owned, leased or operated by the
Company or any of the Company Subsidiaries, except in compliance with
Environmental Laws.

  

  

(h) Neither the Company nor any of the Company Subsidiaries is currently
operating or required to be operating the Company, the Company Subsidiaries,
or any of their assets under any compliance order, schedule, decree or
agreement, any consent decree, order or agreement, or corrective action
decree, order or agreement issued or entered into under any Environmental Law.

  

  

(i) The Company and the Company Subsidiaries have provided Parent and Merger
Sub with copies of all environmental audits, evaluations, assessments,
studies, tests or other evaluations of the Real Property or any other property
formerly owned, leased or operated by the Company or any of the Company
Subsidiaries that are in the possession or subject to the control of the
Company, the Company Subsidiaries, or any of their consultants, agents or
representatives.

  

  

Section 3.20 State Takeover Laws. The Company Board has unanimously approved
this Agreement, the Offer, the Merger and the other transactions contemplated
hereby and has taken all actions necessary so that no anti-takeover statute or
regulation, including any affiliate transaction or control share acquisition,
in each case under the FBCA, including Sections 607.0901 and 607.0902 of the
FBCA, or other applicable Laws of the State of Florida (collectively,
"Takeover Statutes") shall be applicable to the execution, delivery or
performance of this Agreement, the Offer, the consummation of the Merger and
the other transactions contemplated by this Agreement.

  

  

 

 

 

  

 

32  

  

 

 

 

  

  

Section 3.21 Insurance. Section 3.21 of the Company Disclosure Letter lists
all insurance policies of the Company or any of the Company Subsidiaries
covering the assets, business, equipment, properties, operations, Employees,
officers and directors of the Company and the Company Subsidiaries
(collectively, the "Insurance Policies"). All of the Insurance Policies or
renewals thereof are in full force and effect. There is no material claim by
the Company or any of the Company Subsidiaries pending under any of the
Insurance Policies as to which the Company has been notified that coverage has
been questioned, denied or disputed by the underwriters of such policies. All
premiums due and payable under all of the Insurance Policies have been paid,
and the Company and the Company Subsidiaries are otherwise in compliance with
the terms of such policies. Neither the Company nor any Company Subsidiary has
received written notice of termination of, or material premium increase with
respect to, any Insurance Policy. Section 3.21 of the Company Disclosure
Letter identifies each material insurance claim made by the Company or any of
the Company Subsidiaries since the Company Balance Sheet Date and each pending
material insurance claim.

  

  

Section 3.22 Interested Party Transactions. Except for Contracts disclosed on
Section 3.22 of the Company Disclosure Letter, neither the Company nor any of
the Company Subsidiaries is a party to any transaction or agreement with any
Affiliate, shareholder that beneficially owns 5% or more of the Company Common
Stock, or director or officer of the Company or, to the Knowledge of the
Company, any Affiliate of any such owner, officer or director. No event has
occurred since December 31, 2006 that would be required to be reported by the
Company pursuant to Item 404 of Regulation S-K promulgated by the SEC that has
not been so reported as required by Item 404 of Regulation S-K prior to the
date hereof.

  

  

Section 3.23 Compliance with the U.S. Foreign Corrupt Practices Act and Other
Applicable Anti-Corruption Laws.

  

  

(a) The Company and the Company Subsidiaries have complied with the U.S.
Foreign Corrupt Practices Act of 1977 and all other applicable anti-corruption
Laws.

  

  

(b) Neither the Company nor any of the Company Subsidiaries nor any director,
officer, agent, Employee or representative of the Company or any of the
Company Subsidiaries at the direction of or on behalf of the Company or any of
the Company Subsidiaries has corruptly or otherwise illegally offered or given
anything of value to: (i) any official, employee or representative of a
Governmental Entity, any political party or official thereof, or any candidate
for political office, or (ii) any other Person, in any such case while
knowing, or having reason to know, that all or a portion of such money or
thing of value may be offered, given or promised, directly or indirectly, to
any official, employee or representative of a Governmental Entity, any
political party or official thereof, or candidate for political office for the
purpose of the following: (x) influencing any action or decision of such
Person, in his or her official capacity, including a decision to fail to
perform his or her official function, (y) inducing such Person to use his or
her influence with any Governmental Entity to affect or influence any act or
decision of such Governmental Entity to assist in obtaining or retaining
business or to secure an improper business advantage, or (z) where such
payment would constitute a bribe, kickback or illegal or improper payment to
assist the Company or any of the Company Subsidiaries in obtaining or
retaining business for, or with, or directing business to, any Person or in
securing any improper advantage.

  

  

(c) There have been no false or fictitious entries made in the books or
records of the Company or any of the Company Subsidiaries relating to any
illegal payment or secret or unrecorded fund and neither the Company nor any
of the Company Subsidiaries has established or maintained a secret or
unrecorded fund.

  

  

 

 

 

  

 

33  

  

 

 

 

  

  

Section 3.24 Opinion of Financial Advisor; Brokers. The Company has received a
written opinion of Dresner Investment Services, Inc. (the "Company Financial
Advisor"), dated as of the date hereof, to the effect that, as of the date
hereof, and based upon and subject to the factors and assumptions set forth
therein, the consideration to be received by the holders of Company Common
Stock in the Offer and the Merger is fair from a financial point of view to
such holders. Such opinion has not been amended or rescinded. The Company has
furnished to Parent copies of all Contracts to which the Company or any
Company Subsidiary and the Company Financial Advisor is a party pursuant to
which the Company Financial Advisor would be entitled to any payment relating
to the transactions contemplated by this Agreement. Other than the Company
Financial Advisor, no broker, finder, investment banker or other Person is
entitled to any brokerage, finder's or other fee or commission in connection
with the transactions contemplated by this Agreement.

  

  

Section 3.25 No Discussions. Neither the Company nor any Company
Representative is engaged, directly or indirectly, in any discussions or
negotiations with any other Third Party relating to any Alternative Proposal
or Alternative Transaction. The Company has not, directly or indirectly,
terminated or waived any rights under any confidentiality, "standstill," non-
solicitation or similar agreement with any Third Party to which the Company is
or was a party or under which the Company has or had any rights.

  

  

Section 3.26 Vote Required. If required under applicable Legal Requirements in
order to permit the consummation of the Merger, the affirmative vote of the
holders of a majority of the shares of Company Common Stock outstanding on the
record date for the Shareholders Meeting (the "Required Company Shareholder
Vote") is the only vote of the holders of any class or series of the Company's
capital stock necessary to approve this Agreement, approve the Merger or
consummate any of the other transactions contemplated by this Agreement.

  

  

Section 3.27 Compensation Arrangements. On or prior to the date hereof, the
Compensation Committee has (a) approved each Company Benefit Plan or other
arrangement, understanding or agreement, and each amendment or supplement
thereto or modification thereof, pursuant to which any payments have been or
are to be made or benefits have been or are to be granted to any officer,
director or employee of the Company or any of its Subsidiaries (collectively,
the "Compensation Arrangements") as an "employment compensation, severance or
other employee benefit arrangement" within the meaning of Rule 14d-10(d)(2)
under the Exchange Act, and (b) taken all other action necessary to satisfy
the requirements of the nonexclusive safe harbor with respect to such
Compensation Arrangements in accordance with Rule 14d-10(d)(2) under the
Exchange Act (the approvals and actions referred to in clauses (a) and (b)
above, the "Compensation Arrangement Approvals"); all payments made or to be
made and benefits granted or to be granted pursuant to such Compensation
Arrangements (i) were, or will be, paid or granted as compensation for past
services performed, future services to be performed, or future services to be
refrained from being performed, by such officer, director or employee, and
(ii) were not, and will not, be calculated based on the number of securities
tendered or to be tendered in the Offer by such director, officer or employee.
The Company Board has determined that each of the members of the Compensation
Committee are, and the members of the Compensation Committee are, "independent
directors" in accordance with the requirements of Rule 14d-10(d)(2) under the
Exchange Act and the instructions thereto.

  

  

 

 

 

  

 

34  

  

 

 

 

  

  

Section 3.28 Company Information. None of the information to be supplied by or
on behalf of the Company for inclusion or incorporation by reference in (i)
the Offer Documents or the Schedule 14D-9 will, at the date the Offer
Documents or the Schedule 14D-9 are first mailed to the holders of Company
Common Stock and at any time between the time the Offer Documents or the
Schedule 14D-9 are mailed to the holders of Company Common Stock and the
Acceptance Time (taking into account all amendments to the Offer Documents and
Schedule 14D-9 filed by the Company subsequent to such mailing), contain any
untrue statement of a material fact or omit to state any material fact
required to be stated therein or necessary in order to make the statements
therein, in light of the circumstances under which they were made, not
misleading, or (ii) any other document filed with any other regulatory agency
in connection herewith will, at the time such document is filed, contain any
untrue statement of a material fact or omit to state any material fact
required to be stated therein or necessary to make the statements therein, in
light of the circumstances under which they were made, not misleading, except
that no representation or warranty is made by the Company with respect to
statements made or incorporated by reference therein based on information
supplied by or on behalf of Parent or any of its Subsidiaries for inclusion or
incorporation by reference in the Offer Documents or the Schedule 14D-9 and,
if applicable, for inclusion or incorporation by reference in the Proxy
Statement). The Schedule 14D-9 (and, if applicable, Proxy Statement) will
comply as to form in all material respects with the requirements of the
Exchange Act.

  

  

Section 3.29 Full Disclosure. This Agreement (including the Company Disclosure
Letter) does not, and will not, (a) contain any representation, warranty or
information that is false or misleading with respect to any material fact, or
(b) omit to state any material fact necessary in order to make the
representations, warranties and information contained and to be contained
herein (in the light of the circumstances under which such representations,
warranties and information were or will be made or provided) not false or
misleading.

  

  

ARTICLE IV 
 

  

  

REPRESENTATIONS AND WARRANTIES OF PARENT AND MERGER SUB

  

  

Except as disclosed in the disclosure letter, dated as of the date of this
Agreement and delivered to the Company in connection with the execution and
delivery of this Agreement (the "Parent Disclosure Letter"), which disclosure
shall be subject to Section 9.12, Parent and Merger Sub hereby jointly and
severally represent and warrant to the Company as follows:

  

  

Section 4.1 Organization and Qualification; Subsidiaries. Each of Parent and
Merger Sub is a corporation duly organized, validly existing and in good
standing under the Laws of their respective jurisdiction of incorporation.
Since its date of incorporation, Merger Sub has not engaged in any activities
other than in connection with or as contemplated by this Agreement.

  

  

Section 4.2 Authorization of Agreement; No Violation.

  

  

(a) Each of Parent and Merger Sub has all necessary corporate power and
authority to execute and deliver this Agreement and to consummate the
transactions contemplated by this Agreement. The execution and delivery by
Parent and Merger Sub of this Agreement and the consummation by Parent and
Merger Sub of the transactions contemplated by this Agreement have been duly
authorized by all necessary corporate action on the part of Parent and Merger
Sub. This Agreement constitutes a valid and binding agreement of each of
Parent and Merger Sub, enforceable against Parent and Merger Sub in accordance
with its terms, except as such enforcement may be limited by (i) the effect of
bankruptcy, insolvency, reorganization, receivership, conservatorship,
arrangement, moratorium or other Laws affecting or relating to creditors'
rights generally, or (ii) the rules governing the availability of specific
performance, injunctive relief or other equitable remedies and general
principles of equity, regardless of whether considered in a proceeding in
equity or at law.

  

  

 

 

 

  

 

35  

  

 

 

 

  

  

(b) Neither the execution and delivery by Parent and Merger Sub of this
Agreement nor the consummation by Parent and Merger Sub of the Offer or the
Merger, will (with or without notice or lapse of time, or both) (i)
contravene, conflict with, or result in any violation or breach of any of the
provisions of Parent's or Merger Sub's certificate of incorporation or bylaws,
or (ii) assuming that the Parent Consents are duly obtained, (A) violate any
Law or Order applicable to Parent or any of its Subsidiaries or any of their
respective properties or assets, or (B) violate, conflict with, result in a
breach of any provision or the loss of any benefit under, constitute a default
(or an event which, with notice or lapse of time, or both, would constitute a
default) under, result in the termination of or a right of termination or
cancellation under, accelerate the performance required by, or result in the
creation of any Lien upon any property or asset of Parent or Merger Sub under,
any of the terms, conditions or provisions of any Contract to which Parent or
Merger Sub is a party or by which it or any of their respective properties or
assets are bound, except (in the case of clause (ii) above) for such matters
which would not reasonably be expected to have a Parent Material Adverse
Effect.

  

  

Section 4.3 Consents and Approvals. Except for (a) any approvals or filings
required by the HSR Act, (b) compliance with the applicable requirements of
the Exchange Act, the Securities Act and any other state or federal securities
Laws that may be required in connection with this Agreement and the
transactions contemplated by this Agreement, (c) the filing of the Articles of
Merger with the Secretary of State of the State of Florida pursuant to the
FBCA, (d) the consents, notices and approvals set forth in Section 4.3 of the
Parent Disclosure Letter (the consents referred to in clauses (a) through (d),
the "Parent Consents") and (e) such additional consents, notices and
approvals, the failure of which to make or obtain would not reasonably be
expected to have a Parent Material Adverse Effect, no consents or approvals of
any Governmental Entity or any Third Party are necessary in connection with
(i) the execution and delivery by Parent and Merger Sub of this Agreement and
(ii) the consummation by Parent and Merger Sub of the Merger and the other
transactions contemplated by this Agreement.

  

  

Section 4.4 Parent Information. None of the information to be supplied by or
on behalf of Parent or any of its Subsidiaries for inclusion or incorporation
by reference in (a) the Offer Documents or the Schedule 14D-9 will, at the
date the Offer Documents or the Schedule 14D-9 are first mailed to the holders
of Company Common Stock and at any time between the time the Offer Documents
or the Schedule 14D-9 are mailed to the holders of Company Common Stock and
the Acceptance Time (taking into account all amendments to the Offer Documents
or the Schedule 14D-9 subsequent to such mailing), contain any untrue
statement of a material fact or omit to state any material fact required to be
stated therein or necessary in order to make the statements therein, in light
of the circumstances under which they were made, not misleading, or (b) any
other document filed with any other regulatory agency in connection herewith
will, at the time such document is filed, contain any untrue statement of a
material fact or omit to state any material fact required to be stated therein
or necessary to make the statements therein, in light of the circumstances
under which they were made, not misleading; except that no representation or
warranty is made by Parent or Merger Sub with respect to statements made or
incorporated by reference therein based on information supplied by or on
behalf of the Company for inclusion or incorporation by reference in the Offer
Documents or the Schedule 14D-9 (and, if applicable, for inclusion or
incorporation by reference in the Proxy Statement). The Offer Documents will
comply as to form in all material respects with the requirements of the
Exchange Act.

  

  

 

 

 

  

 

36  

  

 

 

 

  

  

Section 4.5 Financing. Parent has delivered to the Company true and complete
copies of (a) the commitment letter, dated as of April 13, 2010 between Parent
and Royal Bank of Canada (as may be amended, amended and restated or otherwise
modified or replaced in accordance with Section 6.12, the "Debt Financing
Commitment"), pursuant to which Royal Bank of Canada (acting alone or through
or with affiliates selected by it) has agreed to lend up to $155,000,000 in
senior secured and $47,500,000 in mezzanine debt financing (any such
financings under the Debt Financing Commitment being collectively referred to
herein as the "Debt Financing") and (b) the commitment letters, dated as of
April 7, 2010 between Parent and SV Life Sciences Advisors, LLC, Thoma Cressey
Fund VIII, L.P., Salix Ventures II, L.P., and Salix Affiliates II, L.P. (the
"Sponsors") (the "Sponsor Financing Commitment" and, collectively with the
Debt Financing Commitment, the "Commitment Letters") pursuant to which the
Sponsors have agreed to provide equity financing in the amount set forth in
the Sponsor Financing Commitment in connection with the Debt Financing (the
"Sponsor Financing"). The Commitment Letters have not been amended or modified
prior to the date of this Agreement, and the respective commitments contained
in the Commitment Letters have not been withdrawn or rescinded in any respect.
The Commitment Letters are in full force and effect. There are no conditions
precedent or other contingencies related to the funding of the full amount of
the Debt Financing or the Sponsor Financing, other than as set forth in or
contemplated by the Commitment Letters. The aggregate proceeds to be disbursed
pursuant to the agreements contemplated by the Debt Financing Commitment and
the Sponsor Financing Commitment, together with cash on hand and other funds
available to Parent and Merger Sub, will be sufficient for Merger Sub to
purchase the shares of Company Common Stock pursuant to the Offer and the
Merger. As of the date of this Agreement, to the knowledge of Parent, there
are no facts or circumstances that create a basis for Parent to believe that
any of the conditions to the Debt Financing will not be satisfied or that the
Debt Financing or the Sponsor Financing will not be available to Parent or
Merger Sub at the Acceptance Time.

  

  

ARTICLE V 
 

  

  

CONDUCT PRIOR TO THE EFFECTIVE TIME

  

  

Section 5.1 Conduct of Business Prior to the Effective Time. Except as
expressly contemplated or permitted by this Agreement or with the prior
written consent of Parent, during the period from the date of this Agreement
and continuing until the earlier of the Board Appointment Date or the
termination of this Agreement, the Company shall, and shall cause each of the
Company Subsidiaries to, (a) conduct its business in the ordinary course
consistent with past practice and in compliance with all applicable Legal
Requirements, (b) maintain and preserve intact its business organizations and
business relationships, retain the services of its officers and Employees, and
maintain its rights and Permits, and (c) take no action that would reasonably
be expected to adversely affect or delay the ability of the Company, Parent or
Merger Sub to obtain any necessary approvals of any Governmental Entity
required for the transactions contemplated hereby or to perform its covenants
and agreements under this Agreement or to consummate the transactions
contemplated hereby.

  

  

Section 5.2 Company Forbearances. During the period from the date of this
Agreement and continuing until the earlier of the Board Appointment Date or
the termination of this Agreement, except as set forth in Section 5.2 of the
Company Disclosure Letter or except as expressly contemplated or permitted by
this Agreement, the Company shall not, and shall not permit any of the Company
Subsidiaries to, without the prior written consent of Parent:

  

  

(a) cause or permit any amendment, modification, alteration or rescission of
the Company Articles, the Company Bylaws or the certificate of incorporation,
bylaws or other charter or organizational documents of the Company
Subsidiaries;

  

  

(b) adjust, split, combine or reclassify any of its capital stock;

  

  

 

 

 

  

 

37  

  

 

 

 

  

  

(c) make, declare or pay any dividend or make any other distribution (whether
in cash, stock or property), or directly or indirectly redeem, purchase or
otherwise acquire any shares of its capital stock or any securities or
obligations convertible (whether currently convertible or convertible only
after the passage of time or the occurrence of certain events) into or
exchangeable for any shares of its capital stock (except (i) dividends or
distributions by any wholly owned Subsidiary of the Company to the Company or
another wholly owned Subsidiary thereof, and (ii) the acceptance of shares of
Company Common Stock in payment of the exercise price or withholding Taxes
incurred by any holder in connection with the exercise of Company Options or
the lapse of restrictions on Company Restricted Stock Units or Company
Restricted Shares);

  

  

(d) grant any stock options, stock appreciation rights, restricted shares,
restricted stock units, deferred equity units, awards based on the value of
the Company's capital stock or other equity-based award with respect to shares
of Company Common Stock under any of the Company Benefit Plans or otherwise,
or grant any individual, corporation or other entity any right to acquire any
shares of its capital stock;

  

  

(e) issue, deliver or sell or authorize or propose the issuance, delivery or
sale of, or purchase or propose the purchase of, any shares of its capital
stock, securities convertible into capital stock or other securities, or
subscriptions, rights, warrants or options to acquire, or other agreements or
commitments of any character obligating it to issue, any such shares of
capital stock, convertible securities or other securities, other than the
issuance of shares of Company Common Stock pursuant to the exercise of Company
Options or Company Restricted Stock Units outstanding as of the date of this
Agreement or the Top-Up Option;

  

  

(f) sell, transfer, pledge, lease, license, mortgage, encumber or otherwise
dispose of any of its material properties or assets, or cancel, release or
assign any material amount of indebtedness to any Person or any material
claims held by any Person, other than pursuant to Contracts in force at the
date of this Agreement;

  

  

(g) incur any indebtedness for borrowed money or assume, guarantee, endorse or
otherwise as an accommodation become responsible for the obligations of any
Third Party (other than any Company Subsidiaries) except in the ordinary
course of business consistent with past practice that does not exceed,
individually or in the aggregate, $200,000;

  

  

(h) (i) amend or otherwise modify, except in the ordinary course of business,
or knowingly violate, in each case in any material respect, the terms of, any
Material Contract, or (ii) create, renew or amend any agreement or Contract
or, except as may be required by applicable Law, other binding obligation of
the Company or the Company Subsidiaries containing (A) any material
restriction on the ability of the Company or the Company Subsidiaries to
conduct its business as it is presently being conducted, or (B) any material
restriction on the ability of the Company or its affiliates to engage in any
type of activity or business;

  

  

(i) make any capital expenditures, capital additions or capital improvements
except for such expenditures, additions, or improvements that do not exceed
$50,000 individually or $300,000 in the aggregate and are (i) in the ordinary
course of business consistent with past practice or (ii) for de novo openings;

  

  

 

 

 

  

 

38  

  

 

 

 

  

  

(j) except as required by existing written agreements or Company Benefit Plans
existing as of the date hereof, (i) increase in any manner the compensation or
benefits of any of the current or former directors, officers or employees of
the Company or the Company Subsidiaries (together, the "Covered Employees"),
(ii) pay any amounts to Covered Employees not required by any current plan or
agreement (other than base salary in the ordinary course of business), (iii)
become a party to, establish, amend, commence participation in, make any
adjustment, terminate or commit itself to the adoption of any stock option
plan or other stock-based compensation plan, compensation (including any
employee co-investment fund), severance, pension, retirement, profit-sharing,
welfare benefit, or other employee benefit plan or agreement or employment
agreement with or for the benefit of any Covered Employee (or newly hired
employees), (iv) accelerate the vesting of any stock-based compensation or
other long-term incentive compensation under any Company Benefit Plans, (v)
(A) hire employees in the position of director or above, or (B) terminate the
employment of any employee in the position of director or clinical
administrator or above (other than due to terminations for cause), or (vi)
take any action which could reasonably be expected to give rise to a "good
reason" (or any term of similar import) claim;

  

  

(k) acquire or agree to acquire by merging or consolidating with, or by
purchasing a substantial portion of the assets of, or by any other manner, any
business or any Person or otherwise acquire or agree to acquire any assets
which are material, individually or in the aggregate, to the Company and the
Company Subsidiaries (taken as a whole);

  

  

(l) implement or adopt any material change in its Tax accounting or financial
accounting methods, principles or practices, except as may be required by
applicable Law, GAAP, Regulation S-X or other Regulation promulgated by the
SEC;

  

  

(m) enter into any new line of business or change in any material respect its
business as currently conducted;

  

  

(n) transfer ownership, or grant any license or other rights, to any Person of
or in respect of any material Company IP, other than grants of non-exclusive
licenses pursuant to License Agreements entered into in the ordinary course of
business consistent with past practice;

  

  

(o) make any material investment either by purchase of stock or securities,
contributions to capital, property transfers, or purchase of any property or
assets of any other individual, corporation or other entity;

  

  

(p) take any action to exempt any Third Party or any action taken by any Third
Party from any Takeover Statute or similarly restrictive provisions of its
organizational documents or terminate, amend or waive any provisions of any
confidentiality or standstill agreements in place with any Third Parties;

  

  

(q) commence or settle any material claim, action or proceeding;

  

  

(r) take any action or fail to take any action that is intended or may
reasonably be expected to result in any of the conditions to the Offer set
forth in Annex I, or the Merger as set forth in Article VII, not being
satisfied;

  

  

(s) file or amend any material Tax Return, make or change any material Tax
election, or settle or compromise any material Tax liability, other than as
required by Law; or

  

  

 

 

 

  

 

39  

  

 

 

 

  

  

(t) agree to take, make any commitment to take, or adopt any resolutions of
its board of directors in support of, any of the actions prohibited by this
Section 5.2.

  

  

Nothing contained in this Agreement shall give Parent, directly or indirectly,
the right to control or direct the Company's or the Company Subsidiaries'
operations prior to the Acceptance Time. Prior to the Acceptance Time, the
Company shall exercise, consistent with the terms and conditions of this
Agreement, complete control and supervision over its and its Subsidiaries'
respective operations.

  

  

Section 5.3 Third Party Proposals

  

  

(a) The Company shall not (and shall not resolve or propose to), directly or
indirectly, and shall cause the Company Subsidiaries and each officer,
director, Employee, agent and representative of the Company and each Company
Subsidiary (including any accountant, attorney, investment banker, financial
advisor or other representatives of the Company) (collectively, the "Company
Representatives") to not (and to not resolve or propose to), directly or
indirectly: (i) solicit, initiate, encourage, induce, facilitate (including by
way of furnishing information) or take any other action to facilitate the
making, submission or announcement of any inquiries or proposals regarding any
merger, share exchange, consolidation, sale of assets, sale of shares of
capital stock (including by way of a tender offer) or similar transactions
involving the Company or any of the Company Subsidiaries that, if consummated,
would constitute an Alternative Transaction (any of the foregoing, including
any inquiries, proposals or, including the indication of any intention to
propose any of the foregoing, being referred to herein as an "Alternative
Proposal"), (ii) furnish any information regarding the Company or any of the
Company Subsidiaries to any Person in connection with or in response to any
Alternative Proposal or Alternative Transaction, (iii) conduct, engage in or
participate in any discussions or negotiations regarding an Alternative
Proposal or Alternative Transaction, or (iv) enter into any agreement
regarding any Alternative Proposal or Alternative Transaction.

  

  

(b) Notwithstanding anything to the contrary in Section 5.3(a), prior to the
Acceptance Time, Section 5.3(a) shall not prohibit the Company Board from
furnishing non-public information regarding the Company or the Company
Subsidiaries to, or entering into discussions or negotiations with, any Person
in response to (and in connection with) an unsolicited bona fide Alternative
Proposal that is submitted to the Company by such Person (and not withdrawn)
if: (i) neither the Company, the Company Subsidiaries nor Company
Representative shall have breached or taken any action inconsistent with any
of the provisions of Section 5.3, (ii) the Company Board reasonably
determines, after having taken into account the advice of the Company
Financial Advisor and the Company's outside legal counsel, that such
Alternative Proposal constitutes, or is reasonably likely to result in, a
Superior Proposal, (iii) the Company Board reasonably determines, after having
taken into account the advice of the Company's outside legal counsel, that
such action is required in order for the Company Board to comply with its
fiduciary obligations to the Company's shareholders under applicable Law, (iv)
at least two (2) Business Days prior to furnishing any such non-public
information to, or entering into discussions or negotiations with, such
Person, the Company gives Parent written notice of the identity of such Person
and of the Company's intention to furnish non-public information to, or enter
into discussions or negotiations with, such Person, and the Company receives
from such Person an executed confidentiality agreement containing customary
limitations on the use and disclosure of all non-public written and oral
information furnished to such Person by or on behalf of the Company, a
customary "standstill" provision, and such additional customary provisions no
less favorable to the Company than the provisions of the Confidentiality
Agreement, and (v) prior to or concurrently with furnishing any such non-
public information to such Person, the Company furnishes such non-public
information to Parent (to the extent such non-public information has not been
previously furnished by the Company to Parent). Without limiting the
generality of the foregoing, the Company acknowledges and agrees that any
action inconsistent with any of the provisions set forth in the preceding
sentence taken by any Company Representative, whether or not such Company
Representative is purporting to act on behalf of the Company or any Company
Subsidiary, shall be deemed to constitute a breach of Section 5.3(a) by the
Company.

  

  

 

 

 

  

 

40  

  

 

 

 

  

  

(c) If the Company, any Company Subsidiary or any Company Representative
receives an Alternative Proposal or any request for non-public information
prior to the Effective Time, then the Company shall promptly (but in no event
later than 24 hours after receipt of such Alternative Proposal or request)
advise Parent orally and in writing of such Alternative Proposal or request.
Such notice shall set forth the identity of the Third Party making or
submitting the Alternative Proposal or request, the material terms and
conditions thereof, and, if available, any written documentation received from
or on behalf of such Third Party setting forth such terms and conditions. The
Company shall keep Parent fully informed, on a current basis, of any changes
in the status of, and modification to, the terms of any such Alternative
Proposal or request, and provide to Parent as soon as practicable (and in any
event within 24 hours) after receipt or delivery copies of all correspondence
and other written material sent or provided to the Company or any of the
Company Subsidiaries from any Third Party with respect thereto, and notify
Parent orally and in writing if it determines to begin providing information
or to engage in discussions or negotiations concerning an Alternative Proposal
pursuant to Section 5.3. The Company shall also provide Parent at least 48
hours prior written notice of any meeting of the Company Board at which the
Company Board is reasonably expected to consider an Alternative Proposal. The
Company shall not enter into any confidentiality or other agreement that would
impede its ability to comply with its obligations under this Section 5.3(c).

  

  

(d) The Company shall, and shall ensure that the Company Subsidiaries, and
cause all Company Representatives to, immediately cease and cause to be
terminated, and shall not authorize or permit any of the Company
Representatives to continue, any and all existing activities, encouragement,
discussions or negotiations with any Third Party with respect to any of the
foregoing, and shall (i) immediately direct all Third Parties who have been
furnished confidential information regarding the Company or the Company
Subsidiaries in consideration of or discussions with respect to an Alternative
Proposal, Alternative Transaction or equity investment to promptly return or
destroy (and confirm destruction of) all such information and shall use its
reasonable best efforts to enforce its remedies under the applicable Contracts
with such Third Party (or such Third Party's Representative) and (ii) prohibit
any Third Party from having access to any physical or electronic data rooms
relating to a possible Alternative Proposal or Alternative Transaction. The
Company further agrees not to, and to cause the Company Subsidiaries not to,
waive, terminate, amend, modify or release any Third Party from, or permit the
waiver, termination, amendment, modification or release of, or fail to enforce
the confidentiality, "standstill" or similar provisions of any agreement to
which the Company or the Company Subsidiaries is or may become a party or
under which the Company or any of the Company Subsidiaries has or acquires any
rights. The Company shall immediately take all steps necessary to terminate
any approval that may have been heretofore given under any such provisions
authorizing any Third Party to make an Alternative Proposal. Neither the
Company nor the Company Board shall approve or take any action to render
inapplicable to any Alternative Proposal or Alternative Transaction Sections
607.0901 or 607.0902 of the FBCA or any similar Takeover Statutes or any
restrictive provision or any applicable anti-takeover provision in the Company
Articles or the Company Bylaws.

  

  

 

 

 

  

 

41  

  

 

 

 

  

  

(e) Except as permitted by Section 5.3(f) or Section 5.3(g), neither the
Company Board nor any committee thereof shall (i) fail to make, withdraw,
amend or modify, or publicly propose to withhold, withdraw, amend or modify,
in a manner adverse to Parent or Merger Sub, the unanimous Company Board
Recommendation, (ii) approve or recommend, or publicly propose to approve or
recommend, or cause or permit the Company or any of its Subsidiaries to
execute or enter into, any letter of intent, memorandum of understanding,
agreement in principle, merger agreement, acquisition agreement, option
agreement, joint venture agreement, partnership agreement or other similar
agreement constituting or relating to, or that is intended to, contemplates or
is reasonably likely to result in, an Alternative Transaction, other than a
confidentiality agreement referred to in Section 5.3(b) (an "Acquisition
Agreement") or resolve, agree or propose to take any such action, (iii)
approve, endorse, adopt or recommend, or publicly propose to approve, endorse,
adopt or recommend, any Alternative Proposal or Superior Proposal, (iv) fail
to recommend to the shareholders of the Company that they reject any tender
offer or exchange offer for the Company Common Stock and reaffirm the
unanimous Company Board Recommendation within ten (10) Business Days after the
commencement of such offer (or, if earlier, prior to the Acceptance Time), (v)
make any public statement inconsistent with the Company Board Recommendation,
or (vi) resolve or agree to take any of the foregoing actions (any of the
foregoing, an "Adverse Recommendation Change").

  

  

(f) Notwithstanding anything to the contrary contained in Section 5.3(e), the
Company Board may, at any time prior to the Acceptance Time, make an Adverse
Recommendation Change and thereafter may cause the Company to terminate this
Agreement in accordance with Section 8.1(h) and concurrently with such
termination cause the Company to enter into a Superior Proposal Definitive
Agreement in accordance and subject to compliance with the provisions of
Section 8.1(h), if: (i) an unsolicited bona fide, written Alternative Proposal
that did not otherwise result from a breach of the provisions of this Section
5.3 is made to the Company and is not withdrawn, (ii) the Company Board
reasonably determines, after having taken into account the advice of the
Company Financial Advisor, that such Alternative Proposal constitutes a
Superior Proposal, (iii) the Company Board reasonably determines, after having
taken into account the advice of the Company's outside legal counsel, that in
light of such Superior Proposal, an Adverse Recommendation Change is required
in order for the Company Board to comply with its fiduciary obligations to the
Company's shareholders under applicable Legal Requirements, (iv) prior to
effecting such Adverse Recommendation Change the Company Board shall have
given Parent at least five (5) Business Days' written notice: (A) that it has
received a Superior Proposal not in violation of the provisions of this
Section 5.3, (B) that it intends to make an Adverse Recommendation Change, and
(C) specifying the material terms and conditions of such Superior Proposal,
including the identity of the Person making such Superior Proposal (and
attaching the most current and complete version of any written agreement or
other document relating thereto) (it being understood and agreed that any
modification thereto shall require a new five (5) Business Days' advance
written notice by the Company), (v) during any such five (5) Business Day
notice period(s), if requested by Parent, the Company engages in good faith
negotiations with Parent to amend this Agreement in such a manner that no
Adverse Recommendation Change is legally required as a result of such Superior
Proposal, and (vi) at the end of any such five (5) Business Day notice period,
the Company Board reasonably determines that the failure to make an Adverse
Recommendation Change would still constitute a breach of the fiduciary
obligations of the Company Board to the Company's shareholders under
applicable Legal Requirements in light of such Superior Proposal (taking into
account any changes to the terms of this Agreement proposed by Parent as a
result of the negotiations required by clause (v) or otherwise).

  

  

 

 

 

  

 

42  

  

 

 

 

  

  

(g) Notwithstanding anything to the contrary contained in Section 5.3(e), the
Company Board may, at any time prior to the Acceptance Time, make an Adverse
Recommendation Change, if: (i) there shall occur or arise after the date of
this Agreement a material event, material development or material change in
circumstances that relates to the Company and the Company Subsidiaries (but
does not relate to any Alternative Proposal) that was not known to, or
reasonably foreseeable by, any of the Company or the Company Subsidiaries on
or prior to the date of this Agreement (or if known, the consequences of which
are not known to or reasonably foreseeable by the Company or the Company
Subsidiaries as of the date hereof), which event, development or change in
circumstance, or any material consequences thereof, becomes known to the
Company or the Company Subsidiaries prior to the Acceptance Time (any such
material event, material development or material change in circumstances
unrelated to an Alternative Proposal being referred to as an "Intervening
Event"), (ii) none of the Company, any Company Subsidiary or any Company
Representative had knowledge, as of the date of this Agreement, that there was
a reasonable possibility that such Intervening Event could occur or arise
after the date of this Agreement, (iii) the Company provides Parent, at least
five (5) Business Days prior to any meeting of the Company Board at which the
Company Board will consider and determine whether such Intervening Event may
require the Company to make an Adverse Recommendation Change pursuant to
clause (i) of the definition of Adverse Recommendation Change, with a written
notice specifying the date and time of such meeting, the reasons for holding
such meeting and a reasonably detailed description of such Intervening Event,
(iv) the Company Board reasonably determines, after having taken into account
the advice of the Company's outside legal counsel, that, in light of such
Intervening Event, an Adverse Recommendation Change pursuant to clause (i) of
the definition of Adverse Recommendation Change is required in order for the
Company Board to comply with its fiduciary obligations to the Company's
Shareholders under applicable Legal Requirements, (v) no Adverse
Recommendation Change pursuant to clause (i) of the definition of Adverse
Recommendation Change has been made for five (5) Business Days after receipt
by Parent of a written notice from the Company confirming that the Company
Board has determined that the failure to make such an Adverse Recommendation
Change in light of such Intervening Event would constitute a breach of its
fiduciary obligations to the Company's shareholders under applicable Legal
Requirements, (vi) during such five (5) Business Day notice period, if
requested by Parent, the Company engages in good faith negotiations with
Parent to amend this Agreement in such a manner that no such Adverse
Recommendation Change is legally required as a result of such Intervening
Event, and (vii) at the end of such five (5) Business Day notice period, the
Company Board reasonably determines that the failure to make such Adverse
Recommendation Change would still constitute a breach of the fiduciary
obligations of the Company Board to the Company's Shareholders under
applicable Legal Requirements in light of such Intervening Event (taking into
account any changes to the terms of this Agreement proposed by Parent as a
result of the negotiations required by clause (vi) or otherwise).

  

  

(h) Nothing contained in this Section 5.3 shall prevent the Company Board from
complying with Rule 14d-9 and Rule 14e-2(a) under the Exchange Act with regard
to an Alternative Proposal; provided that this Section 5.3(h) shall not be
deemed to permit the Company Board to make an Adverse Recommendation Change or
take any of the actions referred to in clause (ii) of Section 5.3(e) except,
in each case, to the extent permitted by Section 5.3(f) and Section 5.3(g).

  

  

(i) The Company shall ensure that the Company Subsidiaries are aware of, and
shall cause the Company Representatives to be aware of, the restrictions
described in this Section 5.3.

  

  

 

 

 

  

 

43  

  

 

 

 

  

  

ARTICLE VI 
 

  

  

ADDITIONAL AGREEMENTS

  

  

Section 6.1 Shareholders Meeting.

  

  

(a) If the approval of this Agreement by the Company's shareholders is
required by applicable Legal Requirements in order to consummate the Merger,
the Company shall, as promptly as practicable following the later of the
Acceptance Time or the expiration of any "subsequent offering period" provided
in accordance with Rule 14d-11 under the Exchange Act, acting through the
Company Board, take all action necessary under all applicable Laws to call,
give notice of, convene and hold a meeting of the holders of Company Common
Stock to vote on the approval of this Agreement (the "Shareholders Meeting").
The Company shall ensure that all proxies solicited in connection with the
Shareholders Meeting are solicited in compliance with all applicable Laws, and
shall, through the Company Board, recommend to its shareholders that they give
the Required Company Shareholder Vote.

  

  

(b) If the approval of this Agreement by the Company's Shareholders is
required by applicable Legal Requirements in order to consummate the Merger,
Parent and Merger Sub shall cause all shares of Company Common Stock owned by
Parent, Merger Sub or any other Subsidiary of Parent to be voted in favor of
the approval of this Agreement and consummation of the Merger at the
Shareholders Meeting.

  

  

(c) Notwithstanding anything to the contrary contained in this Agreement, if
Parent, Merger Sub or any other Subsidiary of Parent shall own, by virtue of
the Offer or otherwise, at least 80% (in the aggregate) of the outstanding
shares of Company Common Stock, the parties shall take all necessary and
appropriate action to cause the Merger to become effective as soon as
practicable after the Acceptance Time without a meeting of the holders of
Company Common Stock, in accordance with Section 607.1104 of the FBCA.

  

  

Section 6.2 Proxy Statement. If the approval of this Agreement by the
Company's Shareholders is required by applicable Legal Requirements in order
to consummate the Merger, the Company shall, as promptly as practicable
following the later of the Acceptance Time and the expiration of any
subsequent offering period provided in accordance with Rule 14d-11 under the
Exchange Act, prepare and file with the SEC the Proxy Statement, and shall:
(i) cause the Proxy Statement to comply in all material respects with the
applicable requirements of the Exchange Act and with all other applicable
Legal Requirements, (ii) respond promptly to any comments received from the
SEC or its staff, and (iii) cause the Proxy Statement to be mailed to the
Company's shareholders as promptly as practicable. The Company shall give
Parent a reasonable opportunity to comment on the Proxy Statement, any
correspondence with the SEC or its staff (including any staff comments on the
Proxy Statement) or any proposed material to be included in or with the Proxy
Statement prior to transmission to the SEC or its staff and shall not, except
as may be required under the Exchange Act, transmit any such document or
material to which Parent reasonably objects. The Company shall respond
promptly to any comments received from the SEC or its staff with respect to
the Proxy Statement, and shall correct promptly any information in the Proxy
Statement if and to the extent that such information shall have become false
or misleading in any material respect. If the solicitation of the Company's
shareholders is required, the Company shall use commercially reasonable
efforts to solicit, from the holders of Company Common Stock, proxies in favor
of this Agreement and the Merger. If at any time prior to the Shareholders
Meeting there shall occur any event that should be set forth in an amendment
or supplement to the Proxy Statement, the Company shall promptly prepare such
an amendment or supplement and, after obtaining the consent of Parent to such
amendment or supplement (which consent shall not be unreasonably withheld,
conditioned or delayed), shall promptly transmit such amendment or supplement
to the Company's shareholders.

  

  

 

 

 

  

 

44  

  

 

 

 

  

  

Section 6.3 Access to Information; Confidentiality.

  

  

(a) The Company shall, and shall cause the Company Subsidiaries to, afford to
the officers, employees, accountants, counsel, advisors, agents and other
representatives of Parent (the "Parent Representatives") (to the extent
permitted under applicable Legal Requirements) reasonable access, during
normal business hours during the period prior to the Effective Time, to all
its properties, books, Contracts, commitments and records, and, during such
period, the Company shall, and shall cause the Company Subsidiaries to, make
available to Parent all information concerning its business, properties and
personnel as Parent may reasonably request. The Company shall, and shall cause
the Company Representatives to, permit Parent's senior officers to meet, upon
reasonable notice and during normal business hours, with the chief financial
officer and other officers of the Company responsible for the Company's
financial statements and the internal controls of the Company and the Company
Subsidiaries to discuss such matters as Parent may reasonably deem necessary
or appropriate. All information exchanged pursuant to this Section 6.3 shall
be subject to the provisions of the Confidentiality Agreement. Without
limiting the generality of any of the foregoing, the Company shall promptly
provide Parent (upon its reasonable request and to the extent permitted under
applicable Legal Requirements):

  

  

(i) copies of all material operating and financial reports prepared by the
Company and the Company Subsidiaries for the Company's senior management or
for use in preparing the Company's consolidated financial statements,
including: (A) copies of the unaudited monthly consolidated balance sheets of
the Company and the Company Subsidiaries and the related unaudited monthly
consolidated statements of operations, statements of shareholders' equity and
statements of cash flows, and (B) copies of any forecasts, write-off reports,
hiring reports and capital expenditure reports prepared for the Company's
senior management;

  

  

(ii) copies of any written materials or communications sent by or on behalf of
the Company to its shareholders;

  

  

(iii) copies of any material notice, correspondence, document or other
communication sent by or on behalf of any of the Company and the Company
Subsidiaries to any party to any Material Contract or sent to any of the
Company and the Company Subsidiaries by any party to any Material Contract
(other than any communication that relates solely to routine commercial
transactions between a Company and the Company Subsidiaries and the other
party to any such Contract and that is of the type sent in the ordinary course
of business and in accordance with past practices);

  

  

(iv) copies of any notice, report or other document filed with or sent to any
Governmental Entity on behalf of any of the Company and the Company
Subsidiaries in connection with the Offer or the Merger or any of the other
transactions contemplated by this Agreement;

  

  

(v) copies of any material notice, report or other document received by any of
the Company and the Company Subsidiaries from any Governmental Entity;

  

  

 

 

 

  

 

45  

  

 

 

 

  

  

(vi) notice of any Proceeding commenced or, to the Company's Knowledge,
threatened against, relating to or involving or otherwise affecting the
Company or any of the Company Subsidiaries, that, if pending on the date of
this Agreement, would have been required to have been disclosed pursuant to
Section 3.13 or Section 3.14 or that related to the consummation of the
transactions contemplated by this Agreement; and

  

  

(vii) notice of any inaccuracy of any representation or warranty or breach of
covenant or agreement contained in this Agreement at any time during the term
hereof that could reasonably be expected to cause the conditions set forth in
Annex I not to be satisfied.

  

  

(b) All information and materials provided pursuant to this Agreement shall be
subject to the provisions of the Confidentiality Agreement entered into
between the parties as of December 7, 2009 (the "Confidentiality Agreement").

  

  

(c) No investigation by the Parent or any Parent Representative shall affect
the representations and warranties of the Company set forth in this Agreement.

  

  

Section 6.4 Efforts; Regulatory Approvals.

  

  

(a) Subject to the terms and subject to the conditions set forth in this
Agreement (including those contained in Section 6.4(c)), each of Parent and
the Company shall, and shall cause their respective Subsidiaries to, use its
commercially reasonable efforts to, take, or cause to be taken, all actions,
and to do, or cause to be done, and to assist and cooperate with the other
party in doing, all things necessary, proper or advisable to consummate and
make effective, in the most expeditious manner practicable, the transactions
contemplated by this Agreement, including (i) the obtaining of all necessary
consents or waivers from Third Parties, including the Company Consents, (ii)
the obtaining of all necessary actions or no-actions, waivers, consents,
authorization, Permits, Orders and approvals from, or any exemption by, any
Governmental Entity and the taking of all reasonable steps as may be necessary
to obtain an approval or waiver from, or to avoid an action or proceeding by
any Governmental Entity, and (iii) the execution and delivery of any
additional instruments necessary to consummate the Offer and the Merger and to
fully carry out the purposes of this Agreement. The parties hereto agree that
they will consult with each other with respect to the obtaining of all Permits
and consents of all Third Parties and Governmental Entities, and the
expiration or termination of the applicable waiting period under the HSR Act
and under any other Antitrust Law necessary or advisable to consummate the
transactions contemplated by this Agreement. Each of Parent and the Company
shall use its commercially reasonable efforts to resolve any objections that
may be asserted by any Governmental Entity with respect to this Agreement, the
Offer and the Merger or the other transactions contemplated by this Agreement,
and the Company shall keep Parent apprised of the status of matters relating
to completion of the transactions contemplated hereby.

  

  

 

 

 

  

 

46  

  

 

 

 

  

  

(b) Subject to applicable Law relating to the exchange of information, each of
Parent, on the one hand, and the Company, on the other hand, shall, in
connection with the efforts referenced in Section 6.4(a) to obtain all
requisite actions, no-actions, waivers, consents, authorizations, Permits,
Orders, approvals, exemptions, and expirations or terminations of applicable
waiting periods for the transactions contemplated by this Agreement under the
HSR Act or any other Antitrust Law, (i) cooperate in all respects with each
other in connection with any filing or submission and in connection with any
investigation or other inquiry, including any proceeding initiated by a
private party, (ii) keep the other party and its counsel informed of any
communication received by such party from, or given by such party to, the
Federal Trade Commission (the "FTC"), the Antitrust Division of the Department
of Justice (the "DOJ") or any other Governmental Entity and of any
communication received or given in connection with any proceeding by a private
party, in each case regarding any of the transactions contemplated by this
Agreement, and (iii) permit the other party and its counsel to review in
advance any written communication intended to be given by it to, and consult
with each other in advance of any meeting, discussion, telephone call or
conference with, the FTC, the DOJ or any other Governmental Entity or, in
connection with any proceeding by a private party, with any other Person, and
to the extent not prohibited by the FTC, the DOJ or other Governmental Entity
or other Person, give the other party and its counsel the opportunity to
attend and participate in such meeting, discussion, telephone call and
conference. In exercising the foregoing rights, each of the parties hereto
shall act reasonably and as promptly as practicable. Neither Parent nor the
Company shall commit to or agree with any Governmental Entity to stay, hold or
extend any applicable working period under the HSR Act or other Antitrust Law
without the prior written consent of the other. Parent and the Company may, as
each deems advisable and necessary, reasonably designate any competitively
sensitive material provided to the other under this Section 6.4(b) as
"Antitrust Counsel Only Material." Such materials and the information
contained therein shall be given only to the outside antitrust counsel of the
recipient and will not be disclosed by such outside counsel to employees,
officers or directors of the recipient unless express written permission is
obtained in advance from the source of the materials (Parent or the Company as
the case may be) or its legal counsel. Notwithstanding anything to the
contrary in this Section 6.4(b), materials provided to the other party or its
outside counsel may be redacted to remove references concerning the valuation
of the Company Common Stock or the business of the Company and the Company
Subsidiaries. For purposes of this Agreement, "Antitrust Law" means the
Sherman Act, as amended, the Clayton Act, as amended, the HSR Act, the Federal
Trade Commission Act, as amended, and all Laws, Orders and judicial doctrines
that are designed or intended to prohibit, restrict or regulate actions having
the purpose or effect of monopolization or restraint of trade or lessening of
competition through merger or acquisition.

  

  

(c) Without limiting the generality of the undertakings pursuant to this
Section 6.4, the parties hereto shall (i) provide or cause to be provided as
promptly as practicable to Governmental Entities with regulatory jurisdiction
over enforcement of any Antitrust Laws (each such Governmental Entity, a
"Governmental Antitrust Authority") information and documents requested by any
Governmental Antitrust Authority or necessary, proper or advisable to permit
consummation of the transactions contemplated by this Agreement, including
preparing and filing any notification and report form and related material
required under the HSR Act and any additional consents and filings under any
Antitrust Laws as promptly as practicable following the date of this Agreement
(but in no event more than fifteen (15) Business Days from the date hereof
except by mutual consent confirmed in writing) and thereafter to respond as
promptly as practicable to any request for additional information or
documentary material that may be made under the HSR Act and any additional
consents and filings under any Antitrust Laws, (ii) use their reasonable best
efforts to take such actions as are necessary or advisable to obtain prompt
approval of consummation of the transactions contemplated by this Agreement by
any Governmental Entity, and (iii) use their commercially reasonable efforts
to contest on the merits, through litigation in United States District Court
and through administrative procedures in relation to other Governmental
Entities, any objections or opposition raised by any Governmental Entity;
provided, however, that nothing in this Section 6.4(c) shall require Parent to
appeal any Order from a Governmental Entity.

  

  

 

 

 

  

 

47  

  

 

 

 

  

  

(d) Except as otherwise provided in Section 6.4(b) with respect to Antitrust
Counsel Only Material, Parent and the Company shall, upon request, furnish
each other with all information concerning themselves, their respective
Subsidiaries, directors, officers, employees and shareholders and such other
matters as may be reasonably necessary or advisable in connection with any
statement, filing, notice, application or other document made by or on behalf
of Parent, the Company or any of their respective Subsidiaries to any
Governmental Entity in connection with the Offer, the Merger and the other
transactions contemplated by this Agreement.

  

  

(e) Parent and the Company shall promptly advise each other upon receiving any
communication from any Governmental Entity in respect of any filing,
investigation or inquiry concerning this Agreement or the transactions
contemplated by this Agreement.

  

  

(f) Each of the Company, Parent and Merger Sub shall give (or shall cause
their respective Subsidiaries to give) any notices to Third Parties, and use,
and cause their respective Subsidiaries to use, their reasonable best efforts
to obtain any Third-Party consents, including the Company Consents. Without
limiting the generality of the foregoing, the Company shall give Parent the
opportunity to participate in the defense of any Proceeding against the
Company and its directors relating to the transactions contemplated by this
Agreement and will obtain the prior written consent of Parent prior to
settling or satisfying any such Proceeding.

  

  

(g) Notwithstanding anything in this Agreement to the contrary, in connection
with the receipt of any necessary governmental approvals or clearances
(including under any Antitrust Law), Parent shall not be required to sell,
hold separate or otherwise dispose of or conduct its business in a specified
manner, or permit the sale, holding separate or other disposition of, any
assets or business of Parent, the Company or any of their respective
Subsidiaries or the conduct of their business in a specified manner prior to
or following the Closing Date.

  

  

Section 6.5 Public Disclosure. Parent and the Company shall consult with each
other before issuing any press release or otherwise making any public
statement regarding the terms of this Agreement or any of the transactions
contemplated by this Agreement, and neither shall issue any such press release
or make any such statement without the prior approval of the other (which
approval shall not be unreasonably withheld, conditioned or delayed), except
as may be required by applicable Law or by obligations pursuant to any listing
agreement with any national securities exchange, in which case the party
proposing to issue such press release or make such public statement or
disclosure shall consult with the other party about, and allow the other party
reasonable time to comment on, such press release or announcement in advance
of such disclosure, and the party will consider such comments in good faith;
provided, however, that any subsequent public statement or disclosure that is
consistent with a public statement or disclosure previously approved by the
other party shall not require a further prior approval of such other party.

  

  

Section 6.6 Cooperation. Upon the terms and subject to the conditions herein
provided, except as otherwise provided in this Agreement (including Section
6.4), each of the parties agrees to use its commercially reasonable efforts to
take or cause to be taken all action, to do or cause to be done and to assist
and cooperate with the other parties in doing all things necessary, proper or
advisable under applicable Law to consummate and make effective, in the most
expeditious manner practicable, the transactions contemplated hereby,
including: (a) the satisfaction of the conditions precedent to the obligations
of the Company (in the case of Parent) or Parent and Merger Sub (in the case
of the Company) to the Offer and the Merger, (b) the obtaining of applicable
consents, waivers or approvals of any Third Party required under the terms of
Material Contracts, (c) the defending of any proceeding challenging this
Agreement or the performance of the obligations hereunder, and (d) the
execution and delivery of such instruments, and the taking of such other
actions, as any other party may reasonably request in order to carry out this
Agreement.

  

  

 

 

 

  

 

48  

  

 

 

 

  

  

Section 6.7 Employee Matters.

  

  

(a) From the Effective Time through at least December 31, 2010, Parent shall
maintain or cause to be maintained employee benefit plans and compensation
opportunities for the benefit of employees (as a group) who are actively
employed by the Company and the Company Subsidiaries on the Closing Date (the
"Closing Date Employees") that provide employee benefits and compensation
opportunities which, in the aggregate, are substantially comparable to the
employee benefits and compensation opportunities (other than equity-based
compensation) that were provided to such Closing Date Employees immediately
prior to the Effective Time.

  

  

(b) To the extent that a Closing Date Employee becomes eligible to participate
in an employee benefit plan maintained by Parent or any of its Subsidiaries,
Parent shall (i) cause such employee benefit plan to recognize the service of
such Closing Date Employee with the Company or the Company Subsidiaries (or
their predecessor entities) for purposes of eligibility, participation,
vesting, and benefit accrual under such employee benefit plan of Parent or any
of its Subsidiaries (excluding the Company Stock Plans which shall be
terminated by the Company without liability to Parent or the Company
contemporaneously with the Effective Time), to the same extent such service
was recognized immediately prior to the Effective Time under a comparable
Company Benefit Plan in which such Closing Date Employee was eligible to
participate immediately prior to the Effective Time; provided that such
recognition of service shall not operate to duplicate any benefits of a
Closing Date Employee with respect to the same period of service, and (ii)
with respect to any health, dental, vision or other welfare plan of Parent or
any of its Subsidiaries (other than the Company and the Company Subsidiaries)
in which any Closing Date Employee is eligible to participate for the plan
year in which such Closing Date Employee is first eligible to participate, use
its reasonable best efforts (subject to applicable plan limitations) to (x)
cause any pre-existing condition limitations or eligibility waiting periods
under such Parent or Subsidiary plan to be waived with respect to such Closing
Date Employee, to the extent such limitation would have been waived or
satisfied under the Company Benefit Plan in which such Closing Date Employee
participated immediately prior to the Effective Time, and (y) recognize any
health, dental or vision expenses incurred by such Closing Date Employee in
the year that includes the Closing Date (or, if later, the year in which such
Closing Date Employee is first eligible to participate) for purposes of any
applicable deductible and annual out-of-pocket expense requirements under any
such health, dental or vision plan of Parent or any of its Subsidiaries.
Neither Parent nor Merger Sub shall take any action to deny COBRA benefits to
any Closing Date Employee who is otherwise eligible for such benefits.

  

  

(c) The Company shall take all actions that may be requested by Parent in
writing prior to the Acceptance Time with respect to (i) causing one or more
Company Benefit Plans or arrangements with any payroll, benefits or human
resources services provider to the Company to terminate or be amended as of
the Closing Date, (ii) causing benefit accrual or entitlement under any
Company Benefit Plan to cease as of the Closing Date, (iii) causing the
continuation on and after the Closing Date of any insurance policy or
arrangement relating to any Company Benefit Plan, and (iv) facilitating the
merger of any Company Benefit Plan into any employee benefit plan maintained
by Parent or any of its Subsidiaries.

  

  

 

 

 

  

 

49  

  

 

 

 

  

  

(d) Nothing in this Section 6.7 shall be construed to limit the right of
Parent or any of its Subsidiaries (including, following the Closing Date, the
Company and the Company Subsidiaries) to amend or terminate any Company
Benefit Plan or other employee benefit plan, to the extent such amendment or
termination is permitted by the terms of the applicable plan, nor shall
anything in this Section 6.7 be construed to prohibit the Parent or any of its
Subsidiaries (including, following the Closing Date, the Company and the
Company Subsidiaries) from terminating the employment of any particular
Closing Date Employee following the Closing Date.

  

  

(e) Without limiting the generality of Section 9.9, the provisions of this
Section 6.7 are solely for the benefit of the parties to this Agreement, and
no current or former employee, director or independent contractor or any other
individual associated therewith shall be regarded for any purpose as a third-
party beneficiary of this Agreement, and nothing herein shall be construed as
an amendment to any Company Benefit Plan or other employee benefit plan for
any purpose.

  

  

Section 6.8 Indemnification of Directors and Officers.

  

  

(a) For six (6) years after the Effective Time, Parent shall cause the
Surviving Corporation to maintain officers' and directors' liability insurance
in respect of acts or omissions occurring prior to the Effective Time covering
each such person currently covered by the Company's officers' and directors'
liability insurance policy on terms with respect to coverage and amount no
less favorable than those of such policy in effect on the date hereof, if any;
provided that in satisfying its obligation under this Section 6.8(a), neither
Parent nor the Surviving Corporation shall be obligated to pay annual premiums
in excess of 225% of the annual premium payable by the Company for such policy
(the "Current Premium"), which amount is set forth in Section 6.8(a) of the
Company Disclosure Letter, and if such premiums for such insurance would at
any time exceed 225% of the Current Premium, then the Surviving Corporation
shall cause to be maintained policies of insurance that, in the Surviving
Corporation's judgment, provide the maximum coverage available at an annual
premium equal to 225% of the Current Premium. The Company shall be permitted
to purchase a prepaid "tail" or runoff policy under the Company's officers'
and directors' liability insurance policy prior to the Closing; provided that
the cost of such "tail" or runoff policy does not exceed 225% of the Current
Premium, which policy may provide such directors and officers with coverage
for an aggregate period of six (6) years with respect to claims arising from
facts or events that occurred on or before the Effective Time, including, in
respect of the transactions contemplated by this Agreement, provided that the
amount paid for such prepaid policy does not exceed 225% of the Current
Premium. The provisions of the first sentence of this Section 6.8(a) shall be
deemed to have been satisfied if a prepaid "tail" or runoff policy has been
obtained prior to the Effective Time. If such a prepaid "tail" or runoff
policy has been obtained prior to the Effective Time, the Surviving
Corporation shall maintain such policies in full force and effect for their
full term, and continue to honor the obligations thereunder.

  

  

 

 

 

  

 

50  

  

 

 

 

  

  

(b) From and after the Effective Time, the Surviving Corporation will, and
Parent will cause the Surviving Corporation to, fulfill and honor in all
respects the obligations of the Company and the Company Subsidiaries pursuant
to: (i) each indemnification agreement in effect between the Company or any of
the Company Subsidiaries and any person who is now, or has been at any time
prior to the date hereof, or who becomes prior to the Effective Time, a
director or officer of the Company or any of the Company Subsidiaries (the
"Indemnified Parties"), and (ii) any indemnification provision and any
exculpation provision set forth in the Company Articles or the Company Bylaws
as in effect on the date of this Agreement. From the Effective Time through
the sixth anniversary of the Effective Time, the certificate of incorporation
and the bylaws of the Surviving Corporation shall contain, and Parent shall
cause the certificate of incorporation and the bylaws of the Surviving
Corporation to so contain, provisions no less favorable with respect to
indemnification, advancement of expenses and exculpation of present and former
directors and officers of the Company and the Company Subsidiaries than are
presently set forth in the Company Articles and the Company Bylaws and such
provisions shall not be amended, repealed, or otherwise modified in any manner
that could adversely affect the rights thereunder of any person benefited by
such provisions. If, at any time prior to the sixth anniversary of the
Effective Time, any Indemnified Party delivers to the Company, the Surviving
Corporation or Parent, as applicable, a written notice asserting a claim for
indemnification under any of the provisions set forth in clauses (i) or (ii)
above, then the claim asserted in such notice shall survive the sixth
anniversary of the Effective Time until such time as such claim is fully and
finally resolved.

  

  

(c) If Parent, the Surviving Corporation or any of its successors or assigns
(i) consolidates with or merges into any other Person and shall not be the
continuing or surviving corporation or entity of such consolidation or merger
or (ii) transfers or conveys all or substantially all of its properties and
assets to any Person, then and in each such case, to the extent necessary,
proper provision shall be made so that the successors and assigns of Parent or
the Surviving Corporation, as the case may be, shall assume the obligations
set forth in this Section 6.8.

  

  

Section 6.9 Section 16 Matters. Prior to the Acceptance Time, the Company may
approve, in accordance with the procedures set forth in Rule 16b-3 promulgated
under the Exchange Act and in accordance with the Interpretative Letter dated
January 12, 1999 issued by the SEC relating to Rule 16b-3, any dispositions of
equity securities of the Company (including derivative securities with respect
to equity securities of the Company) resulting from the transactions
contemplated by this Agreement by each officer or director of the Company who
is subject to Section 16 of the Exchange Act with respect to equity securities
of the Company.

  

  

Section 6.10 Shareholder Litigation. The Company shall give Parent the
opportunity to participate in the defense or settlement of any shareholder
litigation against the Company or its officers or directors relating to any of
the transactions contemplated by this Agreement, and no such settlement shall
be agreed to without Parent's prior written consent.

  

  

Section 6.11 State Takeover Laws. If any "control share acquisition," "fair
price," "moratorium" or other anti-takeover statute becomes or is deemed to be
applicable to the Company, Parent, or Merger Sub, with respect to the Offer,
the Merger, the Support Agreements or any other transaction contemplated by
this Agreement (other than any Alternative Transaction), then each of the
Company, Parent, Merger Sub, and their respective board of directors shall
grant such approvals and take such actions as are necessary so that the
transactions contemplated hereby may be consummated as promptly as practicable
on the terms contemplated hereby and otherwise act to render such statute
inapplicable to the foregoing. The Company and the Company Board shall not
take any action to approve any Alternative Proposal made by a Third Party for
purposes of any state anti-takeover Law or to cause any state anti-takeover
Law that would otherwise apply to any such Alternative Proposal to become
inapplicable thereto.

  

  

 

 

 

  

 

51  

  

 

 

 

  

  

Section 6.12 Financing.

  

  

(a) Parent and Merger Sub shall use their reasonable best efforts to arrange
the Debt Financing on the terms and conditions described in the Debt Financing
Commitment, including using their reasonable best efforts to (i) negotiate
definitive agreements with respect thereto and (ii) to satisfy on a timely
basis all conditions applicable to Parent in such definitive agreements that
are within its control. In the event any portion of the Debt Financing becomes
unavailable on the terms and conditions contemplated in the Debt Financing
Commitment, Parent shall use its reasonable best efforts to arrange to obtain
alternative financing from alternative sources on comparable terms or terms
not materially less favorable (as determined in the reasonable judgment of
Parent) as promptly as practicable following the occurrence of such event. In
connection with its obligations under this Section 6.12, Parent shall be
permitted to amend, modify or replace the Debt Financing Commitment, provided
that Parent shall not make, agree to or allow any modification to or
replacement of the conditions precedent to the funding set forth in the Debt
Financing Commitment in a manner more favorable to the parties providing the
Debt Financing without the prior written consent of the Company (which consent
shall not be unreasonably withheld, conditioned or delayed). Parent shall give
the Company prompt notice of any material breach by any party of the Debt
Financing Commitment of which Parent becomes aware or any termination of the
Debt Financing Commitment. Parent shall keep the Company informed on a
reasonably current basis in reasonable detail of the status of its efforts to
arrange the Debt Financing.

  

  

(b) The Company agrees to provide, and shall cause its Subsidiaries and its
and their respective officers, employees, Company Representatives and
advisors, including legal and accounting advisors, to provide, all reasonable
assistance and cooperation (including with respect to timeliness) in
connection with the arrangement of the Debt Financing as may be reasonably
requested by Parent, including (i) participation in meetings, presentations
(including management presentations), drafting sessions and due diligence
sessions, (ii) no later than the Offer Commencement Date, furnishing Parent
and its financing sources with financial and other pertinent information
regarding the Company as may be reasonably requested by Parent, including
projections, pro forma statements, all financial statements and other
financial data and other pertinent information of the type required by
Regulation S-X and Regulation S-K under the Securities Act, (iii) assisting in
the preparation of (A) an offering document and other customary marketing
materials for any of the Debt Financing and (B) materials for rating agency
presentations, (iv) reasonably cooperating with the consummation of the Debt
Financing and the syndication and marketing efforts for any of the Debt
Financing, including obtaining any rating agency confirmations or approvals
for the Debt Financing, (v) providing and executing documents as may be
reasonably requested by Parent, including a certificate of the chief financial
officer of the Company or any Company Subsidiary with respect to solvency
matters, and consents of accountants for use of their reports in any materials
relating to the Debt Financing, (vi) reasonably facilitating the pledging of
collateral, (vii) using commercially reasonable efforts to obtain accountants'
comfort letters, legal opinions, surveys and title insurance, as reasonably
requested by Parent, and (viii) taking all actions reasonably necessary for
the Company or any Subsidiary to become the borrower or a guarantor under the
Debt Financing prior to or simultaneously with the Closing; provided, however,
in each case, that none of the Company or any of its Subsidiaries shall be
required to pay any commitment or other similar fee or incur any other
liability in connection with the Debt Financing prior to the Effective Time;
and provided further, that Parent shall reimburse the Company for reasonable
and documented out-of-pocket expenses incurred in connection with such
assistance and cooperation.

  

  

 

 

 

  

 

52  

  

 

 

 

  

  

(c) All non-public or otherwise confidential information regarding the Company
obtained by Parent or the Parent Representatives pursuant to Section 6.12(b)
shall be kept confidential in accordance with the Confidentiality Agreement;
provided, however, that Parent and Merger Sub and its Representatives shall be
permitted to disclose information as necessary and consistent with customary
practices in connection with the Debt Financing upon the prior written consent
of the Company (which consent shall not be unreasonably withheld, conditioned
or delayed).

  

  

Section 6.13 Notification.

  

  

(a) From and after the date hereof until the Closing Date, each party hereto
will promptly notify the other party hereto of (i) the occurrence or
nonoccurrence of any event the occurrence or nonoccurrence of which would be
likely to cause any condition to the Offer and the Merger and the other
transactions contemplated by this Agreement not to be satisfied, and (ii) the
failure of such party to comply with any covenant or agreement to be complied
with by it pursuant to this Agreement which would be likely to result in any
condition to the Offer and the Merger and the other transactions contemplated
by this Agreement not to be satisfied. No delivery of any notice pursuant to
this Section 6.13(a) will cure any breach of any representation or warranty of
such party contained in this Agreement or otherwise limit or affect the
remedies available hereunder to the party receiving such notice. Without
limiting the foregoing, the Company and Parent shall promptly advise each
other of any change or event having a Company Material Adverse Effect or
Parent Material Adverse Effect, as applicable.

  

  

(b) From the date of this Agreement through the Closing Date, the Company will
provide to Parent copies of all surveys, reports or deficiency notices
concerning the Centers by the Medicare program, any state survey agency, and
the applicable state Medicaid programs for the period commencing on the date
hereof through the Closing Date.

  

  

Section 6.14 Resignation of Directors and Officers. To the extent requested by
Parent in writing prior to the Closing Date, the Company shall use its
reasonable best efforts to obtain and deliver to Parent at the Closing, to be
effective as of the Closing, duly signed resignations of each officer and
director of the Company designated by Parent.

  

  

Section 6.15 NASDAQ Compliance; Delisting. From the date of this Agreement and
continuing until the earlier of the Board Appointment Date or the termination
of this Agreement, the Company (a) shall remain in compliance with all
applicable listing and corporate governance rules and regulations of NASDAQ,
and (b) agrees not to take or permit to be taken on its behalf any action
which would result in the shares of Company Common Stock no longer being
listed on NASDAQ. From the Acceptance Time to the Closing Date, the Company
shall cooperate with Parent and use its reasonable best efforts to take, or
cause to be taken, all actions, and do or cause to be done all things,
reasonably necessary, proper or advisable on its part under applicable Law
(including the Regulations of NASDAQ) to enable the delisting by the Surviving
Corporation of the Company Common Stock from NASDAQ and the deregistration of
the Company Common Stock under the Exchange Act as promptly as practicable
after the Effective Time.

  

  

Section 6.16 Payment of Company Expenses Upon Acceptance Time. Promptly
following the Acceptance Time, but in any event within three (3) Business Days
of the Acceptance Time, Parent will cause the Company to pay all fees, costs
and expenses incurred by the Company in connection with this Agreement and the
transactions contemplated by this Agreement (including the fees, costs and
expenses of its advisers, brokers, finders, agents, accountants, bankers and
legal counsel and the transaction expenses set forth in Section 6.16 of the
Company Disclosure Letter in accordance with the provisions set forth
thereon).

  

  

 

 

 

  

 

53  

  

 

 

 

  

  

ARTICLE VII

  

  

CONDITIONS PRECEDENT

  

  

Section 7.1 Conditions to Obligation of Each Party to Effect the Merger. The
respective obligations of each party to effect the Merger are subject to the
satisfaction at or prior to the Closing of the following conditions:

  

  

(a) Shareholder Approval. If required by applicable Legal Requirements in
order to consummate the Merger, this Agreement shall have been duly approved
by the Required Company Shareholder Vote;

  

  

(b) No Injunctions or Restraints; Illegality. No temporary restraining Order,
preliminary or permanent injunction, other Order issued by any Court of
competent jurisdiction or other legal restraint or prohibition preventing the
consummation of the Merger substantially on the terms contemplated by this
Agreement shall be in effect; nor shall there be any Law enacted, entered, or
enforced which makes illegal, prevents or otherwise prohibits the consummation
of any of the transactions contemplated by this Agreement, including the
Merger; and

  

  

(c) Consummation of Offer. Merger Sub shall have accepted for payment and paid
for shares of Company Common Stock validly tendered (and not withdrawn)
pursuant to the Offer.

  

  

ARTICLE VIII

  

  

TERMINATION

  

  

Section 8.1 Termination. This Agreement may be terminated and the Offer and
the Merger may be abandoned;

  

  

(a) by mutual written consent of Parent, Merger Sub and the Company, at any
time prior to the Effective Time, in a written instrument authorized by their
respective boards of directors (notwithstanding receipt of the Required
Company Shareholder Vote);

  

  

(b) by either Parent and Merger Sub or the Company, at any time prior to the
Effective Time (notwithstanding receipt of the Required Company Shareholder
Vote), if any Governmental Entity shall have issued a final and non-appealable
Order, decree or ruling or takes any other action having the effect of (i)
permanently enjoining, restraining or otherwise prohibiting (A) the
acquisition or acceptance for payment of, or payment for, the shares of
Company Common Stock pursuant to the Offer, or (B) the consummation of the
Merger, or (ii) making the acquisition or acceptance for payment of, or
payment for, the shares of Company Common Stock pursuant to the Offer or the
consummation of the Merger, illegal; provided, however, that a party shall not
be permitted to terminate this Agreement pursuant to this Section 8.1(b) if
the issuance of such Order, decree or ruling or the taking of such action is
attributable to the failure of such party to perform any covenant in this
Agreement required to be performed by such party at or prior to the Effective
Time;

  

  

 

 

 

  

 

54  

  

 

 

 

  

  

(c) by either Parent and Merger Sub or the Company, if the Acceptance Time
shall not have occurred on or prior to 11:59 p.m., Dallas, Texas time on
January 31, 2011 (the "Outside Date"), provided, however, that: (i) a party
shall not be permitted to terminate this Agreement pursuant to this Section
8.1(c) if: (A) the failure of the Acceptance Time to occur on or prior to the
Outside Date is attributable to the failure of an Offer Condition to be
satisfied, and (B) the failure of such Offer Condition to be satisfied is
attributable to a failure on the part of such party to perform any covenant in
this Agreement required to be performed by such party at or prior to the
Acceptance Time, and (ii) the Company shall not be permitted to terminate this
Agreement pursuant to this Section 8.1(c) unless the Company shall have made
any payment required to be made to Parent pursuant to Section 8.3(a);

  

  

(d) by the Company at any time prior to the Acceptance Time if: (i) any of
Parent's representations or warranties contained in this Agreement shall be
inaccurate as of the date of this Agreement or shall have become inaccurate as
of a date subsequent to the date of this Agreement (as if made on such
subsequent date) (it being understood that, for purposes of determining the
accuracy of such representations and warranties as of the date of this
Agreement or as of any subsequent date, all materiality qualifications
limiting the scope of such representations and warranties shall be
disregarded) and such inaccuracy has a Parent Material Adverse Effect, or (ii)
Parent shall have failed to perform any of its covenants or agreements
contained in this Agreement and such failure constitutes a Parent Material
Adverse Effect; provided; however; that if: (A) any inaccuracy of any of
Parent's representations or warranties as of a date subsequent to the date of
this Agreement or failure to perform Parent's covenants or agreements is
curable by Parent prior to the earlier of the Outside Date or thirty (30) days
after the date on which Parent is notified by the Company in writing of such
breach or failure to perform, and (B) Parent is continuing to exercise
commercially reasonable efforts to cure such inaccuracy or failure to perform,
then the Company may not terminate this Agreement under this Section 8.1(d) on
account of such inaccuracy or failure to perform: (1) during such thirty (30)
day (or shorter) period, or (2) after such thirty (30) day period, if such
inaccuracy or failure to perform shall have been fully cured; provided,
further, however; that the Company shall not have the right to terminate this
Agreement pursuant to this Section 8.1(d) if the Company is then in material
breach of any of its representations, warranties, covenants or agreements
hereunder;

  

  

(e) by Parent and Merger Sub at any time prior to the Acceptance Time if: (i)
any of the Company's representations or warranties contained in this Agreement
shall be inaccurate as of the date of this Agreement or shall have become
inaccurate as of a date subsequent to the date of this Agreement (as if made
on such subsequent date), such that the condition set forth in clause (a) of
Annex I would not be satisfied (it being understood that, for purposes of
determining the accuracy of such representations and warranties as of the date
of this Agreement or as of any subsequent date any update of or modification
to the Company Disclosure Letter made or purported to have been made on or
after the date of this Agreement shall be disregarded), or (ii) the Company
shall have failed to perform any of its covenants or agreements contained in
this Agreement, such that the condition set forth in clause (b) of Annex I
would not be satisfied; provided; however; that if: (A) any inaccuracy of any
of the Company's representations or warranties as of a date subsequent to the
date of this Agreement or failure to perform the Company's covenants or
agreements is curable by the Company prior to the earlier of the Outside Date
or thirty (30) days after the date on which the Company is notified by Parent
in writing of such breach or failure to perform, and (B) the Company is
continuing to exercise commercially reasonable efforts to cure such inaccuracy
or failure to perform, then Parent and Merger Sub may not terminate this
Agreement under this Section 8.1(e) on account of such inaccuracy or failure
to perform: (1) during such thirty (30) day (or shorter) period, or (2) after
such thirty (30) day period, if such inaccuracy or failure to perform shall
have been fully cured; provided, further, however; that Parent shall not have
the right to terminate this Agreement pursuant to this Section 8.1(e) if
Parent is then in material breach of any of its representations, warranties,
covenants or agreements hereunder;

  

  

 

 

 

  

 

55  

  

 

 

 

  

  

(f) by either Parent and Merger Sub or the Company at any time prior to the
Acceptance Time if the Offer shall have expired or shall have been terminated
in accordance with the terms of this Agreement (including Annex I) without
Merger Sub having accepted shares of Company Common Stock pursuant to the
Offer; provided, however, that: (i) a party shall not be permitted to
terminate this Agreement pursuant to this Section 8.1(f) if: (A) the failure
of Merger Sub to accept shares of Company Common Stock for payment pursuant to
the Offer is attributable to the failure of an Offer Condition to be
satisfied, and (B) the failure of such Offer Condition to be satisfied is
attributable to a failure, on the part of the party seeking to terminate this
Agreement, to perform any covenant in this Agreement required to be performed
by such party at or prior to the Acceptance Time, and (ii) the Company shall
not be permitted to terminate this Agreement pursuant to this Section 8.1(f)
unless the Company shall have made any payment required to be made to Parent
pursuant to Section 8.3(a);

  

  

(g) by Parent and Merger Sub at any time prior to the Acceptance Time, if (i)
a Company Triggering Event shall have occurred, (ii) a Company Material
Adverse Effect shall have occurred, or (iii) any event shall have occurred or
circumstance shall have arisen that, in combination with any other events or
circumstances, could reasonably be expected to have or result in a Company
Material Adverse Effect;

  

  

(h) by the Company at any time prior to the Acceptance Time in order to accept
a Superior Proposal and enter into a Superior Proposal Definitive Agreement,
if (i) the Company and the Company Board shall have satisfied all of the
notice, negotiation and other requirements set forth in Section 5.3 and the
negotiation period(s) described therein shall have expired, (ii) the Company
shall have made the payment required to be made to Parent pursuant to Section
8.3(a) and shall have paid to Parent the fee required to be paid to Parent
pursuant to Section 8.3(c), and (iii) concurrently with such termination, the
Company enters into the Superior Proposal Definitive Agreement upon
termination of this Agreement pursuant to this Section 8.1(h); and

  

  

(i) by the Company after the Designated Date if: (i) the Acceptance Time shall
not have occurred on or prior to the Designated Date, (ii) at the applicable
Expiration Date following the Designated Date and at the time of termination
of this Agreement, each of the conditions set forth in Annex I (other than the
condition set forth in clause (m) of Annex I) shall have been satisfied or
shall have been waived, and (iii) at the applicable Expiration Date following
the Designated Date and at the time of termination of this Agreement, there
exists an uncured Financing Failure that resulted in the Acceptance Time not
occurring on or prior to the Designated Date.

  

  

The party desiring to terminate this Agreement pursuant to this Section 8.1
(other than pursuant to Section 8.1(a)) shall give notice of such termination
to the other party or parties.

  

  

Section 8.2 Effect of Termination. In the event of termination of this
Agreement pursuant to Section 8.1, this Agreement shall become void and of no
effect without liability of any party (or any equity holder, director,
officer, employee, agent, consultant or Representative of such party) to each
party hereto; provided, however, that (a) the provisions of Section 6.3(b);
this Section 8.2; Section 8.3 and Article IX shall remain in full force and
effect and survive any termination of this Agreement, and (b) nothing herein
shall relieve any party hereto from any liability for damages resulting from
any fraud or (subject to the provisions of Section 8.3(f)) willful and
material breach of this Agreement.

  

  

 

 

 

  

 

56  

  

 

 

 

  

  

Section 8.3 Expenses and Termination Fees.

  

  

(a) Subject to subsections (b), (c) and (f) of this Section 8.3, whether or
not the Offer or the Merger is consummated, all fees, costs and expenses
incurred in connection with this Agreement and the transactions contemplated
by this Agreement (including the fees, costs and expenses of its advisers,
brokers, finders, agents, accountants, bankers and legal counsel) shall be
paid by the party incurring such expense; provided, however, that Parent shall
pay the filing fee for the premerger notification relating to the transactions
contemplated by this Agreement under the HSR Act; and, provided further,

  

  

(i) that the Company and Parent shall share equally all fees and expenses,
other than attorneys' fees, incurred in connection with: (A) the filing,
printing and mailing of the Offer Documents, Schedule 14D-9 and the Proxy
Statement and any amendments or supplements thereto, and (B) the retention of
any information agent, depositary or other service provider in connection with
the Offer; and

  

  

(ii) in the event that this Agreement is terminated: (A)(1) by Parent pursuant
to Section 8.1(e), and (2) at or prior to the time of such termination an
Alternative Proposal shall have been disclosed, announced, commenced,
submitted or made, or (B) by Parent pursuant to Section 8.1(g)(i) or by the
Company pursuant to Section 8.1(h), then (without limiting any obligation of
the Company to pay any fee payable pursuant to Section 8.3(b) or Section
8.3(c)), in each of clause (A) and (B) of this sentence, the Company shall
make a non-refundable cash payment to Parent, at the time specified in the
next sentence, in an amount equal to the aggregate amount of all fees and
expenses (including all attorneys' fees, accountants' fees, financial advisory
fees and filing fees) that have been paid or that may become payable by or on
behalf of Parent in connection with the preparation and negotiation of this
Agreement, the Support Agreements, the Debt Financing Commitment, the Sponsor
Financing Commitment and otherwise in connection with the Offer, the Merger or
any of the other transactions contemplated by this Agreement and the Support
Agreements, subject to a maximum amount of $2,000,000 (it being understood,
however, that Parent's other remedies, if any, shall not be affected by any
payments under this Section 8.3). In the case of termination of this Agreement
by the Company pursuant to Section 8.1(h), any non-refundable payment required
to be made pursuant to this clause (ii) of this Section 8.3(a) shall be made
by the Company prior to or at the time of such termination; and in the case of
termination of this Agreement by Parent pursuant to Section 8.1(e) or Section
8.1(g)(i), any non-refundable payment required to be made pursuant to this
clause (ii) of this Section 8.1(a) shall be made by the Company within three
(3) Business Days.

  

  

(b) If this Agreement is terminated by Parent pursuant to Section 8.1(e) and:
(i) at or prior to the time of such termination an Alternative Proposal shall
have been disclosed, announced, commenced, submitted or made, and (ii) within
12 months after the date of any such termination, an Alternative Transaction
(whether or not relating to such Alternative Proposal) is consummated or a
definitive agreement contemplating an Alternative Transaction (whether or not
relating to such Alternative Proposal) is executed, then the Company shall pay
to Parent, in cash at the earlier of the time such Alternative Transaction is
consummated or the time such definitive agreement is executed, a non-
refundable fee in the amount of $2,500,000.

  

  

 

 

 

  

 

57  

  

 

 

 

  

  

(c) If this Agreement is terminated by Parent pursuant to Section 8.1(g)(i) or
by the Company pursuant to Section 8.1(h), then the Company shall pay to
Parent, in cash at the time specified in the next sentence (in addition to the
amounts payable pursuant to Section 8.3(a)), a non-refundable fee in the
amount of $2,500,000. In the case of termination of this Agreement by Parent
pursuant to Section 8.1(g)(i), the fee referred to in the preceding sentence
shall be paid by the Company within two (2) Business Days after such
termination; and in the case of termination of this Agreement by the Company
pursuant to Section 8.1(h), the fee referred to in the preceding sentence
shall be paid by the Company at or prior to the time of such termination.

  

  

(d) If this Agreement is terminated by Parent, Merger Sub or the Company
pursuant to Section 8.1(c) or Section 8.1(f) and (i) at or prior to the time
of such termination an Alternative Proposal shall have been disclosed,
announced, commenced, submitted or made, and (ii) within 12 months after the
date of any such termination, an Alternative Transaction (whether or not
relating to such Alternative Proposal) is consummated or a definitive
agreement contemplating an Alternative Transaction (whether or not relating to
such Alternative Proposal) is executed, then the Company shall pay to Parent,
in cash at the earlier of the time such Alternative Transaction is consummated
or the time such definitive agreement is executed, a non-refundable fee in the
amount of $4,500,000.

  

  

(e) Each of Parent, Merger Sub and the Company acknowledges and agrees that
the agreements contained in Sections 8.3(a), (b), (c), and (d) are an integral
part of the transactions contemplated by this Agreement and that, without
these agreements, Parent and Merger Sub would not enter into this Agreement.

  

  

(f) If this Agreement is terminated by the Company pursuant to Section 8.1(i),
the Parent shall pay to the Company in cash, within two (2) Business Days
after such termination, a non-refundable fee in the amount of $6,000,000 (the
"Reverse Termination Fee"). Notwithstanding anything to the contrary contained
in this Agreement, if this Agreement is terminated as set forth in Section
8.1(i), the Company's right to receive the Reverse Termination Fee pursuant to
this Section 8.3(f) shall be the sole and exclusive remedy of the Company and
the Company Subsidiaries and their respective shareholders and Affiliates
against Parent or any of its Related Persons (as defined below) for, and the
Company and the Company Subsidiaries (on their own behalf and on behalf of
their respective shareholders and Affiliates) shall be deemed to have waived
all other remedies (including equitable remedies) with respect to, (i) any
failure of the Offer or the Merger to be consummated, (ii) any breach by
Parent or Merger Sub of its obligation to consummate the Offer and the Merger
or any other covenant, obligation, representation, warranty or other provision
set forth in this Agreement. Upon payment of the Reverse Termination Fee
pursuant to this Section 8.3(f), neither Parent nor any of its Related Persons
shall have any further liability or obligation (under this Agreement or
otherwise) relating to or arising out of this Agreement or any of the
transactions contemplated by this Agreement, and in no event shall the Company
or the Company Subsidiaries (and the Company shall ensure that their
respective Affiliates do not) seek to recover any money damages or losses, or
seek to pursue any other recovery, judgment, damages or remedy (including any
equitable remedy) of any kind, in connection with this Agreement or the
transactions contemplated by this Agreement. The parties agree that the
Reverse Termination Fee and the agreements contained in this Section 8.3(f)
are an integral part of the Offer and the Merger and the other transactions
contemplated by this Agreement and that the Reverse Termination Fee
constitutes liquidated damages and not a penalty. In addition, notwithstanding
anything to the contrary contained in this Agreement, regardless of whether or
not this Agreement is terminated, except for Parent's obligation to pay the
Company the Reverse Termination Fee if and when such Reverse Termination Fee
becomes payable by Parent to the Company pursuant to this Section 8.3(f):

  

  

 

 

 

  

 

58  

  

 

 

 

  

  

    

  |  

(1) neither Parent nor any of Parent's Related Parties shall have any
liability for (x) any inaccuracy in any representation or warranty set forth
in Section 4.5 or any inaccuracy in any other representation or warranty
relating to the Debt Financing (regardless of whether such representation or
warranty refers specifically to the Debt Financing), or (y) any breach of any
of the Parent Financing Covenants; and

   
---|--- 
 

  

  

    

  |  

(2) in the event of any Financing Failure, neither Parent nor any of Parent's
Related Parties shall have any liability of any nature (for any breach of this
Agreement or otherwise) to the Company and the Company Subsidiaries or to any
shareholder or Affiliate of the Company or the Company Subsidiaries.

   
---|--- 
 

  

  

Without limiting the generality of the preceding sentence and notwithstanding
anything to the contrary contained in this Agreement, in no event shall the
Company and the Company Subsidiaries (and the Company shall ensure that the
Company and the Company Subsidiaries' Affiliates do not) seek to recover any
money damages or losses, or seek to pursue any other recovery, judgment,
damages or remedy (including any equitable remedy) of any kind, in connection
with any inaccuracy or breach of the type referred to in the preceding
sentence or in connection with any Financing Failure (except that the Company
may seek to recover the Reverse Termination Fee if and when such Reverse
Termination Fee becomes payable by Parent to the Company pursuant to this
Section 8.3(f). For purposes of this Section 8.3(f), "Related Persons" shall
include: (i) the former, current and future directors, officers, employees,
agents, stockholders, Parent Representatives, Subsidiaries, Affiliates and
assignees of Parent, and (ii) any former, current or future director, officer,
Affiliate or assignee of any Person described in the immediately preceding
clause (i).

  

  

(g) If Parent or the Company fails to pay when due any amount payable pursuant
to this Section 8.3, then: (i) such party shall reimburse the other party for
all fees, costs and expenses (including legal fees, costs and expenses)
incurred in connection with any action taken to collect payment and the
enforcement by the other party of its rights under this Section 8.3, and (ii)
such party shall pay to the other party interest on such overdue amount (for
the period commencing as of the date such overdue amount was originally
required to be paid and ending on the date such overdue amount is actually
paid to the party in full) at a rate per annum equal to 300 basis points over
the "prime rate" (as announced by Bank of America or any successor thereto) in
effect on the date such overdue amount was originally required to be paid.

  

  

ARTICLE IX

  

  

GENERAL PROVISIONS

  

  

Section 9.1 Certain Defined Terms. As used in this Agreement, the following
terms have the following meanings:

  

  

"Acceptance Time" shall mean the first time at which Merger Sub accepts any
shares of Company Common Stock for payment pursuant to the Offer.

  

  

"Acquisition Agreement" has the meaning set forth in Section 5.3(e).

  

  

 

 

 

  

 

59  

  

 

 

 

  

  

"Adjusted Outstanding Share Number" has the meaning set forth in Section
1.1(a).

  

  

"Adverse Action" has the meaning set forth Section 1.3(d).

  

  

"Adverse Recommendation Change" has the meaning set forth Section 5.3(e).

  

  

"Affiliate" means with respect to any Person, a Person that directly or
indirectly through one or more intermediaries controls, is controlled by, or
is under common control with, such Person.

  

  

"Agreement" has the meaning set forth in the Preamble.

  

  

"Alternative Proposal" shall have the meaning set forth in Section 5.3(a).

  

  

"Alternative Transaction" means any of (i) a transaction pursuant to which any
Third Party, directly or indirectly, acquires or would acquire more than 10%
of the outstanding shares of the Company or any of the Company Subsidiaries or
outstanding voting power or of any new series or new class of preferred stock
that would be entitled to a class or series vote with respect to a merger with
the Company or any of the Company Subsidiaries, whether from the Company or
pursuant to a tender offer or exchange offer or otherwise, (ii) a merger,
share exchange, consolidation or other business combination involving the
Company or any of the Company Subsidiaries (other than the Offer and the
Merger), (iii) any transaction pursuant to which any Third Party acquires or
would acquire control of assets (including for this purpose the outstanding
equity securities of any Company Subsidiary and securities of the entity
surviving any merger or business combination including any of the Company
Subsidiaries) of the Company or any of the Company Subsidiaries representing
more than 10% of the fair market value of all the assets, net revenues or net
income of the Company and the Company Subsidiaries, taken as a whole,
immediately prior to such transaction, or (iv) any other consolidation,
business combination, recapitalization or similar transaction involving the
Company or any of the Company Subsidiaries other than the transactions
contemplated by this Agreement.

  

  

"Antitrust Counsel Only Material" has the meaning set forth in Section 6.4(b).

  

  

"Antitrust Law" has the meaning set forth in Section 6.4(b).

  

  

"Articles of Merger" has the meaning set forth in Section 2.2(b).

  

  

"Assets" has the meaning set forth in Section 3.10(c).

  

  

"Board Appointment Date" has the meaning set forth in Section 1.3(a).

  

  

"Book Entry Shares" has the meaning set forth in Section 2.3(b).

  

  

"Business Day" means any day except Saturday, Sunday and any day which shall
be a legal holiday or a day on which banking institutions in the States of
Texas or New York are required by Law or other Governmental Entity to be
closed.

  

  

"Center" means any end-stage renal disease facility or dialysis facility owned
or operated by the Company or any Company Subsidiary, but excluding any
hospital-based dialysis program managed by the Company pursuant to a Contract
with the operator of the applicable hospital.

  

  

"CERCLA" has the meaning set forth in Section 3.19(c).

  

  

 

 

 

  

 

60  

  

 

 

 

  

  

"Certificates" has the meaning set forth in Section 2.10(a).

  

  

"Clayton Act" means the Clayton Antitrust Act of 1914, 15 U.S.C.  12-27, as
amended.

  

  

"Closing" has the meaning set forth in Section 2.2(a).

  

  

"Closing Date" has the meaning set forth in Section 2.2(a).

  

  

"Closing Date Employee" has the meaning set forth in Section 6.7(a).

  

  

"CMS" means the Centers for Medicare and Medicaid Services.

  

  

"COBRA" means Section 4980B of the Code and Sections 601-608 of the Code, both
as amended.

  

  

"COBRA Coverage" has the meaning set forth in Section 3.15(j).

  

  

"Code" means the Internal Revenue Code of 1986, as amended, and the
Regulations promulgated thereunder.

  

  

"Commitment Letters" has the meaning set forth in Section 4.5.

  

  

"Company" has the meaning set forth in the Preamble.

  

  

"Company Articles" means the Articles of Incorporation of the Company, as
amended.

  

  

"Company Balance Sheet Date" has the meaning set forth in Section 3.8.

  

  

"Company Benefit Plan" means any "employee benefit plan," as such term is
defined in Section 3(3) of ERISA, whether or not subject to the provisions of
ERISA, the Company Stock Plans and any other employment, incentive (equity-
based or otherwise), consulting, bonus, stock option, severance, retention,
retirement, disability, insurance, deferred compensation, change in control or
other compensatory plan, contract, policy or arrangement that is sponsored,
maintained, administered or contributed to or required to be contributed to,
or entered into or made by the Company or any Company Subsidiary or any ERISA
Affiliate with or for the benefit of, or relating to, any current or former
director, employee or other independent contractor, or consultant to, the
Company or any Company Subsidiary and with respect to which the Company or any
of the Company Subsidiaries or ERISA Affiliates may have any direct or
indirect liability.

  

  

"Company Board" has the meaning set forth in the Recitals.

  

  

"Company Board Recommendation" has the meaning set forth in the Section
1.2(a).

  

  

"Company Bylaws" means the Amended and Restated Bylaws of the Company.

  

  

"Company Capitalization Date" has the meaning set forth in Section 3.3(a).

  

  

"Company Common Stock" has the meaning set forth in Section 2.3(a)(i).

  

  

"Company Compensation Approvals" has the meaning set forth in Section 3.27.

  

  

 

 

 

  

 

61  

  

 

 

 

  

  

"Company Consents" has the meaning set forth in Section 3.5(a).

  

  

"Company Credit Agreement" means the Credit Agreement, dated as of October 24,
2005 among the Company, as borrower, and KeyBank National Association, as
lender, as amended through the date of this Agreement.

  

  

"Company Disclosure Letter" has the meaning set forth in the first paragraph
of Article III.

  

  

"Company Financial Advisor" has the meaning set forth in Section 3.24.

  

  

"Company IP" means all Intellectual Property owned, used, held for use or
exploited by the Company or any of the Company Subsidiaries.

  

  

"Company Material Adverse Effect" means any change, event, violation,
development, circumstance, effect or other matters which individually or in
the aggregate have, or could reasonably be expected to have, a material
adverse effect on (a) the business, condition, capitalization, assets,
liabilities, operations or financial performance of the Company and the
Company Subsidiaries taken as a whole, (b) the ability of the Company to
consummate the Merger or any of the other transactions contemplated by this
Agreement, or (c) Parent's ability to vote, receive dividends with respect to
or otherwise exercise ownership rights with respect to the shares of the
Surviving Corporation; provided, however, that no change, event, violation,
development, circumstance, effect or other matter which the Company can show
by clear and convincing evidence relates to or results from the following
shall constitute a Company Material Adverse Effect:

  

  

(i) changes in conditions affecting the renal care/dialysis services
industries generally or the United States or global economy which the Company
can show by clear and convincing evidence did not have a disproportionate
impact on the Company;

  

  

(ii) changes in applicable Laws or the interpretation thereof after the date
hereof (other than with respect to Laws or interpretations thereof related to
the payment system for Medicare outpatient end-stage renal disease dialysis
facilities, including (A) 74 FR 49922 ("Medicare Programs; End-Stage Renal
Disease Prospective Payment System; Proposed Rule and Notice"), and (B)
Section 153(b) of the Medicare Improvements for Patients and Providers Act, 42
U.S.C.  1395rr(b)), which shall be included in determining whether a Company
Material Adverse Effect shall have occurred), which the Company can show by
clear and convincing evidence did not have a disproportionate impact on the
Company;

  

  

(iii) changes in GAAP or other accounting standards, or authoritative
interpretations thereof after the date hereof, which the Company can show by
clear and convincing evidence did not have a disproportionate impact on the
Company; and

  

  

(iv) a decrease in the market price of the shares of Company Common Stock;
provided that the exception in this clause (iv) shall not prevent or otherwise
affect a determination that any change or effect underlying such a decrease on
market price has resulted in, or contributed to, a Company Material Adverse
Effect.

  

  

"Company Option" has the meaning set forth in Section 2.6(a).

  

  

"Company Regulatory Agreement" has the meaning set forth in Section 3.6(c).

  

  

"Company Representatives" has the meaning set forth in Section 5.3(a).

  

  

 

 

 

  

 

62  

  

 

 

 

  

  

"Company Restricted Share" has the meaning set forth in Section 2.6(c).

  

  

"Company Restricted Stock Unit" has the meaning set forth in Section 2.6(b).

  

  

"Company SEC Documents" has the meaning set forth in Section 3.6(d).

  

  

"Company Stock Plans" means the Dialysis Corporation of America 1999 Stock
Incentive Plan and the Dialysis Corporation of America 2009 Omnibus Incentive
Plan.

  

  

"Company Subsidiary" means any Subsidiary of the Company and "Company
Subsidiaries" means all of the Subsidiaries of the Company.

  

  

"Company Triggering Event" shall be deemed to have occurred if: (a) the
Company Board or any committee thereof shall have made an Adverse
Recommendation Change, (b) the Company shall have failed to include in the
Schedule 14D-9 the Company Board Recommendation, (c) the Company Board fails
to reaffirm unanimously and publicly its recommendation of this Agreement, the
Offer and the Merger, within five (5) Business Days (or, if earlier, prior to
the Acceptance Time) after Parent requests in writing that such recommendation
be reaffirmed publicly, (d) an Alternative Proposal is publicly announced by a
Third Party, and the Company fails to issue a press release that reaffirms
unanimously its recommendation of this Agreement, the Offer and the Merger,
within five (5) Business Days (or, if earlier, prior to the Acceptance Time)
after such Alternative Proposal is publicly announced, (e) the Company or any
Company Representative shall have breached any of the provisions set forth in
Section 5.3, or (f) any shareholder of the Company who has executed and
delivered a Support Agreement shall have breached any provision of such
Support Agreement.

  

  

"Compensation Arrangement" has the meaning set forth in Section 3.27.

  

  

"Compensation Arrangement Approvals" has the meaning set forth in Section
3.27.

  

  

"Compensation Committee" has the meaning set forth in Section 2.6(e).

  

  

"Compliance Certificate" means the form of certificate set forth in Section
3.13(h)(i) of the Company Disclosure Letter.

  

  

"Compliance Program" has the meaning set forth in Section 3.13(g).

  

  

"Confidentiality Agreement" has the meaning set forth in Section 6.3(b).

  

  

"Continuing Directors" has the meaning set forth in Section 1.3(b).

  

  

"Contracting Directors" has the meaning set forth in Section 1.3(b).

  

  

"Contract" means a note, bond, mortgage, indenture, deed of trust, license,
lease, franchise, Permit, agreement, arrangement, commitment, understanding,
bylaw, contract or other instrument or obligation.

  

  

"Control" (including the terms "controlled," "controlled by" and "under common
control with") means the possession, directly or indirectly or as trustee or
executor, of the power to direct or cause the direction of the management or
policies of a Person, whether through the ownership of stock or as trustee or
executor, by contract or credit arrangement or otherwise.

  

  

 

 

 

  

 

63  

  

 

 

 

  

  

"Court" means any court or arbitration tribunal of the United States or any
domestic state, and any political subdivision thereof.

  

  

"Covered Employees" has the meaning set forth in Section 5.2(j).

  

  

"Current Premium" has the meaning set forth in Section 6.8(a).

  

  

"Debt Financing" has the meaning set forth in Section 4.5.

  

  

"Debt Financing Commitment" has the meaning set forth in Section 4.5.

  

  

"Designated Date" means the date that is the first Business Day that is 45
days after the Offer Commencement Date.

  

  

"Dissenting Shareholders" has the meaning set forth in Section 2.5.

  

  

"Dissenting Shares" has the meaning set forth in Section 2.5.

  

  

"DOJ" has the meaning set forth in Section 6.4(b).

  

  

"Effective Time" has the meaning set forth in Section 2.2(b).

  

  

"Employee" means any individual employed by the Company or any Company
Subsidiary.

  

  

"Employment Agreements" has the meaning set forth in the Recitals.

  

  

"Environmental Law" means all Legal Requirements relating to (a) the control
of any potential pollutant or protection of the air, water or land, (b) solid,
gaseous or liquid waste generation, handling, treatment, storage, disposal or
transportation, and (c) exposure to hazardous, toxic or other substances
alleged to be harmful, and includes (i) the terms and conditions of any
Permit, and (ii) judicial, administrative, or other regulatory decrees,
judgments, and orders of any Governmental Entity. The term "Environmental
Laws" shall include, but not be limited to the following statutes and the
regulations promulgated thereunder: the Clean Air Act, 42 U.S.C.  7401 et
seq., the Clean Water Act, 33 U.S.C.  1251 et seq., the Resource Conservation
and Recovery Act ("RCRA"), 42 U.S.C.  6901 et seq., the Superfund Amendments
and Reauthorization Act, 42 U.S.C.  11011 et seq., the Toxic Substances
Control Act, 15 U.S.C.  2601 et seq., the Safe Drinking Water Act, 42 U.S.C.
 300f et seq., the Comprehensive Environmental Response, Compensation, and
Liability Act, 42 U.S.C.  9601 et seq., the Occupational Safety and Health
Act, 29 U.S.C.  651 et seq., the Hazardous Materials Transportation Act, 49
U.S.C.  1801 et seq., and any state, county, or local regulations similar
thereto.

  

  

"Environmental Permits" means, with respect to any Person, all Permits
relating to or required by Environmental Law and affecting, or relating in any
way to, the business of such Person or any of its Subsidiaries.

  

  

"ERISA" means the Employee Retirement Income Security Act of 1974, as amended,
and the Regulations promulgated thereunder.

  

  

"ERISA Affiliate" means any Person (whether or not incorporated) that is (or
at any relevant time was), together with a specified Person, treated as a
single employer pursuant to Section 4001 of ERISA or Sections 414(b), (c),
(m), (n) or (o) of the Code.

  

  

 

 

 

  

 

64  

  

 

 

 

  

  

"Exchange Act" means the Securities Exchange Act of 1934, as amended, and the
Regulations promulgated thereunder.

  

  

"Exchange Fund" has the meaning set forth in Section 2.9.

  

  

"Expiration Date" has the meaning set forth in Section 1.1(c).

  

  

"FBCA" has the meaning set forth in the Recitals.

  

  

"Federal Trade Commission Act" means 15 U.S.C.  41-58, as amended.

  

  

"Financing Failure" means a refusal or other failure, for any reason, on the
part of any Person that has executed the Debt Commitment Letter or any
definitive financing document relating to the Debt Financing, or on the part
of any other Person obligated or expected at any time to provide a portion of
the Debt Financing, to provide a portion of such Debt Financing.

  

  

"FTC" has the meaning set forth in Section 6.4(b).

  

  

"GAAP" means accounting principles generally accepted in the United States
consistently applied by a specified Person.

  

  

"Governmental Antitrust Authority" has the meaning set forth in Section
6.4(c).

  

  

"Governmental Entity" means any domestic, foreign or supranational government
or subdivision thereof, administrative, governmental, prosecutorial or
regulatory authority, agency, commission, Court, administrative contractor,
tribunal or body or self-regulatory organization.

  

  

"Hazardous Materials" means any (a) toxic or hazardous materials or
substances, (b) solid wastes, including asbestos, polychlorinated biphenyls,
mercury, flammable or explosive materials, (c) medical waste, (d) radioactive
materials, (e) petroleum or petroleum products (including crude oil), and (f)
any other chemical, pollutant, contaminant, substance or waste that is
regulated under any Environmental Law.

  

  

"HIPAA" has the meaning set forth in Section 3.13(f).

  

  

"HSR Act" has the meaning set forth in Section 3.5(a).

  

  

"Immediate Family Member" or "member of a physician's immediate family" means
husband or wife; birth or adoptive parent, child, or sibling; stepparent,
stepchild, stepbrother, or stepsister; father-in-law, mother-in-law, son-in-
law, daughter-in-law, brother-in-law, or sister-in-law; grandparent or
grandchild; and spouse of a grandparent or grandchild.

  

  

"Indemnified Parties" has the meaning set forth in Section 6.8(b).

  

  

"Initial Expiration Date" has the meaning set forth in Section 1.1(c).

  

  

"Insurance Policies" has the meaning set forth in Section 3.21.

  

  

 

 

 

  

 

65  

  

 

 

 

  

  

"Intellectual Property" means collectively, all intellectual property and
other similar proprietary rights in any jurisdiction throughout the world,
whether owned, used or held for use under license, whether registered or
unregistered, including such rights in and to: (a) trademarks, service marks,
brand names, certification marks, trade dress, logos, trade names and
corporate names and other indications of origin, and the goodwill associated
with any of the foregoing, (b) patents and patent applications, and any and
all divisions, continuations, continuations-in-part, reissues, continuing
patent applications, provisional patent applications, re-examinations, and
extensions thereof, any counterparts claiming priority therefrom, utility
models, patents of importation/confirmation, certificates of invention,
certificates of registration and like rights, and inventions, invention
disclosures, discoveries and improvements, whether or not patentable, (c)
trade secrets (including, those trade secrets defined in the Uniform Trade
Secrets Act and under corresponding foreign statutory Law and common Law),
business, technical and know-how information, non-public information, and
confidential information and rights to limit the use or disclosure thereof by
any Person, (d) all works of authorship (whether copyrightable or not),
copyrights and proprietary rights in copyrighted works including writings,
other works of authorship, and databases (or other collections of information,
data works or other materials), (e) software, including data files, source
code, object code, firmware, mask works, application programming interfaces,
computerized databases and other software-related specifications and
documentation, (f) designs and industrial designs, (g) Internet domain names,
(h) rights of publicity and other rights to use the names and likeness of
individuals, (i) moral rights, and (j) claims, causes of action and defenses
relating to the past, present and future enforcement of any of the foregoing;
in each case of (a) to (i) above, including any registrations of, applications
to register, and renewals and extensions of, any of the foregoing with or by
any Governmental Entity in any jurisdiction.

  

  

"Intervening Event" has the meaning set forth in Section 5.3(g).

  

  

"IRS" means the United States Internal Revenue Service.

  

  

"Joint Venture Subsidiaries" has the meaning set forth in Section 3.13(b).

  

  

"Knowledge" means, with respect to the Company, the (a) actual knowledge of
the individuals set forth in Section 9.1 of the Company Disclosure Letter and
(b) the knowledge a prudent individual in such a position could be expected to
discover or otherwise become aware after reasonable inquiry.

  

  

"Law" or "Laws" means any statute, law, code (including the Code) ordinance,
Regulation, rule, guidance, Order, writ, injunction or decree of any state,
commonwealth, federal, foreign, territorial or other court or Governmental
Entity, subdivision, agency, department, commission, board, bureau or
instrumentality of a Governmental Entity, including all decisions of Courts
having the effect of Law in each such jurisdiction.

  

  

"Lease" has the meaning set forth in Section 3.10(c).

  

  

"Leased Real Property" has the meaning set forth in Section 3.10(b).

  

  

"Legal Requirement" means any federal, state, local, municipal, foreign or
other Law, statute, constitution, principle of common Law, resolution,
ordinance, code (including the Code), edict, decree, Regulation, ruling or
requirement issued, enacted, adopted, promulgated, implemented or otherwise
put into effect by or under the authority of any Governmental Entity or
NASDAQ.

  

  

"License Agreement" means any legally binding Contract, whether written or
oral, and any amendments thereto (including license agreements, sub-license
agreements, research agreements, development agreements, distribution
agreements, consent to use agreements, customer or client contracts,
coexistence, non assertion or settlement agreements), pursuant to which any
interest in, or any right to use or exploit any Intellectual Property has been
granted.

  

  

 

 

 

  

 

66  

  

 

 

 

  

  

"Licensed Company IP" means the Intellectual Property owned by a Third Party
that the Company or any of the Company Subsidiaries has a right to use or
exploit by virtue of a License Agreement.

  

  

"Lien" means any mortgage, pledge, security interest, deed of trust,
encumbrance, covenant, condition, restriction, option, lien or charge of any
kind (including any agreement to give any of the foregoing), any conditional
sale or other title retention agreement, any lease in the nature thereof or
the filing of or agreement to give any financing statement under the Uniform
Commercial Code of any jurisdiction.

  

  

"Material Contract" has the meaning set forth in Section 3.11(a).

  

  

"Merger" has the meaning set forth in Section 2.1.

  

  

"Merger Consideration" has the meaning set forth in Section 2.3(a)(i).

  

  

"Merger Sub" has the meaning set forth in the Preamble.

  

  

"Minimum Condition" has the meaning set forth in Section 1.1(a).

  

  

"NASDAQ" means the Nasdaq Stock Market, Inc.

  

  

"Offer" has the meaning set forth in the Recitals.

  

  

"Offer Commencement Date" has the meaning set forth in Section 1.1(a).

  

  

"Offer Conditions" has the meaning set forth in Section 1.1(a).

  

  

"Offer Documents" has the meaning set forth in Section 1.1(d).

  

  

"Offer Price" has the meaning set forth in the Recitals.

  

  

"Offer to Purchase" has the meaning set forth in Section 1.1(d).

  

  

"Option Consideration" has the meaning set forth in Section 2.6(a).

  

  

"Order" means any judgment, order, stipulation, arbitration, decision, award,
injunction, decree or regulatory restriction of any Court or Governmental
Entity, federal, foreign, state or local.

  

  

"Outside Date" has the meaning set forth in Section 8.1(c).

  

  

"Owned Company IP" means the Intellectual Property that is owned by the
Company or any of the Company Subsidiaries.

  

  

"Owned Real Property" means all of the real property and interests in real
property identified in Section 3.10 of the Company Disclosure Letter, together
with all buildings, structures, improvements, and fixtures thereon, together
with all rights of way, easements, privileges and appurtenances pertaining or
belonging thereto, including any right, title and interest of the Company or
the Company Subsidiaries in and to any street or other property adjoining any
portion of such property.

  

  

"Parent" has the meaning set forth in the Preamble.

  

  

 

 

 

  

 

67  

  

 

 

 

  

  

"Parent Consents" has the meaning set forth in Section 4.3.

  

  

"Parent Disclosure Letter" has the meaning set forth in the first paragraph of
Article IV.

  

  

"Parent Financing Covenants" means the covenants and obligations of Parent in
Section 6.12 of this Agreement and all other covenants and obligations of
Parent or Merger Sub in this Agreement that relate to the Debt Financing,
regardless of whether such covenants and obligations refer specifically to the
Debt Financing.

  

  

"Parent Material Adverse Effect" means any material adverse effect on the
ability of Merger Sub's ability to purchase and pay for shares of Company
Common Stock validly tendered (and not withdrawn) pursuant to the Offer.

  

  

"Parent Representatives" has the meaning set forth in Section 6.3(a).

  

  

"Paying Agent" has the meaning set forth in Section 2.9.

  

  

"PBGC" means the Pension Benefit Guaranty Corporation.

  

  

"Permit" means any and all permits, licenses, authorizations, certificates,
franchises, registrations or other approvals granted by any Governmental
Entity.

  

  

"Permitted Encumbrances" means the following: (a) Liens for Taxes, assessments
and other governmental charges not delinquent, (b) easements, leases,
reservations or other rights of others in, or minor defects and irregularities
in title to, property or assets of a specified Person or any of its
Subsidiaries; provided that such easements, leases, reservations, rights,
defects or irregularities do not materially impair the use of such property or
assets for the purposes for which they are held, and (c) liens imposed by Law
for payments not yet due.

  

  

"Person" means an individual, partnership, limited liability company,
corporation, joint stock company, trust, estate, joint venture, association or
unincorporated organization, or any other form of business or professional
entity, but does not include a Governmental Entity or Court.

  

  

"Physician Contracts" has the meaning set forth in Section 3.13(c).

  

  

"Proceeding" means any demand, suit, claim, litigation, arbitration, action,
proceeding (including any civil, criminal, governmental, enforcement,
administrative, investigative or appellate proceeding), hearing, audit,
examination or investigation commenced, brought, conducted or heard by or
before, or otherwise involving, any Governmental Entity or any arbitrator or
arbitration panel.

  

  

"Proxy Statement" means the proxy of the Company to be sent to the Company's
shareholders in connection with the Company Shareholders Meeting.

  

  

"Real Property" has the meaning set forth in Section 3.10(c).

  

  

"Regulation" means any rule or regulation of any Governmental Entity having
the effect of Law.

  

  

"Regulation S-K" means 17 CFR  229.10, et seq.

  

  

"Regulation S-X" means 17 CFR  210.1-01, et seq.

  

  

 

 

 

  

 

68  

  

 

 

 

  

  

"Related Persons" has the meaning set forth in Section 8.3(f).

  

  

"Release" means any depositing, spilling, leaking, pumping, pouring, placing,
emitting, discarding, abandoning, emptying, discharging, migrating, injecting,
escaping, leaching, dumping, or disposing.

  

  

"Representatives" means a party's officers, directors, employees, accountants,
consultants, legal counsel and other representatives.

  

  

"Required Company Shareholder Vote" has the meaning set forth in Section 3.26.

  

  

"Reverse Termination Fee" has the meaning set forth in Section 8.3(f).

  

  

"Schedule 14D-9" has the meaning set forth in Section 1.2(b).

  

  

"Schedule TO" has the meaning set forth in Section 1.1(d).

  

  

"SEC" means the United States Securities and Exchange Commission.

  

  

"Securities Act" means the Securities Act of 1933, as amended, and the
Regulations promulgated thereunder.

  

  

"Shareholders Meeting" has the meaning set forth in Section 6.1(a).

  

  

"Shares" has the meaning set forth in Section 2.3(b).

  

  

"Sherman Act" means the Sherman Antitrust Act, 15 U.S.C. 1-7, as amended.

  

  

"SOX" means the Sarbanes-Oxley Act of 2002, and the Regulations promulgated
thereunder.

  

  

"Shareholders Meeting" has the meaning set forth in Section 6.1(a).

  

  

"Shares" has the meaning set forth in Section 2.3(b).

  

  

"Sponsor Financing" has the meaning set forth in Section 4.5.

  

  

"Sponsor Financing Commitment" has the meaning set forth in Section 4.5.

  

  

"Sponsors" has the meaning set forth in Section 4.5.

  

  

"Stark Law" has the meaning set forth in Section 3.13(d).

  

  

A "Subsidiary" of a specified Person means any corporation, partnership,
limited liability company, joint venture or other legal entity of which the
specified Person (either alone or through or together with any other
Subsidiary) owns, directly or indirectly, 50% or more of the stock or other
equity or partnership interests the holders of which are generally entitled to
vote for the election of the board of directors or other governing body of
such corporation or other legal entity.

  

  

 

 

 

  

 

69  

  

 

 

 

  

  

"Superior Proposal" means any bona fide written proposal made by a Third Party
(a) to acquire, directly or indirectly, 100% of the outstanding shares of
Company Common Stock or 100% of the assets, net revenues or net income of the
Company and the Company Subsidiaries, taken as a whole, and (b) which is
otherwise on terms which the Company Board determines in its reasonable
judgment (after consultation with its financial advisor and outside legal
counsel), taking into account, among other things, all legal, financial,
regulatory and other aspects of the proposal and the Person making the
proposal, that the proposal, (i) if consummated would result in a transaction
that is more favorable, from a financial point of view, to the Company's
shareholders than the Offer and the Merger and the other transactions
contemplated hereby and (ii) is reasonably capable of being completed,
including to the extent required, financing which is then committed and is
reasonably capable of being obtained without delay.

  

  

"Superior Proposal Definitive Agreement" means a binding, written, definitive
Acquisition Agreement providing for the consummation of the transaction
contemplated by such Superior Proposal.

  

  

"Support Agreements" shall have the meaning set forth in the Recitals.

  

  

"Surviving Corporation" shall have the meaning set forth in Section 2.1.

  

  

"Takeover Statute" has the meaning set forth in Section 3.20.

  

  

"Tax" or "Taxes" means (a) any and all federal, state, provincial, county,
local or foreign taxes or levies of any kind and any and all other like
assessments, customs, duties, imposts, charges or fees, including income,
gross receipts, ad valorem, value added, excise, real property, personal
property, asset, sales, use, franchise, license, payroll, transaction,
capital, capital gains, net worth, withholding, estimated, social security,
utility workers' compensation, severance, disability, wage, employment,
production, unemployment compensation, occupation, premium, windfall profits,
transfer, gains, alternative or add-on minimum, stamp, documentary, recapture,
business license, business organization, environmental, profits, lease or
other taxes or other charges imposed by or on behalf or payable to any
Governmental Entity, together with any interest, fines, penalties, assessments
or additions to tax resulting from, attributable to or incurred in connection
with any of the foregoing (whether or not disputed), (b) any liability for the
payment of any item described in clause (a) as a result of being a member of
an affiliated, consolidated, combined or unitary group for any period,
including pursuant to Treasury Regulations Section 1.1502-6 or any analogous
or similar state, local or foreign Law, (c) any liability for the payment of
any item described in clauses (a) or (b) as a result of any express or implied
obligation to indemnify any other Person as a result of any obligations under
any agreements or arrangements with any other Person with respect to such
item, or (d) any successor liability for the payment of any item described in
clauses (a), (b) or (c) of any other Person, including by reason of being a
party to any merger, consolidation, conversion or otherwise.

  

  

"Tax Returns" means any and all reports, returns, declarations, statements,
forms or other information required to be filed with or submitted to any
Governmental Entity in connection with the determination, assessment,
collection or payment of any Tax or in connection with the administration,
implementation or enforcement of or compliance with any Law relating to any
Tax.

  

  

"Third Party" means any Person or group other than Parent, Merger Sub or any
Affiliate thereof.

  

  

"Top-Up Option" has the meaning set forth in Section 1.4(a).

  

  

"Top-Up Shares" has the meaning set forth in Section 1.4(a).

  

  

"Voting Debt" shall have the meaning set forth in Section 3.3(a).

  

  

"WARN Act" has the meaning set forth in Section 3.18(c).

  

  

 

 

 

  

 

70  

  

 

 

 

  

  

Section 9.2 No-Survival. None of the representations and warranties or any
covenant to be performed prior to the Effective Time contained in this
Agreement shall survive the Effective Time.

  

  

Section 9.3 Specific Performance. Parent, Merger Sub and the Company agree
that money damages would not be a sufficient remedy for any breach of this
Agreement by the Company. It is hereby agreed that, prior to the termination
of this Agreement pursuant to Section 8.1, the Parent and Merger Sub shall be
entitled to specific performance and injunctive or other equitable relief as a
remedy for any such breach, and to enforce compliance with those covenants of
the Company. In connection with any request for specific performance or
equitable relief by the Parent and Merger Sub, the Company hereby waives any
requirement for the security or posting of any bond in connection with such
remedy. Such remedy shall not be deemed to be the exclusive remedy for breach
of this Agreement but shall be in addition to all other remedies available at
law or equity to the Parent and Merger Sub. The parties further agree that (a)
by seeking the remedies provided for in this Section 9.3, Parent shall not in
any respect waive its right to seek any other form of relief that may be
available to it under this Agreement, including monetary damages in the event
that this Agreement has been terminated or in the event that the remedies
provided for in this Section 9.3 are not available or otherwise are not
granted, and (b) nothing contained in this Section 9.3 shall require the
Parent to institute any proceeding for (or limit the Parent's right to
institute any proceeding for) specific performance under this Section 9.3
before exercising any termination right under Article VIII (and pursuing
damages after such termination) nor shall the commencement of any action
pursuant to this Section 9.3 or anything contained in this Section 9.3
restrict or limit the Parent's right to terminate this Agreement in accordance
with the terms of Article VIII or pursue any other remedies under this
Agreement that may be available then or thereafter. The Company acknowledges
and agrees that the Company shall not be entitled to specific performance or
injunctive or other equitable relief as a remedy for any breach of this
Agreement by Parent or Merger Sub, to enforce compliance with any covenants of
Parent or Merger Sub, or otherwise.

  

  

Section 9.4 Notices. All notices and other communications given or made
pursuant hereto shall be in writing and shall be deemed to have been duly
given when delivered personally (including by courier or overnight courier
with confirmation), telecopied (with confirmation), or delivered by an
overnight courier (with confirmation) to the parties at the following
addresses or sent by electronic transmission to the telecopier number
specified below:

  

  

(a) If to the Parent or Merger Sub, to:

  

  

U.S. Renal Care, Inc.

  

2400 Dallas Parkway

  

Suite 350

  

Plano, Texas 75093

  

Attention: J. Christopher Brengard, Chief Executive Officer

  

Telecopier No.: (214) 736-2701

  

  

 

 

 

  

 

71  

  

 

 

 

  

  

with a copy to:

  

  

Fulbright and Jaworski L.L.P.

  

2200 Ross Avenue

  

Suite 2800

  

Dallas, Texas 75201

  

Attention: James R. Griffin, Esq.

  

Telecopier No.: (214) 855-8200

  

  

(b) If to the Company, to:

  

  

Dialysis Corporation of America

  

1302 Concourse Drive

  

Suite 204

  

Linthicum, Maryland

  

Attention: Stephen W. Everett, President and Chief Executive Officer

  

Telecopier No.: (410) 694-0596

  

  

with a copy to:

  

  

Arent Fox LLP

  

1675 Broadway

  

New York, New York 10019

  

Attention: Michael S. Blass, Esq.

  

Telecopier No.: (212) 484-3990

  

  

or to such other address or telecopier number as any party may, from time to
time, designate in a written notice given in a like manner.

  

  

Section 9.5 Amendments and Waivers.

  

  

(a) Subject to Section 1.3(d), any provision of this Agreement may be amended
or waived prior to the Effective Time with the approval of the respective
boards of directors of the Company and Parent (whether before or after the
approval of this Agreement by the Company's shareholders) if, but only if,
such amendment or waiver is in writing and is signed, in the case of an
amendment, by each party to this Agreement or, in the case of a waiver, by
each party against whom the waiver is to be effective; provided that no such
amendment or waiver shall be made or given after the adoption of this
Agreement by the Company's shareholders that requires the approval of the
Company's shareholders under applicable Law unless the required further
approval is obtained.

  

  

(b) No failure on the part of any party to exercise any power, right,
privilege or remedy under this Agreement, and no delay on the part of any
party in exercising any power, right, privilege or remedy under this
Agreement, shall operate as a waiver of such power, right, privilege or
remedy; and no single or partial exercise of any such power, right, privilege
or remedy shall preclude any other or further exercise thereof or of any other
power, right, privilege or remedy. The rights and remedies herein provided
shall be cumulative and not exclusive of any rights or remedies provided by
applicable Law.

  

  

 

 

 

  

 

72  

  

 

 

 

  

  

Section 9.6 Severability. Any term or provision of this Agreement that is
invalid or unenforceable in any situation in any jurisdiction shall not affect
the validity or enforceability of the remaining terms and provisions hereof or
the validity or enforceability of the offending term or provision in any other
situation or in any other jurisdiction. If the final judgment of a Court of
competent jurisdiction declares that any term or provision hereof is illegal,
void, invalid or unenforceable, the parties hereto agree that the Court making
such determination shall have the power to limit the term or provision, to
delete specific words or phrases, or to replace any illegal, void, invalid or
unenforceable term or provision with a term or provision that is legal, valid
and enforceable and that comes closest to expressing the intention of the
illegal, void, invalid or unenforceable term or provision, and this Agreement
shall be enforceable as so modified. In the event such Court does not exercise
the power granted to it in the prior sentence, the parties hereto shall
replace such invalid or unenforceable term or provision with a valid and
enforceable term or provision that will achieve, to the extent possible, the
original economic, business and other purposes of such invalid or
unenforceable term as closely as possible in an acceptable manner in order
that the transactions contemplated hereby be consummated as originally
contemplated to the fullest extent possible.

  

  

Section 9.7 Entire Agreement. This Agreement and the documents and instruments
and other agreements specifically referred to herein or delivered pursuant
hereto, including the Exhibits, the Company Disclosure Letter, the Parent
Disclosure Letter, the Support Agreements, the Employment Agreements, and the
Confidentiality Agreement, constitute the entire agreement among the parties
with respect to the subject matter hereof and supersede all prior agreements
and understandings, both written and oral, among the parties with respect to
the subject matter hereof, except for the Confidentiality Agreement, which
shall continue in full force and effect, and shall survive any termination of
this Agreement or the Closing, in accordance with its terms. EACH PARTY HERETO
AGREES THAT, EXCEPT FOR THE REPRESENTATIONS AND WARRANTIES CONTAINED IN THIS
AGREEMENT, NONE OF PARENT, MERGER SUB OR THE COMPANY MAKES ANY OTHER
REPRESENTATIONS OR WARRANTIES AND EACH HEREBY DISCLAIMS ANY OTHER
REPRESENTATIONS OR WARRANTIES MADE BY ITSELF OR ANY OF ITS OFFICERS,
DIRECTORS, EMPLOYEES, AGENTS, FINANCIAL AND LEGAL ADVISORS OR OTHER
REPRESENTATIVES, WITH RESPECT TO THE EXECUTION AND DELIVERY OF THIS AGREEMENT
OR THE TRANSACTIONS CONTEMPLATED HEREBY, NOTWITHSTANDING THE DELIVERY OR
DISCLOSURE TO ANY OTHER PARTY OR ANY OTHER PARTY'S REPRESENTATIVES OF ANY
DOCUMENT OR OTHER INFORMATION WITH RESPECT TO ONE OR MORE OF THE FOREGOING.

  

  

Section 9.8 Assignment. Neither this Agreement nor any of the rights,
interests or obligations shall be assigned by any of the parties hereto
(whether by operation of Law or otherwise) without the prior written consent
of the other parties; provided, however, that Parent and Merger Sub may
transfer or assign its rights and obligations under this Agreement (including
the Top-Up Option), in whole or in part or from time to time in part, to one
or more of their Affiliates at any time, provided that such transfer or
assignment shall not relieve Parent or Merger Sub of any of its obligations
hereunder. Any assignment in violation of the foregoing shall be null and
void. Subject to the preceding two sentences, this Agreement will be binding
upon, inure to the benefit of and be enforceable by the parties and their
respective successors and assigns.

  

  

Section 9.9 No Third Party Beneficiaries. Except for (a) the rights of the
holders of shares of Company Common Stock to receive the Merger Consideration
after the Effective Time, (b) the rights of holders of Company Options,
Company Restricted Stock Units, and Company Restricted Shares pursuant to
Section 2.6, and (c) the provisions of Section 6.8 (Indemnification of
Directors and Officers) (which shall be to the benefit of the parties referred
to in such section), this Agreement is not intended to and shall not confer
upon any Person (other than the parties hereto) any rights or remedies
hereunder.

  

  

 

 

 

  

 

73  

  

 

 

 

  

  

Section 9.10 Governing Law; Exclusive Jurisdiction.

  

  

(a) THIS AGREEMENT AND THE AGREEMENTS, INSTRUMENTS AND DOCUMENTS CONTEMPLATED
HEREBY AND ALL DISPUTES BETWEEN THE PARTIES UNDER OR RELATING TO THIS
AGREEMENT OR THE FACTS AND CIRCUMSTANCES LEADING TO ITS EXECUTION, WHETHER IN
CONTRACT, TORT OR OTHERWISE SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE
WITH THE LAWS OF THE STATE OF DELAWARE (WITHOUT REFERENCE TO SUCH STATE'S
PRINCIPLES OF CONFLICTS OF LAW); PROVIDED, HOWEVER, THAT THE LAWS OF THE STATE
OF FLORIDA SHALL GOVERN ANY MATTERS PERTAINING TO THE INTERNAL CORPORATE
GOVERNANCE OF THE COMPANY, INCLUDING, THE INTERPRETATION OF THE COMPANY
BOARD'S FIDUCIARY DUTIES TO THE COMPANY'S SHAREHOLDERS IN CONNECTION WITH THIS
AGREEMENT, THE OFFER AND THE MERGER. THE DELAWARE COURT OF CHANCERY (AND IF
THE DELAWARE COURT OF CHANCERY SHALL BE UNAVAILABLE, ANY DELAWARE STATE COURT
AND THE FEDERAL COURT OF THE UNITED STATES OF AMERICA SITTING IN THE STATE OF
DELAWARE) WILL HAVE EXCLUSIVE JURISDICTION OVER ANY AND ALL DISPUTES BETWEEN
THE PARTIES HERETO, WHETHER IN LAW OR EQUITY, BASED UPON, ARISING OUT OF OR
RELATING TO THIS AGREEMENT AND THE AGREEMENTS, INSTRUMENTS AND DOCUMENTS
CONTEMPLATED HEREBY OR THE FACTS AND CIRCUMSTANCES LEADING TO ITS EXECUTION,
WHETHER IN CONTRACT, TORT OR OTHERWISE. EACH OF THE PARTIES IRREVOCABLY
CONSENTS TO AND AGREES TO SUBMIT TO THE EXCLUSIVE JURISDICTION OF SUCH COURTS,
AGREES THAT PROCESS MAY BE SERVED UPON THEM IN ANY MANNER AUTHORIZED BY THE
LAWS OF THE STATE OF DELAWARE, AND HEREBY WAIVES, AND AGREES NOT TO ASSERT IN
ANY SUCH DISPUTE, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY CLAIM
THAT (i) SUCH PARTY IS NOT PERSONALLY SUBJECT TO THE JURISDICTION OF SUCH
COURTS, (ii) SUCH PARTY AND SUCH PARTY'S PROPERTY IS IMMUNE FROM ANY LEGAL
PROCESS ISSUED BY SUCH COURTS OR (iii) ANY LITIGATION COMMENCED IN SUCH COURTS
IS BROUGHT IN AN INCONVENIENT FORUM.

  

  

(b) The Company hereto irrevocably and unconditionally confirms and agrees
that it has (i) taken all necessary action to appoint and maintain an agent in
the State of Delaware as the Company's agent for acceptance of legal process,
and (ii) notified Parent and Merger Sub of the name and address of such agent.
The Company hereto agrees that to the fullest extent permitted by Law, service
of process may be made on the Company by prepaid certified mail, and that, to
the fullest extent permitted by applicable Law, service made pursuant to this
Section 9.10(b) shall have the same legal force and effect as if served upon
the Company personally within the State of Delaware. For purposes of
implementing the Company's agreement to appoint and maintain an agent for
service of process in the State of Delaware, the Company does hereby appoint
The Corporation Trust Company as such agent.

  

  

Section 9.11 Waiver of Jury Trial. THE PARTIES HEREBY KNOWINGLY, VOLUNTARILY
AND INTENTIONALLY WAIVE ANY RIGHT WHICH ANY PARTY MAY HAVE TO TRIAL BY JURY IN
RESPECT OF ANY PROCEEDING, LITIGATION OR COUNTERCLAIM BASED ON, OR ARISING OUT
OF, UNDER OR IN CONNECTION WITH THIS AGREEMENT OR ANY COURSE OF CONDUCT,
COURSE OF DEALING, STATEMENTS (WHETHER VERBAL OR WRITTEN) OR ACTIONS OF ANY
PARTY. IF THE SUBJECT MATTER OF ANY LAWSUIT IS ONE IN WHICH THE WAIVER OF JURY
TRIAL IS PROHIBITED, NO PARTY TO THIS AGREEMENT SHALL PRESENT AS A NON-
COMPULSORY COUNTERCLAIM IN ANY SUCH LAWSUIT ANY CLAIM BASED ON, OR ARISING OUT
OF, UNDER OR IN CONNECTION WITH THIS AGREEMENT. FURTHERMORE, NO PARTY TO THIS
AGREEMENT SHALL SEEK TO CONSOLIDATE ANY SUCH ACTION IN WHICH A JURY TRIAL
CANNOT BE WAIVED.

  

  

 

 

 

  

 

74  

  

 

 

 

  

  

Section 9.12 Disclosure Letters. Disclosure of any matter in any section of
the Company Disclosure Letter or the Parent Disclosure Letter shall be deemed
to be disclosed with respect to the (a) corresponding section of this
Agreement and (b) any other Section of this Agreement to the extent that it is
reasonably apparent that such disclosure is applicable to such other Section.
The mere inclusion of an item in such Company Disclosure Letter or the Parent
Disclosure Letter as an exception to a representation or warranty shall not be
deemed an admission that such item represents a material exception or material
fact, event or circumstance or that such item has had or would have a Company
Material Adverse Effect or a Parent Material Adverse Effect, as applicable.

  

  

Section 9.13 Interpretation; Rules of Construction. When a reference is made
in this Agreement to an Article, Section, Exhibit or Schedule, such reference
is to an Article or Section of, or an Exhibit or Schedule to, this Agreement
unless otherwise indicated. The phrase "the date of this Agreement" and terms
of similar import, unless the context otherwise requires, shall be deemed to
refer to the date set forth in the first paragraph of this Agreement. The
table of contents and headings contained in this Agreement are for reference
purposes only and do not affect in any way the meaning or interpretation of
this Agreement. As used in this Agreement, (a) the words "include," "includes"
or "including" shall be deemed to be followed by the words "without
limitation," (b) the word "or" shall not be exclusive, (c) the words "hereof,"
"herein," "hereunder," "hereto" and words of similar import refer to this
Agreement as a whole (including any Exhibits and Schedules hereto) and not to
any particular provision of this Agreement, (d) all references to any period
of days shall be to the relevant number of calendar days unless otherwise
specified, (e) all references to dollars or $ shall be references to United
States dollars, and (f) all accounting terms shall have their respective
meanings under GAAP. All terms defined in this Agreement will have the defined
meanings when used in any certificate or other document made or delivered
pursuant hereto unless otherwise defined therein. The definitions contained in
this Agreement are applicable to the singular as well as the plural forms of
such terms and to the masculine as well as to the feminine and neuter genders
of such term. Any agreement, instrument or statute defined or referred to
herein or in any agreement or instrument that is referred to herein means such
agreement, instrument or statute as from time to time amended, modified or
supplemented, including (in the case of agreements or instruments) by waiver
or consent and (in the case of statutes) by succession of comparable successor
statutes (provided that, in the case of Contracts that are the subject of
representations and warranties set forth herein, copies of all amendments,
modifications, waivers, consents or supplements have been provided on or prior
to the date of this Agreement to the party to whom such representations and
warranties are being made). The parties hereto have participated jointly in
the negotiating and drafting of this Agreement and, in the event an ambiguity
or question of intent arises, this Agreement shall be construed as jointly
drafted by the parties hereto and no presumption or burden of proof shall
arise favoring or disfavoring any party by virtue of the authorship of any
provision of this Agreement.

  

  

Section 9.14 Counterparts; Effectiveness. This Agreement may be signed in any
number of counterparts, each of which shall be an original, with the same
effect as if the signatures thereto and hereto were upon the same instrument.
This Agreement shall become effective when each party hereto shall have
received a counterpart hereof signed by all of the other parties hereto. Until
and unless each party has received a counterpart hereof signed by each other
party hereto, this Agreement shall have no effect and no party shall have any
right or obligation hereunder (whether by virtue of any other oral or written
agreement or other communication). Signatures to this Agreement transmitted by
facsimile transmission, by electronic mail in PDF form, or by any other
electronic means designed to preserve the original graphic and pictorial
appearance of a document, will be deemed to have the same effect as physical
delivery of the paper document bearing the original signatures.

  

  

[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]

  

  

 

 

 

  

 

75  

  

 

 

 

  

  


 

  

  

IN WITNESS WHEREOF, each of the parties hereto has caused this Agreement to be
executed as of the date first written above by their respective officers
thereunto duly authorized.

  

  

  


 

  

  

DIALYSIS CORPORATION OF AMERICA

  

  

  

By: /s/ Stephen W. Everett

  

Name: Stephen W. Everett

  

Title: President and Chief Executive Officer

  

  


 

  

  

U.S. RENAL CARE, INC.

  

  

  

By: /s/ J. Christopher Brengard

  

Name: J. Christopher Brengard

  

Title: Chief Executive Officer

  

  

  

URCHIN MERGER SUB, INC.

  

  

  

By: /s/ J. Christopher Brengard

  

Name: J. Christopher Brengard

  

Title: President

  


 

  

 

 

 

  

 

76  

  

 

 

 

  

  


 

  

ANNEX I

  

  

Conditions to the offer

  

  

The obligation of Merger Sub to accept for payment and pay for shares of
Company Common Stock validly tendered (and not withdrawn) pursuant to the
Offer is subject to the satisfaction of the Minimum Condition and the
additional conditions set forth in clauses (a) through (n) below. Accordingly,
notwithstanding any other provision of the Offer or this Agreement to the
contrary, Merger Sub shall not be required to accept for payment or (subject
to any applicable Regulations of the SEC, including Rule 14e-1(c) under the
Exchange Act) pay for, and may delay the acceptance for payment or (subject to
any such Regulations) the payment for, any tendered shares of Company Common
Stock, and may terminate the Offer at any scheduled Expiration Date or amend
or terminate the Offer as otherwise permitted by this Agreement, if (i) the
Minimum Condition shall not be satisfied by 12:00 a.m., Eastern Time, on the
scheduled Expiration Date of the Offer, or (ii) any of the following
additional conditions shall not be satisfied:

  

  

(a) (i) Each of the representations and warranties of the Company contained in
Section 3.1, Section 3.4, Section 3.5(b), the third sentence of Section
3.7(b), Section 3.9(a), Section 3.20, Section 3.23, Section 3.24 and Section
3.27 shall be true and correct in all respects as of the date hereof and as of
the Expiration Date with the same effect as though such representations and
warranties had been made on and as of the Expiration Date (except to the
extent that any of such representations and warranties expressly speaks only
as of an earlier date, in which case such representation and warranty shall be
true and correct as of such earlier date);

  

  

(ii) the representations and warranties in Section 3.3 shall be true and
correct in all respects (except for any de minimis inaccuracy), with the same
effect as though such representations and warranties had been made on and as
of the Expiration Date (except to the extent that any of such representations
and warranties expressly speaks only as of an earlier date, in which case such
representation and warranty shall be true and correct in all respects (except
for any de minimis inaccuracy) as of such earlier date);

  

  

(iii) disregarding any qualification or limitation as to materiality or
Company Material Adverse Effect contained therein, each of the representations
and warranties of the Company contained in the first, second and fourth
sentences of Section 3.7(b) and each of the representations and warranties of
the Company contained in Section 3.13 of this Agreement shall have been true
and correct in all material respects on and as of the date hereof and shall be
true and correct in all material respects on and as of the Expiration Date
with the same effect as though such representations and warranties had been
made on and as of the Expiration Date (except for representations and
warranties that expressly speak only as of a specific date or time which need
only be true and correct in all material respects as of such date or time);
and

  

  

(iv) each of the other representations and warranties of the Company contained
in this Agreement shall have been true and correct on and as of the date
hereof and shall be true and correct on and as of the Expiration Date with the
same effect as though such representations and warranties had been made on and
as of the Expiration Date (except for representations and warranties that
expressly speak only as of a specific date or time which need only be true and
correct as of such date or time) except for such failures of representations
and warranties to be so true and correct (for this purpose disregarding any
qualification or limitation as to materiality or Company Material Adverse
Effect), do not have, and would not reasonably be expected to have,
individually or in the aggregate, a Company Material Adverse Effect.

  

  

 

 

 

  

 

1  

  

 

 

 

  

  

(b) each covenant or agreement that the Company is required to comply with or
to perform at or prior to the Acceptance Time shall have been complied with
and performed in all material respects;

  

  

(c) since the date hereof, there shall not have been any Company Material
Adverse Effect;

  

  

(d) the waiting period (or any extension thereof) applicable to the Offer or
the Merger under the HSR Act shall have expired or been terminated;

  

  

(e) Parent shall have received a certificate executed by the Company's Chief
Executive Officer and Chief Financial Officer confirming that the conditions
set forth in clauses (a), (b) and (c) of this Annex I have been duly
satisfied;

  

  

(f) no temporary restraining Order, preliminary or permanent injunction or
other Order preventing the acquisition of or payment for shares of Company
Common Stock pursuant to the Offer or preventing consummation of the Merger or
any of the other transaction contemplated by this Agreement or the Support
Agreements shall have been issued by any court of competent jurisdiction or
other Governmental Entity and remain in effect, and there shall not be any
Legal Requirement enacted or deemed applicable to the Offer or the Merger or
any of the other transactions contemplated by this Agreement that makes the
acquisition of or payment for shares of Company Common Stock pursuant to the
Offer, or the consummation of the Merger or any of the other transactions
contemplated by this Agreement or the Support Agreements, illegal;

  

  

(g) there shall not be pending or threatened any Proceeding in which any
Governmental Entity is or is threatened to become a party: (i) challenging or
seeking to restrain or prohibit the acquisition of or payment for shares of
Company Common Stock pursuant to the Offer or the consummation of the Merger
or any of the other transactions contemplated by this Agreement or the Support
Agreements, (ii) relating to the Offer, the Merger or any of the other
transactions contemplated by this Agreement or the Support Agreements and
seeking to obtain from Parent or the Company any damages or other relief that
may be material to Parent or the Company, (iii) seeking to prohibit or limit
in any material respect Parent's ability to vote, transfer, receive dividends
with respect to or otherwise exercise ownership rights with respect to the
stock of the Company, (iv) that could materially and adversely affect the
right or ability of Parent, or the Company, to own the assets or operate the
business of the Company, or (v) seeking to compel the Company, Parent or any
Subsidiary of Parent to dispose of or hold separate any shares of Company
Common Stock or any material assets as a result of the Offer, the Merger or
any of the other transactions contemplated by this Agreement;

  

  

(h) there shall not have occurred and be continuing: (i) any general
suspension of trading in securities on The Nasdaq Global Select Market, or
(ii) any declaration by a Governmental Entity of a banking moratorium in the
United States or any suspension of payments in respect of banks in the United
States;

  

  

(i) the Company Consents shall have been obtained;

  

  

 

 

 

  

 

2  

  

 

 

 

  

  

(j) no Company Triggering Event shall have occurred;

  

  

(k) the Company shall have filed all reports, schedules, forms, registrations,
statements, certifications and other documents required to be filed with the
SEC since the date of this Agreement;

  

  

(l) neither the Chief Executive Officer nor the Chief Financial Officer of the
Company shall have failed to provide any certification with respect to any
Company SEC Documents filed (or required to be filed) with the SEC on or after
the date of this Agreement;

  

  

(m) Parent shall have received the proceeds of the Financing; and

  

  

(n) this Agreement shall not have been terminated in accordance with its
terms.

  

  

The foregoing conditions are for the sole benefit of Parent and Merger Sub and
(except for the Minimum Condition) may be waived by Parent and Merger Sub, in
whole or in part at any time and from time to time, in the sole discretion of
Parent and Merger Sub. The failure by Parent or Merger Sub at any time to
exercise any of the foregoing rights shall not be deemed a waiver of any such
right and each such right shall be deemed an ongoing right which may be
asserted at any time and from time to time.

  

  

3

  

  


 

       '

